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Degradable metals hold considerable promise as materials which exhibit higher mechanical 
properties than degradable polymers while corroding over time to alleviate complications such as 
stress-shielding and infection that is inherent to permanent, bioinert metallic biomaterials. 
Specifically, degradable magnesium (Mg) alloys have emerged as a promising alternative for 
orthopedic and craniofacial applications due to their positive bone remodeling behavior, good 
biocompatibility, and relatively high strength compared to polymers while exhibiting similar 
stiffness to natural bone. Increasing the strength to maintain device integrity during degradation 
while simultaneously controlling the rapid corrosion of Mg to reduce the risk of hydrogen gas 
accumulation and toxicity are ongoing paramount goals for optimizing Mg alloys for 
musculoskeletal applications. In order to address these goals, novel Mg-Y-Ca-Zr based alloys 
were developed with alloying elements judiciously selected to impart favorable properties. 
Processing techniques including solution heat treatment combined with hot extrusion were 
employed to further enhance the desired properties of the material namely, controlled corrosion, 
high strength and ductility, and minimal toxic response. Increasing the Y content contributed to 
improved corrosion resistance yielding corrosion rates similar to commercial Mg alloys. Hot 
extrusion was employed to reduce the grain size, thereby improving mechanical properties 
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 v 
through the Hall-Petch relation. Extrusion yielded extremely high strength relative to other Mg 
alloys, values approaching that of iron-based alloys, due to the presence of Mg12YZn, a long 
period stacking order phase that served to impede dislocation propagation. Both as-cast and 
extruded Mg-Y-Ca-Zr alloys demonstrated excellent in vitro cytocompatibility eliciting high 
viability and proliferation of MC3T3 pre-osteoblast cells and human mesenchymal stem cells. 
Alloying elements Y and Zr were specifically shown to improve cell proliferation. Finally, 
implantation of Mg-Y-Ca-Zr based alloys into the mouse subcutaneous tissue and intramedullary 
cavities of fractured rat femurs resulted in a normal host response and fracture healing, without 
eliciting any local or systemic toxicity. Thus, the alloys investigated in this work demonstrated 
great potential for applications as orthopedic and craniofacial implant biomaterials, warranting 
additional pre-clinical safety and efficacy trials that will be conducted in the near future. 
vi 
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1.0  INTRODUCTION 
1.1 CURRENT BIOMATERIALS FOR ORTHOPEDIC IMPLANTS 
During the past hundred years, biomaterials and the medical devices that have been shaped from 
them have made monumental progress beyond the thousands of years of human history 
preceding the development of various biomaterials systems.  Still, history is laden with examples 
of biomaterials that have laid the foundation for the tremendous progress the field has witnessed 
to reach the rich state it is in today. Even in Europe back in 200 A.D., wrought iron dental 
implants were used giving the appearance of viable osseointegration [1]. Sutures made from 
linen were used by early Egyptians, while catgut was used in the European Middle Ages [2]. The 
first successful contact lenses were used in the late 19th century after being invented by Adolf 
Fick [3].   
With the onset of World War II, as with many other technological advances, the 
knowledge base and development of biomaterials received a boost through the use of durable, 
inert materials by surgeons to replace injured or diseased tissue in the body. These materials 
often were made for other applications such as aerospace or automobiles, but were applied by 
enterprising physicians to address medical problems. The wartime theater where surgeons were 
forced to find solutions for an untold number of patients while often times facing very limited 
resources (along with a lack of governmental regulations and protections) pushed surgeons to 
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improvise and ultimately forge a new era of biomaterials which included polymers such as 
polyurethanes, Teflon, and nylon, and metals such as titanium and stainless steel. 
From this foundation, the field of biomaterials has emerged, with the term defined as 
follows: 
“A biomaterial is a nonviable material used in a medical device, intended to interact with 
biological systems” [4]. 
When interacting with biological systems, the biomaterial must be biocompatible, that is 
it must perform with an appropriate host response in a specific application [4]. Thus, when 
designing and testing biomaterials, a specific device or application must be considered where the 
criteria of appropriate host response can be defined and tailoring of the biomaterial can take 
place in order to satisfy those requirements. The work described in this thesis aims to develop a 
set of biomaterials which satisfy requirements for orthopedic applications. 
Orthopedic implants serve the treatment of bone and joint problems which cause pain and 
distress for millions of people globally. Such ailments are also growing at a rapid pace, 
accounting for half of all chronic diseases in people over the age of 50 in the developed world, 
with the number of people affected by bone related diseases expected to double during the time 
span of 2007 to 2020 [5]. These conditions take a costly toll on the human body and therefore 
often require surgical intervention for the treatment of cases including bone fractures, joint 
deterioration, low back pain, osteoporosis, and scoliosis. An enormous $35.5 billion global 
market [6] is driven to treat these various conditions using orthopedic devices designed to 
perform desired biological functions by substituting, repairing, or providing additional stability 
for different tissues in the musculoskeletal system, i.e. bone, cartilage, ligaments, and tendons.  
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Load-bearing biomaterials, specifically to address orthopedic ailments, must meet a 
number of unique requirements that are dependent on the specific device and application. The 
ability to withstand cyclic load-bearing is a general necessity for orthopedic biomaterials, thus 
mechanical properties such as high strength, ductility, and hardness are often tested for these 
materials. Other appropriate properties of formability, biocompatibility, and corrosion resistance 
in the complex, harsh conditions in the human body must be considered as well, all which led to 
metals becoming the initial gold standard for a number of biomaterial applications. Ceramics and 
polymers are also used, which have facilitated growth in the field of biodegradable implants in 
orthopedic surgical procedures. A summary of biomaterials and their respective orthopedic 
applications is listed in Table 1.1. The field has matured to an extent that all of the materials can 
be further classified as either bio-inert or bio-active, depending on their interactions with 
surrounding tissue and the healing process, as well as biocompatible. A description into each 
class of materials is provided below. 
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Table 1.1. Summary of biomaterials for orthopedic applications. Used with permission of [5]. 
Materials Orthopedic applications 
Metals   
stainless steel (316, 316L)  fracture plates, screws, hip nails  
Co–Cr–Mo alloys  prostheses stems, load-bearing components in total joint 
replacement 
HA-coated Ti alloys  hip and knee prostheses, screws and pins for bone fixation 
Ti6Al4V  prostheses stems  
TNZT alloys (Ti–Nb–Zr–
Ta)  
under investigation  
NiTi  internal fixator for long bone shafts, spinal correctors, vertebral 
spacer anchoring of prostheses and staples 
Ni-free shape memory 
alloys  
under investigation  
Ceramics   
high alumina ceramics  orthopedic load-bearing applications  
ISO alumina standard 6474  dental implants  
PSZ  alveolar ridge augmentations, otolaryngological coatings for 
tissue ingrowth, maxillofacial reconstruction 
Calcium phosphate cements   
R cement  cleft palate, apical barrier 
H cement  periodontal pockets, filling periapical 
Biopex  alveolar bone augmentation, bony defects 
BoneSource periodontal osseous defects, repair of large periodefects 
Calcibon  periapical surgery  
Cementek   
fracture grout   
KyphOs   
mimix   
Norian SRS   
rebone   
a-BSM/biobon/embark   
Bioglasses   
45S5 BG   
45S5.4F BG  maxillofacial reconstruction  
45B15S5 BG  middle-ear reconstruction, dental implants 
52S4.6 BG  percutaneous access devices, junction of spinal vertebrae 
S45P7   
55S4.3 BG   
Glass–ceramics   
KGC ceravital   
KGS ceravital   
KGy213 ceravital  dental implants  
 maxillofacial reconstruction  
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Table 1.1 (continued)  
A/W GC  vertebral prosthesis devices  
MB GC  iliac crest prostheses  
Bioverit   
Polymers   
polymethacrylic acid 
(PMMA)  
acrylic bone cements  
 anchoring of hip prostheses  
 vertebroplasties and kyphoplasties  
polyethylene (PE)  liner of acetabular cups in hip arthroplasties, tibial insert and 
patellar components in total knee, arthroplasties 
polydimethylsulphoxide 
(PDMS)  
replacement for small joints in hand and foot  
polypropylene (PP)  bone fixation devices  
polysulphone (PS)  bone fixation devices, total joint arthroplasties  
polycarbonate (PC)  bioabsorbable fixation devices and bone regeneration  
 drug delivery  
polyglycolic acid (PGA)  bioabsorbable fixation devices and bone regeneration, drug 
delivery 
polylactic acid (PLA)  bioabsorbable fixation devices and bone regeneration, drug 
delivery 
polycaprolactone (PCL)  bioabsorbable devices for bone regeneration  




1.1.1 Inert metals 
As discussed earlier, throughout most of the 20th century, pioneering surgeons designed 
implants using materials with established success in industrial applications. Metallic biomaterials 
were first selected based on their requirement to be as inert as possible in order to minimize 
corrosion and the release of ions and wear particles upon implantation into the human body. 
Stainless steel and cobalt-chromium-based alloys were first used for orthopedic applications. The 
high Cr concentration in stainless steel provided the important benefit of a strongly adherent, 
self-healing oxide layer of Cr2O3 which imparted corrosion resistance. Additions of alloying 
elements such as Ni and Mo further improved the strength and corrosion resistance. The most 
frequently used grade of stainless steel, 316L, contains a controlled low amount of carbon to 
further resist corrosion. Stainless steel is most commonly used in trauma devices such as fracture 
places and screws and has additional advantages of low cost, high availability, and easy 
processing.  
Cobalt-chromium-based and titanium-based alloys began replacing stainless steel in 
applications such as orthopedic joint prostheses due to their better mechanical and corrosion 
properties, improving on the relatively poor wear resistance of austenitic stainless steel where 
wear debris particles were generated from the metal-on-metal friction. For these purposes, Co-Cr 
is especially appropriate because of its excellent corrosion and wear resistance and superior 
fatigue strength. To illustrate these properties, wrought CoNiCrMo alloy has been used in high 
load-bearing joints such as ankle implants. 
Titanium (Ti) and its alloys carry the advantage of being lightweight, with a density of 
4.5 g/cm3 compared to 7.9 g/cm3 for 316 stainless steel and 8.3 g/cm3 for cast Co-Cr-Mo alloys 
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[7]. Ti implants also became recognized for their osseointegration property where bone formed a 
direct structural and functional connection with the surface of titanium [8]. This phenomenon 
was especially important for dental and orthopedic applications in order to reduce the risk for 
implant loosening and ultimately failure. Again, the formation of a protective oxide layer, in this 
case TiO2, on the implant surface provides the mechanism for corrosion resistance. 
Commercially pure Ti (CP Ti) and Ti6Al4V are the most commonly materials in this class for 
fabrication of various medical implants. CP Ti finds the most use in dental implants while 
Ti6Al4V is used predominantly in orthopedic applications. Whereas Ti alloys possess high 
strength-to-weight ratio, excellent mechanical properties, and corrosion resistance, they are 
difficult to process. In addition, concerns with vanadium (V) have been raised as a cytotoxic 
element, thus leading to development of V-free alloys as an example of alloys being designed 
with specific application as biomaterials being the final goal [9]. 
Titanium when alloyed together with nickel forms NiTi alloys which have a “shape 
memory effect” where the material may recover its shape upon heating after having been 
plastically deformed. Here, the transition from a low temperature microstructure to a high 
temperature microstructure provides this effect. The unique shape memory property can be 
harnessed to allow NiTi to be well suited for applications such as dental restoration wiring, 
osteotomy staples, and fracture repair [10]. Similar to potential risks of V in Ti6Al4V, concerns 
over the toxicity of Ni have also been raised, limiting its adoption in Europe and the U.S. A list 




Table 1.2. Mechanical properties of metallic biomaterials compared to natural bone [5, 11-13]. 
Material Elements 







Natural bone  14.1-17.3 104–121 151 
stainless steel 
316L 
balance Fe  
17–20 Cr  
12–14 Ni  
2–3 Mo  
max 0.03 C  
205–210  170–750  465–950  
    
    
    
CoCrMo  balance Co  220–230  275–1585  600–1785  
F75  27–30 Cr     
 5–7 Mo     
 max 2.5 Ni     
MP35N  balance Co   414–1999 931–2068 
 33–37 Ni     
 19–21 Cr     
 9–10.5 Mo     
Ti grade 4  balance Ti  105  692  785  
 max 0.4 O     
Ti4Al6V  balance Ti  110  850–900  960–970  
 5.5–6.5 Al     
 3.5–4.5 V     
Ti6Al7Nb  balance Ti  105  921  1024  
 6Al     
 7Nb     
Ti35Nb5Ta7Zr  balance Ti  55  530  590  
(TNZT)  35 Nb     
 5Ta     
 7Zr     
NiTi  55.9–56.1 Ni  20–70 (martensite)  50–300 (martensite)  755–960  
 balance Ti  70–110 (austenite)  100–800 (austenite)   
TiNb  balance Ti  60–85  —  —  
 25–40 Nb     
Mg sheet 99.98 Mg 45 90 160 
Fe 99.8 Fe 200 150 210 
Fe-30Mn sheet balance Fe 
30 Mn 





In addition to risks involving alloying elements in metallic biomaterials, all of these 
systems discussed thus far possess elastic moduli significantly greater than natural bone. Because 
of this mismatch in modulus, when in contact with bone these metallic devices will take on the 
bulk of the load resulting in a lack of mechanical stimulus on the adjacent bone. This effect, 
called stress-shielding, may induce bone resorption, weakening and loosening of the implant, 
decreased implant stability, and eventually potential failure [14]. Despite efforts to minimize 
corrosion, metallic implants have been found to release ions and particles which have elicited 
toxic effects on surrounding tissues and organs, while also leading to implant loosening [15-18]. 
Other concerns include hypersensitivity [19], growth restriction in pediatric patients [20], 
implant migration, and imaging interferences [21]. Due to these complications as well as the 
risks of infection, an estimated 10% of patients undergo a secondary operation for the removal of 
inert metallic implants [22], exposing them to additional complications, pain, and lengthening 
the recovery process.  
1.1.2 Inert and resorbable polymers  
Initially, polymers used in orthopedic biomaterials included silicone rubber, polyethylene (PE), 
acrylic resins, polyurethanes, polypropylene (PP), and polymethylmethacrylate (PMMA). In the 
1960s, pioneering surgeon, Sir John Charnley, borrowed from dentistry in adopting PMMA for 
anchoring prostheses to surrounding bone in cemented arthroplasties [23]. PMMA remains the 
most common choice for bone cements for orthopedic surgeons, which can be molded into shape 
and cured in vivo while having necessary mechanical properties. Ultrahigh-molecular-weight 
polyethylene (UHMWPE) was also used by Charnley as a liner for of acetabular cups in total hip 
arthroplasties where the properties of low coefficient of friction and low wear rate were desirable. 
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Silicone elastomers have been employed since the 1960s as well for arthroplasties of the finger, 
wrist, and elbow with reports of good stability and low rate of complications [24-26]. A 
recurring theme for these first-generation polymer biomaterials is the encapsulation of the 
implant by a layer of fibrous tissue which may prevent direct bone-to-biomaterial interfacing and 
compromise implant stability. Other complications manifested years after implantation, leading 
to severe lytic reactions and chronic inflammatory responses from micro-fragments [27]. 
The second generation of polymeric biomaterials saw a paradigm shift to polymers which 
exhibited a gradual chemical breakdown and resorption for the basic purpose of not necessitating 
a second surgical event for removal. This class included both synthetic and natural polymers 
such as polyglycolic acid (PGA), polylactic acid (PLA), poly(ε-caprolactone) (PCL), chitosan, 
and hyaluronic acid. Degradation of resorbable polymers is mainly through hydrolysis of the 
polymer chain backbone, with additional enzymatic degradation [28, 29]. Polymeric 
biodegradable sutures made from PGA and PLA were first approved in the 1960s [30]. Since 
then, many orthopedic applications have benefited from these materials including bone 
substitution, repair of bone fractures, cartilage, meniscus, and intervertebral discs, taking the 
form of screws, plates, suture anchors, tacks, rods, and pins [31]. Because they are less stiff and 
dense than traditional metallic implants, polymeric implants offer additional advantages in that 
they reduce the stress shielding effect, while circumventing artefacts in diagnostic imaging that 
are presented by metals. 
Unfortunately, resorbable polymer devices are currently limited to certain applications. 
PLA and PGA are presently used for bone fixation, however are still inferior in mechanical 
properties to their metallic counterparts, thus are only used for less demanding indications [32]. 
Because of this lack in strength and rigidity, larger and bulkier designs must be used for polymer 
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osteosynthesis devices compared to metals. Since 1989, a number of complications have arisen 
from degradable orthopedic biomaterials including swelling, sterile sinus formation, synovial 
inflammation, bone resorption, foreign body reactions, and osteoarthritis [33-38]. Foreign body 
giant cell reactions (FBGCR) may arise due to micro-particles and hydrophobic characteristics of 
the PLA and PGA [39]. The highly-crystalline fragments and particles may take over 10 years to 
fully degrade and result in chronic inflammatory responses [40, 41] and tumorigenesis [42]. 
Other implications from the degradation process of PLA and PGA are a drop in pH and change 
in osmolarity which further cause toxic responses [43-46]. 
1.1.3 Ceramics 
 First generation ceramic biomaterials encompassed alumina, zirconia, and porous 
ceramics. Early applications of bioceramics were to replace traditional metallic femoral heads of 
hip prostheses with high-density and high-purity alumina [47]. Ceramics were later used to line 
acetabular cups due to their excellent wear rates, corrosion resistance, and biocompatibility, 
improving upon previous polyethylene cups [48]. Porous ceramics were introduced to allow for 
bone ingrowth to provide better stabilization for implants. Ceramics, mainly bioglasses (BGs), 
glass-ceramics, and calcium phosphates (CaP) have been utilized mainly as bone substitutes and 
bone void fillers since the 1970s [49]. Due to poor mechanical properties such as low tensile 
strength and fracture toughness, BGs are not appropriate for load-bearing applications [5]. The 
similarities between CaP based materials with natural bone, i.e. the mineralized component 
hydroxyapatite, Ca10(PO4)6(OH)2, along with β-tricalcuim phosphate (β-TCP), has led to wide 
adoption as a bioactive ceramic with osteoconductive properties [50]. Degradation of CaPs 
varies, with HA being relatively inert, while other CaPs such as TCP having higher solubility [51, 
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52]. However, CaP blocks are brittle thus prone to fatigue fractures, therefore restricting their use 
for complex weight bearing locations [53]. The generally slowly resorbing nature of bulk 
ceramics has also led to problems very similar to the inert metallic as well as polymeric systems, 
such as hindering the replacement by natural bone [54]. 
1.1.4 Resorbable metals 
To avoid the negative consequences presented by inert metals, ceramics, and polymers, 
resorbable metals have been gaining considerable traction in the research world and just recently 
in clinical use for orthopedic applications. For resorbable metals to be successful as orthopedic 
applications, they must fulfill the following criteria [49, 55]: 
1) The material must be biocompatible and its degradation by-products must be non-
cytotoxic. 
2) The material must be biodegradable and should degrade at the same rate as the 
healing rate of the surrounding tissue. 
3) The mechanical properties of the material and device must be appropriate to 
regenerate bone tissue while bearing load at the site of implantation. The material 
must also maintain its structural integrity during the early stages of new bone 
formation. 
In terms of satisfying these criteria, biodegradable metals use their corrosion properties as 
an advantage, flying in stark contrast to the convention of developing metals which are designed 
to be as inert as possible. This degradation must occur in a controlled manner so that while the 
implant is degrading and its strength diminishes, load is gradually transferred to the healing bone 
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tissue until it completely disappears once the tissue has fully healed. This profile of gradual 
degradation and reduction in mechanical support from a high initial point is shown in Figure 1.1. 
 
 
Figure 1.1. Schematic diagram of the ideal change in strength over time of degrading orthopedic 
implants. Used with permission of [56]. 
 
Compared to polymers, biodegradable metals also offer superior mechanical properties, 
crucial for orthopedic applications. Their degradation response however, unlike polymers, occurs 
via the electrochemical reaction upon introducing the metal to an aqueous environment wherein 
metals give away electrons and form positive ions during the anodic dissolution of the metal and 
a reduction (cathodic) reaction takes place, leading to the formation of a corrosion product: 
M  Mn+ + ne- (anodic reaction) (1) 
2H2O + 2e-  H2 + 2OH- (cathodic reaction)     (2) 
2H2O + O2 + 4e-  4OH- (cathodic reaction)      (3) 
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Mn+ + nOH-  M(OH)n (product formation) (4) 
 
Where M is a metal with valence number of n. 
Table 1.3 shows standard electrode potentials of the anodic reaction of most metals at 
room temperature, providing a comparison of their relative ease to lose electrons to form ions in 
an aqueous solution. The more negative the standard electrode potential, the more readily the 
metals lose electrons and form ions, and hence are more susceptible to corrosion. 
 
Table 1.3. Selected standard electrode potentials of metal in aqueous solution at 25 °C relative to 
the standard hydrogen electrode [57]. 
Half-reaction E°(V) 
Ni2+(aq) + 2 e–    Ni(s) -0.25 
Co2+(aq) + 2 e–    Co(s) -0.28 
Cd2+(aq) + 2 e–    Cd(s) -0.403 
Cr3+(aq) + e–    Cr2+(aq) -0.41 
Fe2+(aq) + 2 e–    Fe(s) -0.44 
Ga3+(aq) + 3 e–    Ga(s) -0.53 
Cr3+(aq) + 3 e–    Cr(s) -0.74 
Zn2+(aq) + 2 e–    Zn(s) -0.763 
Cr2+(aq) + 2 e–    Cr(s) -0.91 
Mn2+(aq) + 2 e–    Mn(s) -1.18 
V2+(aq) + 2 e–    V(s) -1.18 
Zr4+(aq) + 4 e–    Zr(s) -1.53 
Al3+(aq) + 3 e–    Al(s) -1.66 
Mg2+(aq) + 2 e–    Mg(s) -2.37 
Na+(aq) + e–    Na(s) -2.714 
Ca2+(aq) + 2 e–    Ca(s) -2.87 
Sr2+(aq) + 2 e–    Sr(s) -2.89 
Ba2+(aq) + 2 e–    Ba(s) -2.9 
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Rb+(aq) + e–    Rb(s) -2.925 
K+(aq) + e–    K(s) -2.925 
Li+(aq) + e–    Li(s) -3.045 
 
 
Among these metals, there are three predominant classes of resorbable metals which 
occupy the space: iron-based alloys, zinc-based alloys, and magnesium-based alloys.  
Iron-based biodegradable metals of the three have the highest strength, up to 1550 MPa 
for Fe-10Mn-1Pd (wt. %) [58]. In vivo studies using both pure Fe [59, 60] and Fe-10Mn-1Pd and 
Fe-21Mn-0.7C-1Pd (wt. %) [61] demonstrated that Fe-based alloys corrode very slowly inside 
the body and therefore their suitability for bulk temporary implants has been called into question. 
Whereas the in vitro degradation rate of Fe-10Mn-1Pd and Fe-21Mn-0.7C-1Pd exceeded that of 
pure Fe, the in vivo degradation rate as measured after implantation in a rat transcortical femur 
model showed no significant difference between the groups [61].  
Due to the observations of slow in vivo degradation, physical metallurgical principles and 
techniques have been attempted in accelerate corrosion. Alloying Fe with elements such as Mn, 
Pd, W, Sn, B, C, S, and Si [13, 58, 62-69] along with microstructural modification using 
electroformed iron have been pursued to accelerate corrosion [70, 71]. The more refined 
microstructure and microstructural defects of electroformed iron resulted in more areas for 
corrosion attack [71]. Mn has been widely explored as an alloying element for Fe which lowers 
the standard electrode potential of Fe and exhibits anti-ferromagnetic behavior over 29 wt. % to 
avoid limitations in imaging [72, 73]. With the low degradation rate of iron biomaterials, high 
biocompatibility has been observed with no significant inflammatory response or systemic 
toxicity [60, 74]. 
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Zn based alloys have only recently emerged as a candidate biodegradable metal during 
the 21st century, with Vojtěch et al. reporting the use of Zn-1Mg and Zn-3Mg (wt. %) as a 
material for bone fixation [75]. The addition of 1 wt. % Mg improved mechanical properties 
while greater Mg content resulted in a detrimental effect on the mechanical properties, verified 
by Wang et al. who alloyed Zn with up to 45 wt. % Mg [76]. Zn based biomaterials have also 
exhibited degradation rates slower than Mg-based systems and faster than Fe-based systems, 
with an in vivo degradation rate in rat arteries of 0.22 mm/year [77]. However, Zn materials are 
limited by their relatively low strength and plasticity compared to other metals [75] though Zn 
based bulk metallic glass (BMG) Ca32Zn38Mg12Yb18 showed significantly higher strength and 
good cytocompatibility with MG63 osteoblast cells [78]. Nonetheless, both Fe and Zn based 
degradable biomaterials are in a nascent phase with only preliminary animal studies having taken 
place, and efficacy studies with prototype devices still very much needed before clinical trials 
and ultimate human use. On the other hand, Mg based alloys have made far more progress, 
which will be discussed in the following section. 
1.2 MAGNESIUM: A PROMISING BIOMATERIAL 
1.2.1 Historical precedence of magnesium implants 
The potential benefits of magnesium as a degradable biomaterial has resulted in a rapid rise over 
recent years in research interest, as manifested by an exponential increase over the past ten years 
in publications, now dwarfing those of traditional metallic biomaterials such as stainless steel as 




Figure 1.2. Publications from 2002 to 2014 on magnesium and stainless steel biomaterials 
(retrieved from the Web of Science using “magnesium” and “stainless steel” as a search query 
within the category “biomaterials”). 
 
Despite its seemingly meteoric rise, magnesium had actually been used as a biomaterial 
in numerous instances over the past 200 years. Elemental magnesium was discovered by the 
English chemist Sir Humphry Davy in 1808 who isolated magnesium by decomposing wet 
magnesium sulphate by electrolysis using a voltaic cell and a mercury cathode. Early uses for 
magnesium were mainly limited to the pyrotechnical industry including powder and wires [79]. 
These wires were used by physician Edward C. Huse in 1878 as ligatures to stop bleeding of the 
radial artery and in an varicocele operation [80]. Dr. Huse enthusiastically noted Mg’s ability to 
be absorbed in this first recorded use of it as a biomaterial, also promoting that it could be used 
“everywhere under all conceivable circumstances and contingencies”, “will never break”, “can 
never provoke irritation”, and finally “will always act, tuto cito et jucunde”, Latin for safely, 
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quickly, and pleasantly [80]. From this initial glowing endorsement, Austrian physician Erwin 
Payr went on to pioneer the field of biodegradable magnesium implants. While Payr found 
available Mg wire too brittle to be relied upon as a suture material [81], he discovered a variety 
of other medical applications for the degradable metal. From 1892-1905, Payr discussed the use 
of pure Mg in devices including tubular connectors for blood vessel, intestine, and nerve 
anastomosis, plates, arrows, sheets, and rods [81-87].  
In 1932, Dr. Lambotte reported the implantation of a Mg plate fixed with six steel screws 
to stabilize a 17 year old adolescent’s fractured tibia [88]. Substantial gas cavities, local swelling, 
and pain unfortunately resulted, due to a mismatch in the electrode potentials of Mg and steel 
leading to galvanic corrosion and the accelerated attack of the anode Mg in the galvanic couple. 
After realizing his mistake, Lambotte conducted trials with only Mg device in rabbits and dogs 
where he observed full resorption of Mg within seven to ten months without signs of any 
postoperative pain or distress [88]. These encouraging results led Lambotte and his colleague, 
Jean Verbrugge, to treat four children with supracondylar humerus fractures using Mg nails [89-
91]. All healed naturally without suppuration or granulation tissue formation, with the only 
complication manifesting in the formation of gas pockets, which disappeared after a few weeks 
and did not cause a major concern. Verbrugge also implanted Mg plate and screws for a 
transdiaphyseal humerus fracture of an 8 year old child, for which the plate had nearly 
completely degraded with formation of gas pockets by three weeks’ time although the bone 
fracture had undergone healing.  
 None of the patients Verbrugge implanted with Mg osteosynthesis devices showed signs 
of infection or adverse reactions to the degrading Mg, which did not appear to cause any 
difference in the periosteal reaction compared to traditional inert implants [90, 91]. Following 
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the footsteps of Dr. Verbrugge, Dr. Earl McBride procured magnesium alloys from his 
contemporary in Antwerp and investigated Mg screws, nails, pegs, plates, circular bands, and 
medullary pegs for fracture fixation [92, 93]. McBride found that magnesium adequately 
maintained fixation of bone fragments for union to occur while having a shorter, more favorable 
absorption time than other contemporary degradable materials such as beef bone or cow horn. He 
also importantly observed the stimulation of periosteal proliferation and encouraged its use in 
limited orthopedic applications. In 1948, Troitskii and Tsitrin documented success in using Mg-
Cd plates and screws for osteosynthesis [94]. Again, full degradation and stimulation of callus 
bone formation were observed, resulting in reported faster recovery for patients.  
 Despite this non-trivial body of work of implantable Mg devices, especially in orthopedic 
applications, Mg has only recently been approved by regulatory bodies for clinical use. The 
MAGNEZIX® compression screw for small bone fractures obtained CE marking of Medical 
Devices for medical applications within Europe in 2013 after a randomized, controlled clinical 
study was conducted using the Mg alloy screw in hallux valgus surgery [95]. More recently, in 
2015, U&I Corporation received the South Korean Ministry of Food And Drug Safety approval 
for the K-MET, another positive approval showing applicability of Mg for osteosynthesis. This 
recent momentum for the adoption of Mg implants shows the impetus to optimize Mg alloys to 
fulfill the potential that so many throughout history believed in. Thorough testing of Mg alloy 
properties must take place to achieve optimal characteristics to meet the needs of orthopedic 
biomaterials and remedy the problems other orthopedic biomaterials currently face. 
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1.2.2 Materials properties of magnesium 
Critical to orthopedic implants is their mechanical and other material properties which dictate 
their success in sustaining the stresses of load-bearing applications. Mg has a number of 
advantageous properties many of which are comparable to natural bone [96]. It is very 
lightweight, with a density of 1.74 g/cm3, similar to that of cortical bone (1.8 – 2.1 g/cm3), and 
much less than stainless steel, titanium alloys, and Co-Cr alloys. The elastic modulus of 
magnesium alloys of 41-45 GPa [96] is much closer to natural bone compared to other 
commonly used metallic implants as seen in Table 1.2, thus reducing the risk of stress shielding. 
The high specific toughness, rigidity, good machinability, and ability of Mg to be cast also make 
it an attractive material for medical applications.  
However, compared to other permanent metals, absolute strength and plastic 
deformability is limited due to Mg’s hexagonal close-packed structure (HCP), which shows a 
principle slip plane on the (0001) basal plane along the < 112�0 > direction [97]. With only two 
independent slip systems, the Taylor criterion which states that five independent slip systems 
must be available for homogenous plastic flow to occur [98] is not met. Furthermore, the critical 
resolved shear stress (CRSS) for the basal slip system of Mg is much lower than for non-basal 
slip systems of other metals [99]. In order to activate the additional slip systems (pyramidal and 
prismatic), the temperature must be increased to increase ductility (as shown in Figure 1.4b) and 
to conduct forming techniques. Another consequence of the low number of slip systems is 
preferential orientation of the crystals during forming, generating a textured material [100]. 
Thus, during extrusion for example, the basal planes are mainly oriented in the same direction as 
extrusion, resulting in anisotropic properties. 
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To overcome these issues and to effectively improve mechanical properties, grain 
refinement methods are applied. An increase in ductility occurs upon reduction in grain size at a 
transition grain size with a “low-to-high-ductility” transition as temperature increases at different 
grain sizes [101]. 
This phenomenon occurs due to cross slip from basal to non-basal planes having the 
ability to occur, with dislocations on basal and non-basal planes present within fine grains as 
opposed to at the grain boundaries as well as grain boundary sliding [102, 103]. With micron size 
grains, compatibility stresses are restricted near grain boundaries and have much higher 
influence on fine-grained materials. 
Grain refinement also has a profound effect on material strength through the Hall-Petch 
relation where grain boundaries act as pinning points to impede the propagation of dislocations 
[104, 105]. This effect of grain boundary strengthening limits dislocation accumulation, where 
dislocations generate repulsive stress fields to allow dislocation sources in adjacent grains to be 
activated and continue deformation. By diminishing dislocation accumulation, higher force must 
be applied to activate dislocations thereby elevating the metal’s strength. The Hall-Petch relation 
is expressed by the following equation: 
𝜎𝜎Y = 𝜎𝜎0 + 𝑘𝑘Y ∙ 𝑑𝑑
−12 
Where 𝜎𝜎Y is the yield stress, 𝜎𝜎0 is the friction stress when dislocations move on the slip plane, d 
is the average grain size, and 𝑘𝑘Y is the stress concentration factor. 
Microstructure modification by work hardening, where the density of grain boundaries is 
increased by forming techniques, such as extrusion and rolling is also used to increase the 
strength. Dislocations interact through their repulsive and attractive stress fields leading to 
entanglement, again impeding dislocation propagation as seen in grain boundary strengthening. 
 22 
Introducing alloying elements can also improve strength via solid solution strengthening, 
whereby dislocation movement is impeded by lattice distortions caused by solute elements where 
the stress fields around the solutes interfere with those of the dislocations. When alloying 
elements are above their solubility limit in Mg, secondary phase precipitates are formed, which 
may lead to precipitation hardening whereby these particles create stress fields which again 
interact with dislocations, increasing yield strength. A related method to improve strength is age 
hardening, a heat treatment used to increase yield strength. First, the alloy is heated to dissolve 
solute atoms after which rapid cooling across the solvus line of the solute element is performed 
to generate a supersaturated solid solution that remains stable due to the quenching, preventing 
diffusion. Aging is then conducted where the supersaturated solid is heated below the solvus 
temperature to produce finely dispersed precipitates which restrict dislocation movement during 
deformation leading to strength enhancement. 
1.2.3 Corrosion mechanism of magnesium 
Magnesium and its alloys are known to have a low corrosion resistance in aqueous environments 
relative to other metals as described in section 1.1.4. This property, while severely detrimental to 
structural applications, is central to its use as a biodegradable implant material. The corrosion 
behavior of Mg in water at room temperature is plotted in the Pourbaix diagram shown in Figure 




Figure 1.3. Pourbaix diagram of Mg in water at 25 °C showing corrosion, passivation, and 
immunity. The region of water stability lies between the dashed lines [106]. 
 
Mg corrodes in aqueous solutions according to the following overall reaction leading to 
the formation of hydrogen gas and magnesium hydroxide: 
Mg (s) + 2H2O (aq) ↔ H2 (gas) + Mg(OH)2 (s) 
This overall reaction includes the following partial reactions: 
Mg (s) ↔ Mg2+ (aq) + 2e- (anodic reaction) 
2H2O (aq) + 2e- ↔ H2 (gas) + 2OH- (aq) (cathodic reaction) 
Mg2+ (aq) + 2OH- (aq) ↔ Mg(OH)2 (s) (product formation) 
The magnesium hydroxide forms a quasi-passive layer accumulating on the surface of the 
degrading magnesium, providing some protection. Chloride ions in solution at concentrations 
above 30 mmol/l may result in the breakdown of the magnesium hydroxide layer, converting it to 
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soluble magnesium chloride salt [107]. Inside the human body, fluids contain chloride 
concentration of about 150 mmol/l which may cause severe pitting corrosion on Mg alloys and 
the release of hydrogen gas that may accumulate into harmful pockets. Undissolved Mg(OH)2 on 
the surface of degrading Mg may also provide favorable sites for hydroxyapatite (HA) nucleation 
by consuming calcium and phosphate ions from the surrounding fluid [108]. This overall 
corrosion behavior of polycrystalline Mg alloys in biological solutions is illustrated in Figure 
1.4. 
 
Figure 1.4. Schematic depiction of the corroding surface of polycrystalline Mg alloys: (a) 
galvanic corrosion between Mg and grain boundaries; (b) partially protective film of Mg(OH)2 
covering the surface; (c) attack by chloride ions to transform Mg(OH)2 into Mg(Cl)2; (d) 
hydroxyapatite formation by consuming local Ca2+ and PO43−; (e) particles removed from the 
bulk Mg entering the surrounding solution. Adapted from source, used with permission of [109]. 
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Magnesium corrosion may take place by galvanic corrosion observed when severe 
corrosion occurs in the Mg matrix close to cathodic areas. Whereas external galvanic corrosion 
could occur if Mg were in contact with a nobler metal, as was the case in Lambotte’s Mg plate 
coupled with steel screws, this issue is easily mitigated by eliminating contact with other metals 
and the risk of internal galvanic corrosion is far more prevalent. Internal galvanic corrosion 
occurs with the presence of cathodic secondary phases or impurities in the Mg matrix. Most 
alloying elements are therefore selected with a lower potential difference with regards to their 
secondary phases and Mg, resulting in less severe corrosion. Characteristic impurities, such as 
Fe, Cu, Ni, and Be, have low solubility in Mg and low hydrogen overvoltage resulting in 
significant micro-galvanic corrosion. To limit the amount of impurities, careful selection of high 
purity alloying elements and master alloys along with controlled processing methods is hence 
very much required. Beyond 35-50 ppm for Fe, 100-300 ppm for Cu, 20-50 ppm for Ni, and 4 
ppm for Be, substantial galvanic corrosion will occur which will threaten the mechanical 
integrity of a Mg implant device [110]. 
As discussed in the previous section, processing techniques and alloying elements play 
critical roles in affecting a Mg alloy’s grain size and grain size distribution. Grain boundary 
distribution not only affects mechanical properties but also may serve as a site for corrosive 
attack due to their high internal energy and segregation of alloying elements to represent 
cathodic regions to the anodic Mg matrix in the interior of the grains. Although logic would 
dictate that coarse grains would be preferable to reduce areas where corrosion may set in, 
contradictory reports of minimized segregations in small grained Mg alloys leading to a more 
uniform corrosion behavior with smaller pits [111] have been discussed. Other explanations of 
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fine-grained alloys possessing greater corrosion resistance include grain boundaries acting as 
corrosion barriers with their reduced propensity for corrosion due to similar work potentials as 
the matrix phase [112, 113]. The method of imparting grain refinement has influence as well, 
with dislocations reported to locally decrease the equilibrium potential and increasing dissolution 
[114] while extrusion compared to equal channel angular pressing (ECAP) resulting in superior 
corrosion resistance due to larger grain area and interphase boundaries [115]. 
Application of these specific corrosion behaviors must also be considered for orthopedic 
implants where the Mg device is placed under conditions of excessive stress. During these 
scenarios, stress corrosion cracking (SCC) can occur even at stresses below yield strength, 
leading to premature brittle cracks initiated at locations with sharp contours such as corrosion 
pits and pre-existing macro/microscopic flaws. With propagation of these cracks the risk of 
sudden implant failure becomes a major concern for orthopedic implants, especially for devices 
such as screws, plates, and pointed pins which possess sharp contours. Mg alloys have been 
reported to be susceptible to SCC in chloride solutions [116], and even in “inert” metals such as 
stainless steels and titanium [117, 118]. SCC fracture propagation may either occur at the anodic 
matrix close to the grain boundary through electrochemical corrosion (intergranular failure) or by 
preferential attack near cathodic precipitates and stress concentrations or at areas of Mg(OH)2 
protective film rupture due to stress (transgranular failure) [119]. Hydrogen embrittlement (HE) 
may also cause SCC, where hydrogen diffusion to tip of cracks and magnesium hydride 
formation may lead to brittle facture or decohesion [120]. 
Magnesium alloys must overcome the risk of rapid corrosion which may lead to implant 
instability and premature failure within 3-4 months, when it must remain mechanically stable as 
an orthopedic biomaterial to allow for fracture healing, callus formation, new bone formation, 
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and finally functional bone tissue healing to sufficiently restore strength at the injury site [121]. 
Thus addressing the rapid corrosion of Mg is vital due to its direct impact on the mechanical 
properties and biocompatibility.  
1.2.4 Toxicity and biocompatibility of magnesium alloys 
Magnesium is the fourth most abundant cation in the human body, with about 21-28 g stored in 
the body and approximately half of it stored in bone tissue [122]. The normal blood serum level 
and extracellular fluid level of Mg is around 0.7-1.06 mmol/L [110], and people normally 
consume about 300 mg of Mg per day. Mg is also essential to human metabolism, is a cofactor 
for many enzymes, and stabilizes the structures of DNA and RNA.   The Mg(OH)2 corrosion 
product is also non-toxic and along with excess Mg, are harmlessly excreted through urine [122], 
to such an extent that the most common cause of hypermagnesemia being renal failure [123].  
Hydrogen gas released from the degrading Mg diffuses over time through the skin or can be 
removed by aspiration but nonetheless do not appear to cause any harm in earlier clinical studies 
[88, 89].  
Especially advantageous for orthopedic applications, Mg has been shown to have a 
positive influence on bone growth [124-126], with in vivo studies showing higher bone mass 
found around Mg bone implants compared to controls of polymeric (Figure 1.5) or titanium 




Figure 1.5. Flouroscopic images of cross-sections of a degradable polymer (a) and a magnesium 
rod (b) performed 10 mm below the trochanter major in a guinea pig femur. Both specimens 
were harvested 18 weeks postoperatively. In vivo staining of newly formed bone by calcein 
green. Scale bar=1.5mm; I=implant residual; P=periosteal bone formation; E=endosteal bone 
formation. Used with permission of [125]. 
 
The rich historical precedence of Mg in orthopedic implants discussed earlier along with 
the advantages in terms of the physical, chemical and biological properties make Mg alloys 
suitable for load bearing orthopedic and craniofacial applications. This work seeks to optimize a 
system of alloys featuring elements such as Y, Ca, Zn, and Zr primarily for orthopedic 
applications while also evaluating their effect on bone healing as well as in vitro and in vivo cell 
and tissue response. Accordingly, four specific aims have been crafted as discussed henceforth. 
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1.3 SPECIFIC AIMS 
Biodegradable materials for orthopedic and craniofacial applications have been primarily 
developed to avoid complications associated with the use of inert metals. However, the onset or 
mere risk of complications often necessitates the removal of metallic implants following healing. 
Biodegradable magnesium (Mg) has demonstrated promise due to its similar mechanical 
properties to natural bone. Magnesium degrades to form a soluble corrosion product harmlessly 
excreted through urine as discussed above, though rapid corrosion of Mg alloys that may reduce 
implant stability and result in potentially toxic hydrogen gas formation which may accumulate 
around the implant. The goal of this proposed work is thus to develop alloys which address the 
rapid corrosion of Mg by synthesizing novel polycrystalline Mg alloys containing yttrium (Y), 
zirconium (Zr), and other alloying elements selected due to their known biocompatibility as well 
as their ability to induce corrosion resistance to the Mg alloys and improve the mechanical 
properties, particularly mechanical strengths, and utilizing appropriate post-processing 
techniques (i.e. heat treatment and extrusion). These techniques are primarily employed to 
improve the corrosion resistance and mechanical properties compared to pure Mg to arrive at the 
optimized alloy systems for orthopedic and craniofacial implant applications. 
The specific hypothesis to be tested by the specific aims below is that Mg-Y-Ca-Zr based 
alloys with controlled amounts of Y, addition of Zn to introduce a long-period stacking order 
secondary phase, and significant grain refinement using extrusion will: 
1) Improve the mechanical properties of the alloys, 
2) Increase corrosion resistance, 
3) Maintain cell function without eliciting toxicity, and 
4) Demonstrate in vivo biocompatibility and allow for bone fracture healing. 
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Alloying elements were accordingly added as indicated because magnesium corrosion 
and mechanical properties are strongly affected by the presence of these elements even when 
present in the metal as a solid solution [128]. Further, Y and Ca contribute to grain boundary 
strengthening of magnesium alloys [129] and improve the corrosion resistance [109, 130, 131]. 
Zr also serves as an effective grain refining agent [132], imparting grain boundary strengthening 
[110] and corrosion resistance [133]. Post-processing techniques were used to modify the 
microstructure as this is well known to improve the mechanical response and corrosion behavior. 
In vitro corrosion and mechanical properties and the effect of the alloys and their degradation 
products on pre-osteoblast cells and human mesenchymal stem cells were used to evaluate the 
effect of alloying elements and post-processing. The most viable alloy candidate for orthopedic 
and craniofacial applications was then selected based on high strength, corrosion resistance, and 
low cytotoxicity, combined with promotion of osteoblast differentiation. This alloy was further 
investigated for in vivo biocompatibility and effect on bone healing by implantation into the 
intramedullary cavity of a rat femur after a full osteotomy. 
A summary of the specific aims of this thesis to achieve the work described above are 
given below: 
1.3.1 Specific Aim 1: Synthesize novel Mg-Y-Ca-Zr based alloys and perform materials 
characterization to assess the changes in microstructure after addition of alloying elements 
and post-processing treatments 
In this specific aim, novel Mg-Y-Ca-Zr-based alloys were synthesized using melting and casting 
followed by heat treatment and extrusion. Rationale for the addition of the various alloying 
elements is described, as well the effects of the addition of these elements on modifying the 
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microstructure by virtue of materials characterization, including microstructure analysis and 
phase characterization are analyzed and discussed.  
1.3.2 Specific Aim 2: Characterize the effect of yttrium and zinc addition and post 
processing on the corrosion behavior and mechanical properties of Mg-Y-Ca-Zr alloys 
Grain refinement and the presence of secondary phases and elements diffused into the Mg alloys 
are known to significantly affect the corrosion behavior and mechanical properties of the alloy. 
Having analyzed the microstructure and phases present in the alloys in Specific Aim 1, the goal 
is to evaluate the corrosion behavior of the alloys using potentiodynamic polarization 
measurements and mass loss in a simulated physiological solution. A second goal is to perform 
mechanical testing in tension and compression. The results of these tests were then used to 
understand microstructural/composition-functional relationship of the Mg-Y-Ca-Zr system of 
alloys. 
1.3.3 Specific Aim 3: Evaluate the effect of Yttrium and Zinc addition, post processing, 
and alloying element salts, on cell viability and proliferation of pre-osteoblast and human 
mesenchymal stem cells. Further evaluate expression of osteoblast differentiation markers 
and biocompatibility in murine subcutaneous tissue 
This portion of the study included the evaluation of the effect of the degrading magnesium alloys 
on pre-osteoblast and human mesenchymal stem cell viability, proliferation, and differentiation. 
This study is conducted by exposing cells to media containing degradation products, adding 
alloying element salts to cell culture media, seeding cells directly on the surface of the alloys. 
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The effect of Mg alloys on osteogenic differentiation has also been investigated by measuring 
alkaline phosphatase activity, and gene expression of osteogenic markers of cells seeded on the 
alloys. Finally, a preliminary in vivo study was conducted by implanting the alloys into mouse 
subcutaneous tissue and analyzing the local host response. Corrosion behavior was also 
evaluated by mass loss in vivo. 
1.3.4 Specific Aim 4: Assess the in vivo corrosion, bone formation, and host response of 
Mg-Y-Zn-Ca-Zr alloy in a rat femur osteotomy model 
With the ultimate goal of fabricating orthopedic medical devices from the alloys described in this 
thesis, observing the biological responses following implantation of the material in a bone 
healing animal model is a required step to determine the safety of the Mg alloy. Following the 
preliminary study of as-cast Mg-Y-Ca-Zr alloys that were implanted into the subcutaneous tissue 
of nude mice, this aim focuses on assessing the behavior of the degradation behavior of the Mg-
Y-Zn-Ca-Zr alloy in a bone model in vivo. Two devices were accordingly manufactured and 
implanted into Sprague-Dawley rats as described below: 
1) Sharpened pins were implanted into the medullary cavity of rat femurs accessed by a full 
osteotomy 
2) Wires were wrapped around the midsection of rat femurs 
Degradation behavior was determined quantitatively using micro-CT analysis of the 
implants and degradation product volume before and after implantation. The host response of the 
degrading alloy and its corrosion products on bone formation around the implant was then 
investigated following histological analysis of the implant region. Finally, local and systemic 
toxicity was also evaluated using histology and elemental analysis of the kidney and liver, 
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combined with a detailed blood profile to assess the pathological response after 2, 8, and 14 
weeks of implantation. 
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2.0  SPECIFIC AIM 1: SYNTHESIZE NOVEL MG-Y-CA-ZR BASED ALLOYS AND 
PERFORM MATERIALS CHARACTERIZATION TO ASSESS THE CHANGES IN 
MICROSTRUCTURE AFTER ADDITION OF ALLOYING ELEMENTS AND POST-
PROCESSING TREATMENTS 
2.1 INTRODUCTION 
Accelerated corrosion of Mg alloys as indicated in section 1.2 has limited its adoption as a 
biomaterial due to the accumulation of hydrogen gas pockets around the implant as well as 
insufficient mechanical performance and implant stability throughout the degradation and tissue 
healing process [134, 135]. In order to improve corrosion resistance and increase mechanical 
properties of pure Mg, the addition of suitable alloying elements Y, Ca, Zr, and Zn were 
introduced as outlined as a rationale for this aim. 
In alloying Mg, there are only limited choices biocompatible alloying elements that can 
be selected among Al, Mn, Zn, Ca, Li, Zr, Y, and rare earth (RE) elements that are used to 
generate Mg implant materials, generally influencing the mechanical and material properties of 
Mg alloys [110]. Mg-Y-Ca-Zr alloys have been successfully fabricated as ignition-proof alloys 
due to their ability to improve oxidation resistance [136, 137]. The introduction of Y can be 
justified by its ability to contribute to grain boundary strengthening of the magnesium alloys 
[129] and also improving the corrosion resistance at wt. % higher than 3% when alloyed with 
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Mg [130, 138]. Ca, as well as Y help to form a stable and chemically less reactive hydroxide 
layer to impart greater corrosion resistance as shown by density functional theory calculations 
[139]. Ca is also a major component of mineralized natural bone [140] and is the most abundant 
mineral in the human body that is known to improve the corrosion resistance and mechanical 
properties of Mg alloys when added up to 1 wt. % [109, 131]. Zr on the other hand, serves as an 
effective grain refining agent [132, 141-143] by imparting grain boundary strengthening [110] 
and corrosion resistance [133]. Zr also is a powerful iron removal agent, typically helping to 
reduce the content of iron to under 20 ppm in Zr-containing magnesium alloys, thus decreasing 
the risk for corrosion from iron impurities [100]. Further, adding Ca to Zr-containing alloys 
promotes solute undercooling, in turn, facilitating more suitable sizes for Zr nuclei to become 
effective nucleation sites to further reduce grain size [132, 136, 141-143]. Zn is also one of the 
most abundant essential elements in the human body, and can improve the corrosion resistance 
and mechanical properties of Mg alloys as well as the castability in larger amounts (greater than 
2 wt. %). The combination of Y and Zn in Mg alloys also has been shown to result in the 
formation of a specific structure, long period stacking order (LPSO) structure, which consists of 
periodic stacks of close-packed planes along the atomic c-axis, resulting in high strength and 
ductility. 
The original Mg-Y-Ca-Zr alloy system used in the preliminary studies was modified and 
enhanced to create the second group of alloys discussed in this thesis. First, the Zr content was 
increased from 0.4 wt. % to 1 wt. % due to indications from ICP-OES measurements that the 
amount of Zr going into the solution was much lower than expected in the Mg-alloy cast ingots. 
This reduction in the amount of Zr is commonly observed due to settling of Zr particles into a Zr 
rich layer at the bottom of the crucible, with only Zr remaining in the molten Mg solution having 
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an effect in the grain refining process [79]. Hence Zr is added above the final desired weight 
percentage to compensate for losses during melting, contamination, pickup of iron, precipitation, 
etc. to maintain adequate levels without further processing [79]. In order to further determine the 
effects of Y addition on the Mg alloy, an alloy without Y (Mg-1Zr-0.6Ca) was also synthesized 
to compare to the alloys containing Y.  
Alloys containing Y and Zr have achieved clinical success having been used in drug 
eluting stents in patients with de-novo coronary lesions [144] and screws in hallux valgus 
surgery (which received CE marking of Medical Devices for medical applications within Europe) 
[95]. Both devices demonstrated good safety profiles and performance as alternative to 
resorbable polymeric and metallic materials. 
In addition to selection of alloying elements, processing methods also highly influence 
the microstructure and hence properties of the alloys. In this study, T4 solution treatment at 525 
°C for 8 hours was attempted to reduce the volume fraction of secondary phases by providing the 
driving force for favoring diffusion into the α-Mg matrix. Hot extrusion was also conducted as a 
means to impart grain refinement, which is in actuality a more effective approach for producing 
homogenous and fine grains than other methods for producing wrought Mg such as rolling and 
forging [145]. 
The nominal compositions of the various alloys and processing methods used for 
generating the alloys considered in this specific aim are listed in Table 2.1. The alloy 
abbreviations used to designate the alloys discussed in this thesis shown in Table 2.1 were 
determined using ASTM B 275 standard on codification, where no more than two letters 
representing alloying elements of the two greatest amounts are to be listed [146]. W represents 
yttrium, X represents calcium, K represents Zr, and Z represents Zn. The codification WX11 and 
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WX41 alloys in the as-cast and T4 heat treated form was changed to WK11 and WK41 after 
addition of 1.0 wt. % Zr made it the second greatest alloying element present, thus replacing the 
X for calcium with a K for zirconium. 
 
Table 2.1. Nominal composition of Mg alloys (wt.%) investigated in this work. 
Alloy   Chemical compositions (wt.%) 
Y Ca Zr Zn Mg Condition tested 
WX11 1.0 0.6 0.4 0.0 Balance As-cast and T4 
WX41 4.0 0.6 0.4 0.0 Balance As-cast and T4 
KX11 0.0 0.6 1.0 0.0 Balance Extruded 
WK11 1.0 0.6 1.0 0.0 Balance Extruded 
WK41 4.0 0.6 1.0 0.0 Balance Extruded 
WZ42 4.0 0.6 1.0 2.0 Balance Extruded 
       
2.2 MATERIALS AND METHODS 
2.2.1 Metallurgical processing of Mg-Y-Ca-Zr based alloys 
Elemental ingots of Mg (US Magnesium Inc., Salt Lake City, UT, 99.97%), Ca (Alfa-Aesar, 
Ward Hill, MA, 99.5%), and Zn (Alfa-Aesar, 99.99%) were weighed according to the nominal 
composition and melted in a mild steel crucible using an electrical resistance furnace (Wenesco 
Inc., Chicago, IL) with the addition of a Mg-30Y wt. % master alloy melted from pure Mg and Y 
(Alfa-Aesar, 99.9%) prepared inside a graphite crucible melted using an induction furnace (MTI 
Corporation, Richmond, CA) purged with ultrahigh-purity (UHP) Ar and vacuumed to avoid 
oxidation of the pure elements. The master alloys and pure elements were cleaned thoroughly to 
remove residue and oxide scale and melted in a mild steel crucible using the Wenesco electrical 
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resistance furnace under the protection of Ar + 0.5% SF6 cover gas. The melting and pouring 
temperature was 750 °C, and once the temperature was reached, equivalent amount of zirconium 
was added using Zirmax (Mg-33.3% Zr) master alloy (Magnesium Elektron Ltd., Manchester, 
UK). After the Mg-Zr master alloy was added, the melt was stirred for 10 s at an interval of 1 
min and 5 min to dissolve and disperse the zirconium particles uniformly into the melt. The melt 
was held for an additional 30 min and poured into a cylindrical mild steel mold preheated to 500 
°C with dimensions of 44.5 mm diameter × 82.5 mm length. The holding and stirring times to 
release Zr particles from the Zirmax master alloy was essential to achieve higher solubility of Zr 
in the melt and optimal grain refinement [147]. To compare as-cast samples to solution treated 
samples, a heat treatment of (T4) at 525 °C for 6 h was performed on the alloy ingots inside a 
tubular furnace covered under continuous UHP Ar flow and quenched in room temperature 
water.  
Extruded alloys were prepared from as-cast alloys by first applying solution treatment at 
400 °C for 20 hours and quenching in room temperature water to increase the alloys’ ductility 
and homogenize the secondary phases while not causing grain growth, as shown in Appendix B. 
After reducing the ingot diameter to 37.8 mm using a lathe, the alloys were hot extruded with an 
extrusion ratio of 10 and 30 at the following temperatures: 
 
Table 2.2. Temperatures used to preheat ingots for 30 minutes and during extrusion of 
solution treated alloys. ER = extrusion ratio. 
Alloy Extrusion temperature 
ER 10 ER 30 
KX11 350 °C  
WK11 350 °C  
WK41 400 °C  




The alloys were compared to as-cast Mg (US Magnesium Inc.), as-drawn 99.9% pure Mg 
(Goodfellow Corp., Coraopolis, PA), and as-drawn AZ31 (Goodfellow Corp.) in reported tests. 
Inductively coupled plasma optical emission spectroscopy (ICP-OES, iCAP duo 6500 Thermo 
Fisher, Waltham, MA), was used to experimentally confirm the alloy compositions and presence 
of impurities by dissolving alloy samples in 15% nitric acid, diluting in water 5x, and measuring 
concentration of the alloying elements and impurity elements of the solution containing the 
dissolved alloys. 
2.2.2 Phase characterization of Mg-Y-Ca-Zr based alloys 
In order to determine the phase formation, X-ray diffraction (XRD) was conducted using Philips 
X’Pert PRO diffractometer employing CuKα (λ=1.54056 Å) radiation with a Si-detector 
(X’celerator). The X-ray generator operated at 45 kV and 40 mA at a 2θ range of 10-80°. Peak 
identification was determined using the X’Pert High Score Plus software. 
2.2.3 Microstructure analysis of Mg-Y-Ca-Zr based alloys 
Samples of the Mg alloys were mounted in epoxy, mechanically polished (Tegramin-20, Struers, 
Ballerup, Denmark) with 1200 grit SiC paper down to 0.05 µm with an alumina slurry, and 
chemically etched in a solution of 5 mL acetic acid, 6 g picric acid, 10 mL water, and 100 mL 
ethanol. The microstructure was observed using optical microscopy (Axiovert 40 MAT, Carl 
Zeiss, Jena, Germany) and scanning electron microscopy (SEM, JEOL JSM-6610, JEOL Ltd., 
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Tokyo, Japan) with energy dispersive X-ray (EDX, EDAX Genesis, Mahwah, NJ) to conduct 
elemental analysis.  Average grain size was measured according to ASTM E112 [148] following 
the Abrams three-circle procedure with ~70 grains considered for each calculation. 
2.3 RESULTS 
2.3.1 Materials properties of as-cast and solution treated Mg-Y-0.6Ca-0.4Zr based alloys 
Inductively coupled plasma optical emission spectroscopy (ICP-OES) measurements (Table 2.3) 
showed some reduction in alloying elements from their as-weighed nominal compositions likely 
due to the re-melting process. A reduction in Zr was primarily due to settling of large zirconium 
particles and clusters in the liquid melt [149] and was counteracted by adding more Zr when 
melting, increasing from the content in the preliminary study of 0.4 wt. % (for WX11 and WX41 
alloys) to 1.0 wt. % (for KX11, WK11, WK41, and WZ42 alloys). Low impurity levels were 
observed, as necessary to avoid substantial galvanic corrosion. 
 




Alloy   Chemical compositions (wt.%) 
Y Ca Zr Zn Al Cu Fe  Mn Ni Si Mg 
WX11 0.66 ± 0.03 0.52 ± .01 0.13 ± 0.004 -- -- 0.016 0.003 0.008 0.008 0.006 Balance 
WX41 3.18 ± 0.10 0.63 ± 0.41 0.074 ± 0.013 -- -- 0.015 0.009 0.005 0.003 0.007 Balance 
KX11 0.0033 0.52 ± 0.002 0.62 ± 0.005 <0.0001 0.0003 0.0005 0.0008 0.003 <0.0001 <0.0001 Balance 
WK11 0.98 ± 0.003 0.51 ± 0.002  0.63 ± 0.003 <0.0001 0.0003 0.008 0.001 0.003 <0.0001 <0.0001 Balance 
WK41 3.37 ± 0.18 0.40 ± 0.065 0.51 ± 0.009 <0.0001 <0.0001 0.004 0.003 0.003 <0.0001 <0.0001 Balance 
WZ42 3.98 ± 0.033 0.54 ± 0.005 0.61 ± 0.008 2.00 ± 0.015 <0.0001 0.002 0.001 0.003 <0.0001 <0.0001 Balance 
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The presence of different phases in the Mg alloys was characterized by X-ray diffraction 
(XRD) as shown in Figure 2.1. The XRD patterns show that all the alloys were composed of hcp 
α-Mg, without detecting the presence of any unalloyed Y, Ca, Zr, or intermetallic phases. 
However, there was a distinct preferential orientation of the Mg (101) plane in all of the 
synthesized as-cast and solution treated alloys compared to as-cast pure Mg which shows the 
typical Mg (002) plane to be the most intense peak likely due to the presence of Zr acting as 
nucleating sites for grain refinement leading to possible preferential orientation. 
 
 
Figure 2.1. XRD patterns of as-cast pure Mg, WX11, and WX41. 
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Figure 2.2 shows optical microscopy images of the microstructure of as-cast and solution 
treated WX11 and WX41 alloys containing grains of α-Mg with secondary phases (dark regions) 
located at the grain boundaries and precipitates within the matrix.  
The average grain size of the alloys was: WX11 as-cast - 79 µm, WX11 T4 treated – 98 
µm, WX41 as-cast – 98 µm, and WX41 T4 – 200 µm, dominated by the presence of uniform 
equiaxed α-Mg grains throughout the microstructure. As expected, the solution treatment led to 
an increase in the grain size. However, addition of alloying elements greatly reduced the grain 
size compared to high-purity Mg as shown in Figure 2.2e, which noticeably lacked the presence 
of dark secondary phases. As-drawn AZ31, having undergone grain refinement due to the 
commercial drawing process, exhibited much finer grain size (Figure 2.2f) compared to the Mg-




Figure 2.2. Optical micrographs of Mg-Y-Ca-Zr alloys after polishing and etching: a) WX11 as-
cast; b) WX11 T4 heat treated; c) WX41 as-cast; d) WX41 T4 heat treated; e) pure Mg as-cast; f) 
AZ31 as-drawn. 
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SEM and EDX (Figure 2.3) confirmed the optical microscopy images in that the WX11 
and WX41 as-cast alloys contained grain boundaries and precipitates of higher amounts of Y and 
Ca (Figure 2.3a and c), indicating the presence of secondary phases of composition, with lower 
amounts of Y, Ca, and Zr at the grain boundaries but consisting mostly of Y in precipitates, due 
to precipitate segregation during solidification, a common phenomenon with casting. T4 solution 
treatment successfully dissolved these secondary phases into the bulk α-Mg, leading to partial 
homogenization of the as-cast alloy. The Y-rich intermetallic particles were observed to contain 
about 75% wt. % Y to form αY, which were still present after T4 solution treatment (Figure 2.3b 
and d).  A higher volume fraction of second phase particles was observed in the WX41 alloys 
due to its higher Y content compared to WX11.  The increase in grain size after T4 solution 
treatment was likely due to energy driving coalescence of smaller grains along the triple point 
grain boundary regions and formation of supersaturated α-Mg solid solution after the precipitates 




Figure 2.3. SEM images of Mg-Y-Ca-Zr alloys after polishing and etching: a) WX11 as-cast; b) 
WX11 T4 heat treated; c) WX41 as-cast; d) WX41 T4 heat treated with corresponding EDX of 
grain boundaries and precipitates as noted by arrows. Scale bar = 50 µm. 
2.3.2 Changes in phase and microstructure with extrusion and addition of Y and Zn to 
Mg-Y-1Zr-0.6Ca based alloys 
The modified Mg-Y-Ca-Zr alloy system contained 1.0 wt. % Zr. An alloy without Y (Mg-1Zr-
0.6Ca) and an alloy containing Zn (Mg-4Y-2Zn-1Zr-0.6Ca) were also synthesized to compare 
the materials and in vitro characteristics to the Mg-Y-Zr-Ca alloys. These alloys were extruded at 
an extrusion ratio of 10 (initial cross sectional area divided by final cross sectional area) at 
temperatures shown in Table 2.2 and subject to further analysis. 
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XRD (Figure 2.4) of the Mg alloys shows that after extrusion for KX11, WK11, and 
WK41, the alloys consisted still mainly of single phase Mg. The addition of Y led to a shift in all 
the peak positions, particularly of the (101) oriented peak at ~37o 2  value due t    
expansion caused by the introduction of Y into the Mg hcp lattice.  Similar preferred orientation 
is seen here unaffected by the increase in Zr content. As expected, the WZ42 alloy, which 




Figure 2.5. Optical micrographs showing the microstructure of Mg alloys extruded with 
extrusion ratio 10: a,f) KX11, b,g) WK11, c,h) WK41, d,i) WZ42 and extrusion ratio 30 – e,j) 





After extrusion, the Mg alloys underwent significant grain refinement as shown in the 
optical microscopy images of microstructure (Figure 2.5). Compared to the as-cast and T4 
treated alloy microstructure shown in Figure 2.2, after hot extrusion, the grain size was reduced 
to well under 50 µm. The WZ42 alloy contained grains both small and large, and when extruded 
at an extrusion ratio of 30 compared to 10, resulted in more of the large grains of ~20 – 40 µm 
being disrupted into more refined grains of < 15 µm in the transverse direction. 
Further inspection of the microstructure was conducted using SEM and EDX (Figure 
2.6). Bright regions in the back-scattered SEM images revealed intermetallic phases consisting of 
Mg, Ca, Y, and Zr, as well as impurity elements of Al, however since an extremely low 
concentration of Al was measured in the alloys using ICP-OES in Table 2.3, the Al detected by 
EDX may have come from the alumina slurry used during polishing. Non-equilibrium phases 
containing alloying elements were present in KX11 and WK11 (Figure 2.6a, b). WK41 (Figure 
2.6c) contained the phase Mg2Y as it contained more Y, ~4 wt. %, compared to WK11 which 
only contains ~1 wt. % Y. In the WZ42 alloy, a unique LPSO phase consisting of Mg, Zn, and Y 
roughly corresponding to Mg12YZn with Mg atomic percent 12 times that of Y was confirmed by 
SEM and EDX analysis shown in Figure 2.6d. The amount of bright regions of precipitates in the 
alloys increased with the higher amount of alloying elements added to the Mg solution, in the 
order of KX11 < WK11 < WK41 < WZ42. The size of the secondary phases, with the exception 
of the LPSO phase in the WZ42 alloy, appeared to be generally smaller, < 2 µm, and more 
dispersed in the extruded alloys seen in Figure 2.6 compared to the as-cast and T4 heat treated 




Figure 2.6. SEM images and EDX analysis at indicated locations of Mg alloys after polishing 
and etching: a) KX11; b) WK11; c) WK41; d) WZ42 after extrusion with extrusion ratio of 10. 
Sections were taken in the transverse plane to the direction of extrusion. Scale bar = 10 µm. 
2.4 DISCUSSION 
Alloying elements strongly affect the microstructure and mechanical properties of magnesium 
alloys. Higher Y content has been reported to result in grain coarsening [150], which was 
observed to a small degree in Figure 2.2 when comparing the WX11 to the WX41 alloys. The 
measured Zr content as seen in Table 2.3 was also reduced in the WX41 alloy, which may also 
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have contributed to the higher grain size compared to WX11. Y-rich intermetallic particles with 
Y wt. % of ~75% were observed in the Mg-Y-Zr-Ca alloys as has been observed in Mg-Y binary 
alloys [130], though implementation of T4 solution treatment resulted in dissolution of second 
phase precipitates from the grain boundaries as well as grain coarsening. 
The alloy compositions studied were modified and expanded after the initial studies using 
as-cast Mg-Y based alloys. First, to further explore the effect of Y and Zn addition, a 
composition without Y was added to compare with the Y-containing alloys, and added Zn to 
explore the effects of the LPSO phase of Mg12YZn intermetallic. Due to a loss of Zr during 
melting which was observed in the as-cast alloys, which saw a diminished Zr content from the 
nominal concentration of 0.40% reduced to 0.13% and 0.074% wt. % as measured by ICP-OES 
for the WX11 and WX41 alloys, respectively, the amount of Zr added to the initial melts was 
increased. The loss of Zr occurred because once saturation with Zr has been achieved, Zr is 
continually lost from the Mg solution as it reacts with iron from the crucible and other 
contaminants, also forming hydrides with hydrogen [79]. Thus, it is crucial to add an excess of 
active Zr to the melt to compensate for the losses occurring [79]. Another change that was 
implemented was reducing the temperature for heat treatment. As seen in Figure 2.2b and 2.2d, 
significant grain growth was observed after conducting heat treatment on the WX11 and WX11 
alloys at 525 °C, reducing the positive effects of grain refinement imparted by the Zr addition. 
The temperature of solution treatment was reduced to 400 °C while extending the time from 8 
hours to 20 hours, still resulting in diffusion of precipitates while lowering corrosion rate and 
avoiding significant grain growth, as shown in Appendix B, Figure B.1 and Figure B.2.  
This modified alloy system was then hot extruded which drastically changed the alloy 
microstructure. While the X-ray diffraction patterns still showed single-phase Mg for all alloys 
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except WZ42 which contained LPSO Mg12YZn, the grain size dramatically decreased after 
extrusion. Extrusion process for Mg alloys is a thermo-mechanical process influenced by the 
working temperature and extrusion ratio. Increasing extrusion temperature increases grain size 
due to dynamic recrystallization where nucleation and growth of new grains occur during 
deformation [151]. However, the effect of extrusion ratio on grain size has been met with 
contradictory results, with some studies reporting a grain size decrease with increasing extrusion 
ratio [145, 152] whereas other reported the contrary [153]. Here, a breakdown was observed of 
the large LPSO phase grains, while overall the grains seen in the longitudinal section did not 
appear to drastically change. The occurrence of this fiber-shaped LPSO phase elongated along 
the direction of extrusion has been observed in other Mg-Zn-Y containing alloys [153], where  a 
higher extrusion ratio generated more heat during extrusion bringing about dynamic 
recrystallization, seen to a greater effect in the extrusion ratio 30 WZ42 alloy. This effect may be 
due to conflicting influences of a higher temperature used for extrusion performed at extrusion 
ratio 30 (450 °C) as opposed to 425 °C when the alloy was extruded at an extrusion ratio of 10, 
acting to recrystallize and grow grains while the higher deformation served to reduce grain size. 
All the alloys appeared to undergo partial dynamic recrystallization with a combination of fine 




3.0  SPECIFIC AIM 2: CHARACTERIZE THE EFFECTS OF YTTRIUM AND ZINC 
ADDITION AND POST PROCESSING ON CORROSION BEHAVIOR AND 
MECHANICAL PROPERTIES OF MAGNESIUM-YTTRIUM-CALCIUM-ZIRCONIUM 
ALLOYS 
3.1 INTRODUCTION 
Critical in gaining a deep understanding of the Mg-Y-Ca-Zr based alloys of this work was to 
draw relationships between the microstructure and composition with the functional properties of 
corrosion behavior and mechanical properties. For orthopedic biomaterials, both characteristics 
are essential in determining the efficacy of a device.  
The first major challenge in developing a biodegradable osteosyntheses response was to 
achieve mechanical properties that are in the likely same range as those characteristic of 
permanent metallic implants [32]. Biodegradable materials must maintain stability in complex in 
vivo environments, bearing a combination of various mechanical loads including tension, 
compression, and fluid shear stress [154]. Whereas degradable polymers have improved since the 
1980s due to progress in knowledge and production methods, their mechanical properties still do 
not approach those of permanent metals. Thus, devices made from biodegradable polymers are 
designed to compensate the lack of strength and rigidity though the use of larger, bulkier designs. 
Naturally, the location of the skeletal injury often dictates the mechanical requirements of the 
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implant and material [155]. As the material degrades, the decrease in strength should be steady, 
predictable, and repeatable, resulting in gradual transfer of load to the surrounding and newly 
formed bone whose growth may be encouraged by the increased loading [156]. 
The property of degradation of implanted materials for orthopedic devices is also of 
interest to eliminate the need for device removal in a second surgery while providing room for 
growth of native tissue. No implant residues should remain, while the degradation products can 
be metabolized by the human body at an appropriate rate to maintain load for the given 
application.  
As discussed earlier, alloying elements were added to contribute to improvement of the 
mechanical properties and corrosion resistance. A common effect of their incorporation was to 
impart solid solution strengthening, precipitation strengthening, and grain boundary 
strengthening. The post-processing technique of heat treatment to diffuse the secondary phases 
limits the extent of microgalvanic corrosion wherein the anodic α-Mg matrix has a lower 
corrosion potential than any secondary phases, corroding preferentially as a galvanic couple 
[157]. Grain refinement achieved through hot extrusion also was expected to improve the 
mechanical strength by grain boundary strengthening. This aim sought to assess the effects of 
these alloy additions, namely progressively increasing Y content and Zn incorporation, as well as 
the effect of heat treatment and extrusion on the mechanical properties and degradation of the 
resultant Mg alloy systems in order to determine optimal processing conditions for achieving 
high strength and corrosion resistant alloys. 
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3.2 MATERIALS AND METHODS 
3.2.1 Corrosion testing of Mg-Y-Ca-Zr based alloys 
The potentiodynamic polarization technique was used to test corrosion of the WX11 and WX41 
as-cast and T4 treated alloys. Samples were connected to a copper wire using silver epoxy and 
mounted in epoxy resin. The mounted samples of dimensions 10 mm × 10 mm × 1 mm were 
mechanically polished, sonicated in isopropyl alcohol, and dried in air. The potentiodynamic 
corrosion study was carried out with an electrochemical workstation (CH-604A, CH Instruments, 
Inc., Austin, TX) at a scanning rate of 1 mV/s and potential window of 500 mV above and below 
the open circuit potential. A three electrode cell was employed with platinum as the counter 
electrode, Ag/AgCl as the reference electrode, and the sample as the working electrode. The test 
was performed in Dulbecco’s Modified Eagle Medium (DMEM, with 4.5 g/l glucose, L-
glutamine, and sodium pyruvate, Cellgro, Manassas, VA) supplemented with 10% fetal bovine 
serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin at pH 7.2 ± 0.2 and held at 37.4 
°C. Before each measurement, the sample was immersed in the corrosion media to provide 
stability. The cathodic and anodic portions of the generated Tafel plots were fit linearly to allow 
calculation of corrosion potential, Ecorr, and corrosion current density, icorr. 
Corrosion of the Mg alloys was also measured using mass loss in a corrosion solution. 
Polished samples of the as-cast and T4 treated WX11 and WX41 were immersed in DMEM with 
with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin at 37 °C, 
while the extruded KX11, WK11, WK41, and WZ42 alloys were immersed in HBSS at 37 °C. 
Samples removed after up to 5 weeks of immersion were dried at room temperature and their 
surfaces and surface cross sections analyzed using SEM and EDX to analyze the surface layer 
 56 
composition and morphology. The sample masses were measured after immersion in a solution 
containing 200 g/L of chromic acid and 10 g/L of AgNO3 for 1 minute to remove the corrosion 
products. The corrosion rate was calculated according to ASTM G31-72 [158] using the 
following equation: 
C = (K × W)/(A × T × D) 
Where C is the corrosion rate (mm year-1, mmpy), the constant K is 8.76 x 104, W is the mass 
loss (g), A is the sample area exposed to solution (cm2), T is the time of exposure (h), and D is 
the density of the material (g cm–3). 
3.2.2 Microhardness testing of Mg-Y-Ca-Zr based alloys 
Vickers microhardness was measured by applying a load of 100 g for 10 s to samples polished 
and etched for microstructure, and measuring the indentation created by the square pyramidal 
diamond indenter using optical microscopy. The Vickers Pyramid number (HV) was determined 
by F/A, where F is the force applied to the diamond indenter in kilograms-force and A is the 
surface area of the resulting indentation in square millimeters. A was determined by the formula: 




where d is the average length of the diagonal left by the indenter in millimeters. The HV number 
was then calculated by: 







where F is in kgf. 
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3.2.3 Mechanical testing of Mg-Y-Ca-Zr based alloys 
For mechanical testing, samples were machined along the long axis of the Mg alloy ingots and 
extruded rods in dimensions in accordance with ASTM-E8-04 [159] for tensile testing and 
ASTM-E9-09 [160] for compressive testing. Tensile bar samples with a gauge area of 3 × 3 mm 
and length of 12 mm were machined for tensile samples. Compressive cylindrical samples were 
machined of 10 mm diameter × 20 mm length. Compressive and tensile testing for as-cast and 
T4 solution treated alloys WX11 and WX41 were conducted by OrthoKinetic Testing 
Technologies, LLC (Southport, NC) at room temperature using an MTS11 – 50 kN electro-
mechanical load frame (MTS, Eden Prairie, MN) with laser extensometer. For extruded alloys 
KX11, WK11, WK41, and WZ42, tensile tests were performed using an Instron 5566 
mechanical testing system (Instron, Norwood, MA) with static axial clip-on extensometer. 
Tensile tests were conducted at room temperature at a crosshead speed of 1.3 mm/min, while 
compression tests were carried out at a speed of 2 mm/min. Engineering yield strength, ultimate 
strength, Young’s modulus (E), percent elongation were determined from the stress-strain 
curves. Ultimate strengths of the alloys were determined as the maximum tensile stress from the 
stress-strain curves. Yield strengths were determined as the stress at the yield point during the 
tensile tests. 
3.2.4 Statistical analysis 
Statistical analysis was conducted using SPSS Statistics 17.0 (SPSS Inc., Chicago, IL). 
Differences between groups were analyzed using one-way ANOVA with post-hoc testing using 
Tukey’s test when group sizes were equal or Gabriel’s pairwise test when group sizes were 
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unequal. P < 0.05 was accepted as a statistically significant difference between means and is 
denoted in figures. Error bars within figures represent standard deviation. 
3.3 RESULTS 
3.3.1 Corrosion behavior of Mg-Y-Ca-Zr based alloys as a result of Y and Zn additions 
The corrosion rates of the as-cast and T4 Mg-Y-Ca-Zr alloys (WX11 and WX41) compared to 
pure as-cast Mg and as-drawn AZ31 were calculated based on mass loss after immersion as well 
as by potentiodynamic polarization measurements, and are shown along with corrosion potential 
and concentration of Mg ions released into the immersion solution in Figure 3.1. The corrosion 
potential (Figure 3.1b) of the WX41 alloys was higher than the WX11 alloys and the control 
materials, pure Mg and AZ31, respectively. T4 solution treated alloys conducted on the as-cast 
WX11 and WX41 alloys at 525 °C also demonstrated a higher corrosion potential and 
breakdown potential compared to their as-cast counterparts. Potentiodynamic corrosion rates of 
the WX41 alloys were lower than the WX11 alloys and were similar to that of commercial 
AZ31.  Solution treatment increased potentiodynamic corrosion rate of the WX11 alloy, though 
did not affect WX41. 
Figure 3.1a shows that alloy corrosion rate calculated from the mass loss immersion test 
appeared to start stabilizing after 2 weeks of immersion. After 2 weeks of immersion, the 
corrosion rate of WX41 as-cast was significantly lower than those of the WX11 alloys. The 2 
week corrosion rates of the WX41 alloys were also not significantly different than high-purity 
Mg. After 3 weeks of immersion, once again the WX41 as-cast alloys demonstrated a lower 
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corrosion rate compared to WX11, and similar to high purity Mg. T4 solution treatment did not 
appear to have a major effect on immersion corrosion rate. The corrosion media used for the 
mass loss corrosion experiments was used to determine concentration of Mg released into 
solution after 1, 2, and 3 weeks (Figure 3.1c). The WX41 alloys again showed higher corrosion 
resistance compared to WX11, releasing lower concentration of Mg at each time point, 
comparable to as-cast pure Mg and commercially obtained AZ31.  Heat treatment did not seem 





Figure 3.1. Corrosion properties of Mg-Y-Ca-Zr alloys, as-cast 99.99% pure Mg, and AZ31 in 
DMEM with 10% FBS: a) corrosion rate as measured using mass loss after 1, 2, and 3 weeks 
immersion (n = 3 per group per time point) and potentiodynamic corrosion (n = 1 per group). 
Significant difference (p < 0.05) between * and **; between † and ‡, between §. b) corrosion 
potential and breakdown potential (n = 1 per group); c) concentration of Mg released in 
corrosion media after 1, 2, and 3 weeks immersion (n = 3 per group per time point). Significant 
difference (p < 0.05) between * and **; † and ‡. 
 
Figure 3.2 shows SEM micrographs of the Mg-Y-Ca-Zr alloys after potentiodynamic 
polarization test cleaned with CrO3/AgNO3 solution to remove the corrosion products. All the 
samples demonstrated localized pitting corrosion, a commonly seen phenomena in Mg alloys 









Figure 3.2. SEM images showing surface morphologies of a) WX11 as-cast; b) WX11 T4 heat 
treated; c) WX41 as-cast; d) WX41 T4 heat treated; e) pure Mg; f) AZ31 after potentiodynamic 
polarization in DMEM with 10% FBS at 37 °C and cleaning with CrO3/AgNO3 solution. Arrows 
denote corrosion at grain boundaries. 
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Micrographs of dried samples after 3 weeks immersion were captured using SEM to 
further assess corrosion (Figure 3.3). Localized corrosion was observed with deposits of 
corrosion product rich in C and O on the corroded surface (EDX shown in Figure 3.3a and b). 
The region immediately surrounding these corrosion deposits was generally rich in Mg (Figure 
3.3a and e). Finally, most of the surface of the samples was covered in a layer rich in O, Ca, P, 
and Mg. Ca and P that are essential components in bone, and have been reported as forming a 
layer of amorphous calcium phosphate layer on rare earth containing alloys after degradation in 
vivo [125, 162]. After removal of corrosion products, SEM shown in Figure 3.4 revealed that the 




Figure 3.3. SEM images showing surface morphologies of a) WX11 as-cast; b) WX11 T4 heat 
treated; c) WX41 as-cast; d) WX41 T4 heat treated; e) pure Mg; f) AZ31 after 3 weeks static 





Figure 3.4. SEM images showing surface morphologies of a) WX11 as-cast; b) WX11 T4 heat 
treated; c) WX41 as-cast; d) WX41 T4 heat treated; e) pure Mg; f) AZ31 after 3 weeks static 
immersion in DMEM with 10% FBS at 37 °C and cleaning with CrO3/AgNO3 solution. 
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 Extruded alloys also underwent corrosion testing after being immersed in solution for 1, 
3, and 5 weeks at 37 °C, with average values plotted in Figure 3.5. Compared to the commercial 
material controls, the alloys demonstrated a significantly lower corrosion rate than pure Mg but 
generally higher than AZ31 but comparable or lower than in-house generated AZ31, despite 
most alloy corrosion rates not being significantly different from AZ31 after 1 week degradation. 
AZ31 alloy produced using the same conditions as the other novel alloys (AZ31 in-house) and 
also extruded at a ratio of 10 corroded more rapidly than the commercially obtained AZ31, with 
corrosion rates similar to or higher than the Mg-Y-Ca-Zr based alloys. Finally, a comparison 
between WZ42 extruded at an extrusion ratio of 30 resulted in higher corrosion rates than when 
the same composition alloy was extruded at a lower ratio of 10, with this result potentially 
compounded by the additional 25 °C required for an extrusion ratio of 30 allowing further 
precipitation of intermetallics. Generally a trend was observed where the corrosion rate was 
reduced by increasing the Y content. Alloying WK41 with Zn (WZ42) did not significantly 
affect the corrosion rate. No discernable correlations were observed between corrosion rates and 
time of immersion.  
Comparing the immersion corrosion rates of the extruded alloys to the as-cast and 
solution treated (Figure 3.1), both groups of alloys degraded faster relative to extruded 
commercial AZ31. Furthermore, for both as-cast/solution treated and extruded alloys, an 
increasing content of Y reduced the corrosion rate, an important aspect of introducing and 
increasing the amounts of Y. 
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Figure 3.5. Average corrosion rates of extruded Mg-Y-Ca-Zr-based alloys compared to extruded 
pure Mg and AZ31 (in commercial and produced in-house forms). Groups labeled * were 
significantly different (p < 0.05) from one another at that time point and those labeled † were 
significantly different (p < 0.05) from all other groups at that time point. n = 3 for all groups at 
all time points. 
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 Following removal of degradation products to measure mass loss, samples immersed for 
1 week were imaged for their surface morphology (Figure 3.6), and cross section imaged after 5 
weeks immersion (Figure 3.7) using SEM. The surfaces of all the Mg alloys revealed filiform 
corrosion with the presence of pits. Still, the surface after 1 week remained largely uniform 
having undergone little corrosion. Pure Mg however did suffer from more severe pitting 
corrosion, with pits in the discontinuous surface seen in Figure 3.7a. Fairly uniform surfaces of 
the alloys developed were seen in the cross sectional images after 5 weeks, with regions that 
appeared flat with scattered pits, most prevalent in WK11, pure Mg, and AZ31 cast in-house. 
While the depth of corrosion in WZ42 with ER 10 appeared greater than ER 30, the latter form 
of the alloy’s surface appeared to be more discontinuous with cracks visible on the surface layer. 
The more rapid corrosion of AZ31 cast in-house compared to commercial AZ31 was visible in 




Figure 3.6. SEM images at 50x and 250x magnification showing surface morphologies of 
extruded a) pure Mg, b) commercially obtained AZ31, alloys produced in-house extruded with 
extrusion ratio of 10: c) AZ31, d) KX11, e) WK11, f) WK41, and g) WZ42 after 1 week static 




Figure 3.7. SEM images at 100x and 250x magnification showing cross sectional morphologies 
of extruded a) pure Mg, AZ31 obtained b) commercially and c) processed in-house, and d) 
KX11, e) WK11, f) WK41, and g) WZ42 alloys extruded with extrusion ratio 10 and h) WZ42 
extruded with extrusion ratio of 30 after 5 weeks static immersion in HBSS at 37 °C and 
cleaning with CrO3/AgNO3 solution. Location of sample metal and mounting epoxy is indicated 
in a). 
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3.3.2 Microhardness of Mg-Y-Ca-Zr based alloys as a result of Y and Zn additions 
Microhardness results shown in Figure 3.8 demonstrated significantly increased values over pure 
Mg upon the addition of alloying elements. Furthermore, a significant increase in microhardness 
was observed with the addition of Zn to the Y containing alloys. No change was observed in the 
microhardness of the WZ42 alloy extruded at a ratio of 10 compared to 30. 
 
 
Figure 3.8. Vickers microhardness of extruded Mg alloys. Group labeled * was significantly 
different (p < 0.05) than all other groups, and groups labeled † were significantly different (p < 
0.05) from all other groups but not from one another. ER = extrusion ratio. n = 5 for all groups at 
all time points. 
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3.3.3 Mechanical properties of Mg-Y-Ca-Zr based alloys as a result of Y and Zn additions 
and extrusion 
Compression and tensile mechanical properties of the as-cast and heat treated alloys are 
presented in Figure 3.9. Ultimate compressive strain (Figure 3.9a) of as-cast WX11 and WX41 
alloys were significantly larger than that of as-cast pure Mg and as-drawn AZ31. Ultimate 
compressive strength (Figure 3.9a) for the as-cast experimental alloys was also greater than for 
as-cast pure Mg, while AZ31 exhibited significantly greater ultimate compressive strength over 
all of the other materials tested due to the significant work hardening and grain refinement 
imparted on it by the drawing process. T4 solution treatment applied to the as-cast alloys at 525 
°C resulted in a significant reduction in compressive strength and strain, while an increase in 
compressive yield strength (Figure 3.9b) was observed with an increased Y content. As-cast 
WX41 demonstrated significantly higher ultimate tensile strength (Figure 3.9c) than as-cast 
WX11. Similar to compression test results, applying the T4 solution applied at 525 °C to the as-
cast Mg-Y-Ca-Zr alloys resulted in a reduction in the ultimate tensile strength and tensile yield 
strength compared to the as-cast alloys, while no significant effect on tensile strain could be 
observed after heat treatment. AZ31 displayed much higher tensile strength and strain over the 
other tested materials. Tensile properties of the Mg-Y-Ca-Zr alloys were either greatly improved 
or observed to be comparable to those of pure Mg. Values of Young’s modulus (Figure 3.9d) for 
the tested alloys varied between 34-60 GPa, similar to the measured value for AZ31 (42 GPa), 
with high variance within the groups observed. 
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Figure 3.9. Mechanical properties of Mg-Y-Ca-Zr alloys, pure Mg, and AZ31: a) ultimate 
compressive strength and ultimate compressive strain; Significant difference (p < 0.05) between 
* and all other groups; †, ‡ and other groups. b) compressive yield strength; Significant 
difference (p < 0.05) between * and all other groups; †, ‡ and other groups. c) ultimate tensile 
strength and ultimate tensile strain; Significant difference (p < 0.05) between *, § with all other 
groups; †, ‡ with other groups. d) tensile yield strength and Young’s modulus; Significant 
difference (p < 0.05) between § with all other groups; †, ‡ with other groups. n ≤ 3 for all groups 
at all time points. 
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Tensile mechanical properties of the extruded alloys are reported in Figure 3.10 and 
Figure 3.11. Ultimate tensile strength (Figure 3.10) for all the extruded Mg alloys developed in 
this work were significantly higher than the commercial controls – extruded pure Mg and AZ31. 
While the ultimate tensile strength remained similar for KX11, WK11, and WK41, it was 
drastically improved upon adding Zn to the composition in the form of WZ42, for which strength 
was significantly higher when extruded at ER 10 versus 30.  The ultimate tensile strain of all 
measured extruded materials were all similar except for KX11, which had a significantly higher 
elongation than all other groups save AZ31. 
Yield strength (Figure 3.11) of the extruded alloy KX11, WK11, WK41, and WZ42 were 
higher than commercial pure Mg and commercially obtained extruded AZ31, with WK41 having 
the lowest yield strength among those alloys in its system, whereas again the WZ42 alloys 
possessed significantly higher strength. The Young’s modulus of all the tested alloys were not 
significantly different from each other, ranging from 40-60 GPa. 
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Figure 3.10. Average ultimate tensile strength and strain of extruded Mg alloys. Measurements 
of ultimate tensile strains labeled * were significantly different (p < 0.05) from each other. 
Measurements of ultimate tensile stress labeled † were significantly different (p < 0.05) from all 
other groups but not from one another. Measurements of ultimate tensile stress labeled ‡ were 





Figure 3.11. Average tensile yield strength and Young’s modulus of extruded Mg alloys. 
Measurements of yield strength labeled * were significantly different (p < 0.05) from all other 
groups; groups labeled † and ‡ were significantly different (p < 0.05) from all other groups but 
not from one another. ER = extrusion ratio. n = 5 for all groups at all time points. 
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3.4 DISCUSSION 
In this specific aim, the three main variables of: 1) alloy composition (increasing amount of Y 
and addition of Zn), 2) extruded versus non-extruded, and 3) as-cast versus T4 solution treated 
were explored for their effects on corrosion behavior and mechanical properties.  
Corrosion resistance has been a major point of interest in magnesium alloy research due 
to severe pitting corrosion observed in Mg alloys when exposed to physiological chloride 
environment beyond 150 mmol/L [163] as well as at sites of low hydrogen overpotential [128]. 
Microstructure and grain size play crucial roles in controlling corrosion, with reports of an 
increase in grain size resulting in a change in corrosion resistance. Comparing the immersion 
corrosion rates of the extruded alloys (Figure 3.5) to the as-cast and solution treated alloys 
(Figure 3.1a), both groups of alloys degraded faster relative to extruded commercial AZ31. 
Corrosion rates of the extruded alloys did not improve significantly over the as-cast and T4 
treated alloys studied here, and may be due to a number of causes. On one hand, Aung and Zhou 
[112] demonstrated that increasing grain size through heat treatments at various temperatures of 
AZ31B-H24 resulted in an increase in corrosion rate as explained by the grain boundaries acting 
as a physical corrosion barrier. Fine grained alloy microstructures processed by friction stir 
processing of Mg-Y-RE [164] and equal channel angular pressing (ECAP) of AZ31 [165] also 
displayed better corrosion behavior as a result of the finer grained alloys. Small grain size was 
suggested to lead to greater corrosion resistance by the presence of a more compact layer of 
phosphorous containing compounds and magnesium hydroxide when the alloy is exposed to 
physiological medium serving to protect against the action of chloride ions resulting in higher 
charge transfer resistance [165, 166] as well as more uniform corrosion with smaller pits because 
of the fine grain size [111]. On the other hand however, conflicting studies have shown that 
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reduction in grain size leads to a decrease in corrosion resistance, through addition of a grain-
refining agent [167] or ECAP [168] as a result of corrosion initiation and propagation at grain 
boundaries, with corrosion filaments following grain boundary paths, acting as sites of micro-
galvanic corrosion. It is expected that the lack of noticeable change in corrosion from change in 
grain size as stemming from a combination of these conflicting effects on corrosion by 
microstructural variations. 
Another method of controlling corrosion rate was by applying a T4 solution treatment to 
reduce the volume fraction of secondary phases by diffusion into the α-Mg matrix, thus limiting 
the extent of microgalvanic corrosion where the anodic α-Mg matrix has a lower corrosion 
potential than any secondary phase, corroding preferentially as a galvanic couple [157]. This was 
observed in comparing the corrosion surface of as-cast to solution heat treated alloys in Figure 
3.1, where the as-cast alloys with higher secondary phase concentration at the grain boundaries 
encountered visible corrosion at these grain boundaries, which was not seen in the solution 
treated alloys.  
Differing the Y content in Mg-alloys may affect the corrosion behavior as reported by 
Liu and colleagues [130]. By increasing Y content, the volume fraction of Y-containing 
intermetallics increases, thereby enhancing the microgalvanic corrosion. On the other hand, Liu 
et al. [130] determined that increasing Y above 3% may also result in a more protective 
passivation layer of Y2O3 and decreased cathodic current, which was also determined 
theoretically [139].  
This stronger passivation of alloys containing greater Y content was shown in the higher 
corrosion potentials (Figure 3.1b) of as-cast and T4 treated WX41 compared to the as-cast and 
T4 treated versions of WX11. T4 solution treatment was also observed to shift the corrosion 
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potential of the Mg-Y-Ca-Zr alloys to more noble potentials due to the reduction of intermetallic 
particles along the grain boundaries into the solid solution, possibly allowing for the protective 
oxide layer to cover a larger region of the alloy surface, as suggested by Neil et al. [167] after 
heat treating Mg-Zn-RE-Zr alloys. After solution treatment, more positive breakdown potentials 
of the Mg-Y-Ca-Zr alloys were also observed, indicating a higher resistance to the breakdown of 
the passive film and onset of pitting corrosion [167]. The potentiodynamic corrosion rates 
(Figure 3.1a) as calculated using corrosion current density of the Mg-Y-Ca-Zr alloys decreased 
with an increase in Y content, which occurs through suppression of the cathodic reaction in the 
corrosion process [168]. Immersion corrosion (Figure 3.1a) and Mg concentration measurements 
(Figure 3.1c) confirmed this reduction in corrosion rate from WX11 to WX41 alloys. In the 
extruded alloys, an increase in Y content similarly led to a reduction in corrosion rate as seen in 
the results of Figure 3.5. KX11, the alloy processed without Y exhibited the highest corrosion 
rate while also displaying a surface most affected by corrosion compared to the alloys containing 
Y which displayed a more uniform surface (Figure 3.6). Filiform corrosion has been observed in 
Mg-Y containing alloys [169] which occurs due to the non-uniform hydroxide film on the 
surface allowing for locations of active corrosion to remain which can propagate. This active 
corrosion site produces high concentrations of local Mg2+ which attracts chloride ion, allowing 
the filiform corrosion to be maintained in random directions. This corrosion mechanism was 
confined to the surface due to the formation of Mg(OH)2 and other passivating products such as 
Y2O3 which prevents the corrosion from propagating into the interior of the Mg sample as seen 
in the cross sectional images of the experimental alloys in Figure 3.7d-h. 
Solution treatment of the as-cast alloys WX11 and WX41 caused a large increase in the 
potentiodynamic corrosion rate of WX11, while only a slight increase in corrosion rate was 
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observed for WX41. However, these trends were not reflected in the immersion corrosion and 
Mg concentration measurements, where T4 treatment did not result in a marked change or 
decrease in the corrosion rate. This may have been due to a combination of T4 treatment 
dissolving the intermetallic phases, reducing microgalvanic galvanic corrosion, while also 
increasing grain size, which may retard passivation kinetics [164]. The linked up corrosion 
cavities seen on the surface of the alloys are commonly observed on corroded Mg alloys [170].  
Corrosion rate calculated from potentiodynamic polarization curves were lower than 
those calculated from mass loss during immersion possibly because the corrosion mechanism of 
Mg involves a fraction of the uni-positive Mg ion reacting as an intermediate step, reacting 
chemically as well as partially electrochemically, causing electrochemical measurements to 
underestimate the corrosion rate compared to weight loss or hydrogen evolution methods [130, 
170, 171]. Corrosion products developed over a 3 week immersion period in DMEM with 10% 
FBS (Figure 3.3) revealed large amounts of Ca and P in deposits (EDX in Figure 3.3a & b), 
consistent with observations of aggregations of calcium-containing corrosion products [121]. 
The presence of Ca and P containing cations may result in passivation and pit formation (as seen 
in Figure 3.2) because of the precipitation of phosphate and carbonate salts [172, 173].  
Interestingly, a stark contrast was observed between the commercially obtained AZ31 
and AZ31 as-cast, heat treated, and extruded in-house at an extrusion ratio of 10. Likely the 
differences in production process where industrial scale methods of generating bulk quantities in 
more controlled environments resulted in a more homogenous AZ31 with fewer impurities 
compared to the lab-scale operation which was used to produce AZ31 in-house [174]. These 
impurities, defects, and inclusions likely led to the more rapid corrosion of our AZ31.  
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Experimental error propagation resulting in variation in immersion corrosion rates within 
groups may have arisen due to variabilities in weight measurement from the scale, variations in 
the surface area from machining error, and slight differences in immersion time, in addition to 
variation between sample homogeneity and surface finish through machining and polishing. 
Mechanical properties of Mg alloys are known to be sensitive to changes in 
microstructure according to the Hall-Petch relation where finer grains results in higher grain 
boundary strengthening [49, 50]. In this work, grain size increased after performing T4 solution 
treatment on as-cast alloys, but decreased after performing hot extrusion. Appropriately, the as-
cast Mg-Y-Ca-Zr alloys maintained higher strength in compression and tension and higher 
compressive strain compared to the alloys after grain coarsening occurred from solution 
treatment. The higher presence of secondary phases in the as-cast Mg-Y-Ca-Zr alloys may have 
contributed to precipitation strengthening by acting as impediments for dislocation movement 
during plastic deformation. This phenomenon as well as solid solution strengthening has been 
utilized in RE containing alloys [32], and may explain the marginally higher tensile strengths for 
as-cast alloys containing higher Y content. As-drawn AZ31 solidifies with a fine grain size to 
meet mechanical property requirements for industrial applications [51], while the as-cast high 
purity Mg devoid of any alloying elements exhibited comparatively low mechanical properties, 
suffering from a lack of solid solution strengthening or precipitation strengthening. The extruded 
pure Mg also demonstrated significantly lower strength compared to all alloys tested. After 
extrusion, significant grain refinement occurred causing a significant increase in strength, with 
ultimate tensile strength of the as-cast and T4 treated alloys before extrusion not exceeding 175 
MPa increasing to over 286 MPa for alloys following hot extrusion. Unlike the increase in 
strength seen after increasing the Y content in as-cast WX41 versus WX11 (Figure 3.9), an 
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increase in Y did not result in an increase in strength in the extruded alloys. Despite the higher 
percentage of alloying elements and precipitates, extruded WK41 which contained 4 wt. % Y did 
not show higher strength than KX11 and WK11 which contained 0 and 1 wt. %, respectively. 
This is likely due to the higher temperature to preheat the alloy slug held during extrusion 
required to soften the ingot to allow to pass through the die for WK41 which causes the alloy to 
undergo a higher extent of dynamic recrystallization and grain growth, hence reducing strength. 
With the introduction of Zn and thereby the LPSO phase in the WZ42 alloy, high microhardness 
and strength with moderate elongation were observed, with the Hall-Petch relationship and 
alignment of the LPSO phase along the direction of extrusion acting as hardening phases via a 
short-fiber strengthening mechanism like a composite material [175]. WZ42 extruded at a ratio 
of 30 may have seen its slight reduction in ultimate tensile strength due to higher deformation 
and temperature increase during hot extrusion leading to further dynamic recrystallization. 
Finally, a significantly higher elongation in the KX11 alloy lacking Y has been confirmed 
experimentally where higher Y content led to weakened ductility [154] as greater Y content in 
the solid solution and precipitates deteriorate the alloy ductility [110].  
The Young’s modulus of the tested alloys all were in a similar range being more 
appropriate for orthopedic applications than stainless steel or titanium as they were closer to the 
modulus of natural bone (6-24 GPa) [15]. This may reduce the risk of stress shielding compared 
to the traditionally used permanent metals. 
Experimental error resulting in variation in mechanical testing results within groups may 
have occurred due to slight variability in sample dimensions from machining error, variances in 
data collection of the force and strain measured by the mechanical testing unit, and deviations in 
 83 
sample alignment when positioning samples, in addition to differences in sample to sample 
homogeneity. 
Compared to other alloys reported in literature, the high strength of the WZ42 alloy 
compared especially favorably.  In a comprehensive representation of degradable metals (Figure 
3.12), WZ42 exhibits a yield tensile strength approaching that of wrought Fe, above any other 
Mg alloy reported thus far, with a moderate elongation of ~15%. Due to the high strength and 
reasonable ductility, this alloy was selected as the most optimum candidate for in vivo rat animal 
testing described in detail in Specific Aim 4. The other extruded alloys, KX11, WK11, WK41, 
also demonstrated high strength comparatively with moderate elongation. The as-cast WX11 and 




Figure 3.12. The yield tensile strength and elongation of cast and wrought Mg alloys with alloys 
from this thesis included – WX11 and WX41 in as-cast form and KX11, WK11, WK41, and 




4.0  SPECIFIC AIM 3: EVALUATE THE EFFECT OF YTTRIUM AND ZINC 
ADDITION, POST PROCESSING, AND ALLOYING ELEMENT SALTS, ON CELL 
VIABILITY AND PROLIFERATION OF PRE-OSTEOBLAST AND HUMAN 
MESENCHYMAL STEM CELLS. FURTHER EVALUATE EXPRESSION OF 
OSTEOBLAST DIFFERENTIATON MARKERS AND BIOCOMPATIBILITY IN 
MURINE SUBCUTANEOUS TISSUE 
4.1 INTRODUCTION 
It is of paramount importance to completely validate and demonstrate the biosafety of the 
degradation products of degradable magnesium for it to be adopted as an acceptable biomaterial 
for implantable devices. As discussed earlier, the degradation of Mg alloys gives rise to metal 
cations, oxides, hydroxides, phosphates, and carbonates, while also changing local pH and 
generating hydrogen gas which leads to gas pocket formation when implanted into animals. 
Below a threshold concentration, these degradation products are considered tolerable by the 
human body and do not result in any catastrophic outcomes leading to loss of patient life [110, 
176]. The effects of the degradation products on local cells and tissue and their ability to be 
cleared by the body depends largely on their solubility in aqueous solutions. The most common 
and by far, the most stable byproduct of Mg alloy degradation is Mg(OH)2 which has a moderate 
solubility (Ksp) of 8.9 x 10-12 with the next product that is formed by conversion of the hydroxide 
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to a salt being MgCl2 which in contrast, is extremely soluble. The toxicity of the other alloying 
elements and their salts also must be considered to gain a full understanding of the potential 
toxicity of Mg alloys. Not only is it important to understand the toxicity and cellular responses to 
degradation products of the Mg alloys, but it is also extremely important to consider the direct 
interaction between the implant surface and local cells to ensure that the cells may attach and 
proliferate on the Mg implant surface. 
For bone applications, implant materials should allow for growth of surrounding bone 
tissue and thereby reduce the incidence of implant loosening [177, 178]. From this standpoint, 
Mg has shown advantages of stimulating bone formation around and in contact with Mg implants 
[125-127, 179] to allow for better implant stability, integration with surrounding bone, and 
replacement of the biomaterial by native tissue. To compare between different materials and their 
characteristics before proceeding with costly and time-consuming animal tests and to reduce the 
ethical burden of these trials, in vitro tests are used to preselect the appropriate implant material 
candidates. 
In addition to testing the alloys themselves, it was also sought to assess the individual 
contributions of each alloying element to the effects on cell response. Table 4.1 lists the toxicity 
and tolerance information on Mg and the alloying elements used in this study. In this aim it was 
decided to expand on these tests of the alloying element salts while also adding alloy extracts to 
pre-osteoblast and human mesenchymal stem cells to evaluate their viability, proliferation, and 
differentiation into the osteoblast lineage. In addition, a preliminary murine subcutaneous 
implant model was used to compare WX11 and WX41 as-cast samples for local toxicity and 
corrosion as an in vivo biocompatibility pilot study. 
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Table 4.1. Summary of the pathophysiology and toxicology of Mg and alloying elements used in 
the alloys of this work [154, 180]. The toxicity levels for bone cells are according to the 
cytotoxicity test of the metal salts; (+) represents mild toxicity, (+-) symbolizes moderate 
toxicity, and (-) indicates severe toxicity. 
Element Human 
amount 




Mg 25 g 0.73-1.06 mM Activator of many 
enzymes; co-regulator 
of protein synthesis and 
muscle contraction; 
stabilizer of DNA and 
RNA 
Excessive Mg 
leads to nausea 
0.7 g + 
Ca 1100 g 0.919-0.993 mM More than 99% has a 
structure function in the 
skeleton; the solution 
Ca has a signal 
function, including 
muscle contraction, 







0.8 g + 
Zn 2 g 12.4-17.4 µM Trace element; appears 
in all enzyme classes; 







15 mg - 
Zr <250 
mg 
0.011 mg/dm-3 Probably excreted in 
feces; low systemic 
toxicity to animals 
High 
concentration 





Y 0.5 mg 0.1 mg/l 
 
Substituted for Ca2+ and 
matters when the metal 
ion at the active site; 
compound of drugs for 




high affinity for 




4.4 µg +- 
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4.2 MATERIALS AND METHODS 
4.2.1 Cell culture and maintenance 
MC3T3 pre-osteoblast cell line and human mesenchymal stem cells (hMSCs) were used to test 
the cytocompatibility of the alloys studied. These two cell lines were used to test the effects of 
the alloys on both osteoblast pre-cursor cells, hMSCs, and further differentiated mesenchymal 
cells, pre-osteoblasts, before full osteoblastic maturity. Their culture conditions are described 
below. 
4.2.1.1 Mouse pre-osteoblast cell line (MC3T3-E1) 
The murine pre-osteoblastic cell line (MC3T3-E1, American Type Culture Collection, Rockville, 
MD) were cultured in growth media consisting of modified Eagle’s medium alpha (αMEM, Life 
Technologies, Carlsbad, CA), 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 
μg/ml streptomycin at 37 °C in an environment of 95% relative humidity with 5% CO2. Cells 
after passage four were used in all experiments at a seeding density of 50,000 cells mL-1. For 
osteogenic differentiation studies, MC3T3-E1 growth media was used supplemented with 100 
nM dexamethasone, 50 μM ascorbic acid, and 10 mM β-glycerophosphate, also known as 
differentiation inducing media. 
 89 
4.2.1.2 Human mesenchymal stem cells (hMSCs) 
hMSCs obtained from normal human bone marrow (Lonza, Allendale, NJ) were cultured in 
growth media of αMEM with 20% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin at 37 
°C in an environment of 95% relative humidity with 5% CO2. Cells after passage three were 
used. In osteogenic differentiation studies, growth media was supplemented with 100 nM 
dexamethasone, 50 μM ascorbic acid, and 10 mM β-glycerophosphate as differentiation inducing 
media. 
4.2.2 Direct LIVE/DEAD cell viability and adhesion test 
MC3T3-E1 cells were cultured directly on the Mg alloys, as-cast and extruded pure magnesium, 
and extruded AZ31. 1 mm thick samples were polished up to 1200 grit, ultrasonically cleaned in 
isopropyl alcohol, air dried, and UV sterilized for 1 h. The alloy samples were incubated in cell 
culture media for 10 min after which cells were seeded on the samples at a density of 4 × 104 
cells/mL. Cell viability was evaluated at 1 and 3 days using the LIVE/DEAD 
Viability/Cytotoxicity Kit (Invitrogen Corporation, Karlsruhe, Germany) following the 
manufacturer protocol. This kit determines cell viability by differentiating between live and dead 
cells with fluorescence microscopy of two different wavelengths. Briefly, the Mg-Y-Ca-Zr 
samples with attached MC3T3-E1 cells were washed with PBS and stained for 30 min at room 
temperature with 2 μmol/L ethidium homodimer-1 and 4 μmol/L calcein AM in PBS. After 
incubation in the LIVE/DEAD solution for 30 min in room temperature, live cells and dead cells 
images were captured using fluorescence microscopy. 
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4.2.3 F-actin and nuclei staining, SEM/EDX imaging of fixed cells 
MC3T3 cells seeded on alloys cultured for 72 hours were fixed with 4% paraformaldehyde, 
permeabilized with 0.1% Tween 20 solution. F-actin staining was performed using tetramethyl 
rhodamine isothiocyanate-conjugated phalloidin and nuclei staining was performed using DAPI. 
Fluorescence images were visualized with a fluorescence microscope. Following fluorescence 
imaging, samples were dehydrated in a gradient ethanol/PBS mixture (30%, 50%, 70%, 90%, 
95%, 100%) for about 10 minutes each and dried. Sample surfaces with attached cells were then 
observed by SEM and surface elemental composition was measured using EDX. 
4.2.4 Alloy degradation product extract collection for indirect in vitro tests 
Mg alloy samples, as-cast and extruded pure magnesium, and extruded AZ31 were polished up 
to 1200 grit, ultrasonically cleaned in isopropyl alcohol, air dried, and sterilized by ultraviolet 
radiation for 1 h. The specimens were incubated in MC3T3 growth media, hMSC growth or 
differentiation media at 37 °C in a humidified atmosphere with 5% CO2 for 72 h. The sample 
weight to extraction medium ratio for as-cast and T4 treated WX11 and WX41 was 0.2 g/mL in 
accordance with the EN ISO standard 10933:12 [41], while for studies involving extruded KX11, 
WK11, WK41, and WZ42 the ratio used was ~0.8 cm2/ml media to provide further dilution as 
recommended by Fischer et al [182]. This starting extraction ratio was designated as 100% 
extract, with less concentrated extracts prepared by diluting the 100% extract to concentrations 
of 50%, 25%, and 10% or 25%, 10%, 1%, and 0.1% to explore a broader range of concentration. 
Extracts were sterile filtered through 0.2 μm syringe filters before being added to cells in the 
MTT, CyQUANT, alkaline phosphatase assays below. 
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4.2.5 MTT cytotoxicity test 
MC3T3 cells were seeded in 96-well cell culture plates at 6 x 103 cells/200 μl medium in each 
well and incubated for 24 h. Culture medium without extract served as the negative control and 
10% DMSO culture medium as the positive control. After the 24 hour incubation, medium was 
replaced with 200 μl of extraction medium with varying concentrations and incubated for 1 and 3 
days. The cytotoxicity of the corrosion extracts were tested using the MTT assay. Media and 
extracts were replaced with fresh cell culture medium to prevent interference of the magnesium 
in the extract with the tetrazolium salt [42]. The MTT assay was performed according to the 
Vybrant MTT Cell Proliferation Kit (Invitrogen Corp.) by first adding 10 μl of 12mM 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dissolved in phosphate buffer 
solution (PBS) to each well. The samples were incubated with MTT for 4 h, after which 100 μl 
formazan solubilization SDS-HCl solution was added to each well and incubated for up to 12 h. 
The absorbance of the samples was measured using the Synergy 2 Multi-Mode Microplate 
Reader (BioTek Instruments, Winooski, VT) at a wavelength of 570 nm. The absorbance of the 
samples with mean positive control subtracted was divided by the absorbance of the mean 
positive control subtracted from the mean negative control to determine percent viability of cells 
compared to the controls, where cells cultured with fresh media constituted 100% cell viability.  
4.2.6 CyQUANT proliferation test 
MC3T3 and hMSC cells were seeded in 96-well cell culture plates at 6 x 103 cells/200 μl 
medium in each well and incubated for 24 h. Culture medium without extract served as the 
negative control and 10% DMSO culture medium as the positive control. After the 24 hour 
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incubation, medium was replaced with 200 μl of extraction medium with varying concentrations 
and incubated for 1, 3, and 5 days. The effects on cell proliferation from the corrosion extracts 
were tested using the CyQUANT assay, where the CyQUANT dye binding solution binds to 
cellular DNA, which is highly regulated and closely proportional to cell number. The media was 
removed and cells rinsed with Dulbecco's Phosphate-Buffered Saline (DPBS). After removing 
the DPBS, 50 µL of the CyQUANT dye binding solution was added to each well which was then 
covered and incubated at 37 °C for 30 minutes, the fluorescence intensity of each sample well 
was measured using the microplate reader with excitation at 485 nm and emission detection at 
530 nm. The fluorescence intensity of the samples was divided by the intensity of the mean 
negative controls (cells cultured in fresh media) to determine percent viability of cells compared 
to the control, with cells cultured with fresh media constituting 100% normal proliferation. After 
measurement the cells were also imaged using fluorescence microscopy with excitation 
wavelength of excitation ~494 nm amd emission ~517 nm 
4.2.7 Alkaline phosphatase activity 
Alkaline phosphatase plays an important role in the mineralization process by hydrolyzing 
organic phosphate substrates to release free inorganic phosphate, a mineralization promoter, and 
decreasing the concentration of extracellular pyrophosphate, an inhibitor of mineral formation 
[183]. ALP activity was quantified using the p-nitrophenol phosphate (pNPP) technique. After 3, 
7, and 14 days of culture of hMSCs with the different extract media collected in growth media, 
the cells were rinsed with DPBS and lysed for 20 min using cell lysate (Sigma-Aldrich). ALP 
activity was measured using pNpp as the substrate according to the manufacturer’s protocol. The 
substrate solution was incubated with cell lysis supernatant for 1 h at 37 °C without exposure to 
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light, followed by termination of the reaction by adding 0.5 M NaOH. pNpp produced was 
measured at 410 nm using the microplate reader and normalized to the total DNA content as 
measured using the Quant-iT DNA assay (Thermo Fisher). ALP activity was compared to 
hMSCs cultured in growth media and differentiation media. 
4.2.8 Quantitative real-time polymerase chain reaction (qRT–PCR) 
After culturing in osteogenic media, RNA extraction was performed using the NucleoSpin RNA 
II kit (Macherey Nagel, Bethlehem, Pa) according to the manufacturer's protocol. The RNA 
concentration and purity were determined by measuring the absorbance at 260 and 280 nm using 
a microplate reader. Reverse transcription was then performed using the ImProm II Promega 
reverse transcription kit (Promega, Madison, WI) according to the manufacturer's protocol. 
Primers for human glyceraldehyde 3-phosphate dehydrogenase (GAPDH), runt-related 
transcription factor 2 (RUNX2), alkaline phosphatase (ALP), and osteocalcin (OCN) were used 
in the qRT-PCR experiments (Table 4.2). RUNX2 is the first transcription factor required for 
inducing mesenchymal cells into immature osteoblasts, where its expression is upregulated 
[184]. ALP is an important enzyme maximally expressed during the matrix maturation phase of 
osteoblast differentiation as it provides high concentrations of phosphate at the site of mineral 
deposition [185]. OCN is a bone-specific protein synthesized by osteoblasts that indicates 
osteogenic maturation, implicating bone mineralization and calcium ion homeostasis [186]. 
 
Table 4.2. qRT-PCR primer sequences used for human mesenchymal stem cells. 
 
Forward primer (5′–3′) Reverse primer (5′–3′) 
GAPDH TTGTCCTGCGACTTCAACA GTGGTCCAGGGTTTCTTACTCC 
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Forward primer (5′–3′) Reverse primer (5′–3′) 
RUNX2 AACCCACGAATGCACTATCCA CGGACATACCGAGGGACATG 
ALP GACCCTTGACCCCCACAA GCTCGTACTGCATGTCCCCT 
Osteocalcin CCGGAGCAGTGTGAGCTTATA GATGCGTTTGTAGGCGGTC 
 
4.2.9 In vivo murine subcutaneous study 
All experimental procedures for the murine subcutaneous study were approved by the Animal 
Care and Use Committee (IACUC) at the University of Cincinnati. Healthy nude mice were 
housed under controlled conditions and maintained with a standard pellet diet and water. Mice 
were anesthetized using isoflurane through a nosecone. A skin incision was made to create a 
subcutaneous pocket on the back of the mouse. Pure Mg, AZ31, and WX11 and WX41 as-cast 
alloys of dimensions 5 mm diameter × 1.4 mm thickness were inserted into the pocket and the 
incisions were closed by surgical staples. After 7, 40 and 70 days, the mice were sacrificed in a 
CO2 chamber followed by the cervical dislocation. The Mg/Mg alloy implants with surrounding 
tissue were recovered, carefully separated from the tissue, cleaned, air-dried, and the final mass 
was measured to determine change in mass due to corrosion to calculate corrosion rate according 
to the mass loss equation in section 3.2.1.  Tissue surrounding the implant was fixed in 10% 
formalin in PBS, paraffin-embedded, and sectioned (4 µm/section) for hematoxylin-eosin (H&E) 
staining. 70 day explanted samples were also imaged using SEM and analyzed using EDX before 
and after removal of corrosion products. 
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4.3 RESULTS 
4.3.1 Cell viability and adhesion on surface of Mg-Y-Ca-Zr based alloys 
Figure 4.1 shows pre-osteoblast MC3T3-E1 cells cultured directly on the WX11 and WX41 
alloys for 1 and 3 days, and then stained with calcein-AM (green fluorescence in live cells) and 
ethidium homodimer-1 (red fluorescence in dead cells). After 1 and 3 days of culture, both 
WX11 and WX41 as-cast and T4 heat treated alloys (Figure 4.1a-d, h-k) demonstrated 
comparable live cell density compared to pure Mg (Figure 4.1e & l) and AZ31 (Figure 4.1f & 
m). Relatively few apoptotic cells compared to live cells were observed on each material, 
indicating generally good cell viability. Tissue culture plastic displayed higher cell viability 
compared to the Mg-based materials. No significant differences in cell morphology were 
observed among the different groups. Cell density was still high among the Mg-Y-Ca-Zr alloys 
after 3 days culture compared to 1 day, indicating the cells were not significantly affected by 




Figure 4.1. Fluorescent images of live (green) and dead (red) MC3T3-E1 cells attached after 1 
and 3 days culture on a & h) WX11 as-cast; b & i) WX11 T4 heat treated; c & j) WX41 as-cast; 




The direct live/dead assay for extruded alloys (Figure 4.2) displayed high cell density of 
attached live MC3T3 cells on the extruded alloys after 1 and 3 days of culture. Relatively few 
apoptotic cells compared to live cells and normal cell morphology was observed on each alloy, 
indicating high cell viability. After 1 day, cell density on the WZ42 alloy appeared similar to that 
of tissue culture plastic, and higher than the other alloys. After 3 days culture, live cell 
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attachment on the WK41 and WZ42 alloys was very high and similar to that on tissue culture 
plastic. Comparing the cell density on the alloys from 1 to 3 days, the increasing number 
indicated healthy cell proliferation. Cell morphology shown in the f-actin and nuclei staining of 
Figure 4.3 shows healthy, spread cell morphology with filaments plainly observed demonstrating 
good cell adhesion. 
 
Figure 4.2. Live (green) and dead (red) MC3T3 cells on the surface of polished and extruded Mg 
alloy surfaces after 1 (above) and 3 (below) days of culture. Scale bar = 200 µm. 
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Figure 4.3. Phalloidin staining for F-actin (red) and DAPI staining for cell nuclei (blue) of 
MC3T3 cells on the surface of polished extruded Mg alloy surfaces after 3 days of culture. Scale 
bar = 20 µm. 
 
The alloy samples with MC3T3 cells attached to the surface were then imaged using 
SEM (Figure 4.4). High cell attachment, especially seen in samples WK41 and WZ42 alloys was 
confirmed, as well as the relatively lower cell number attached to the KX11 alloy. Deposits of 
corrosion product were also observed on the surface of the corroded Mg alloys, as seen in the 
brighter areas in the SEM images. 
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Figure 4.4. SEM images of MC3T3 cells attached to surface of extruded a) commercially 
obtained AZ31, b) pure Mg, c) KX11, d) WK11, e) WK41, and f) WZ42 after 3 days culture. 
 
Full frame EDX analysis was also performed on various regions throughout the samples 
during imaging with SEM. Calcium and phosphorous weight percentages were graphed in Figure 
4.5 which shows maximal Ca and P content present in the WZ42 alloy, while the surface of the 
KX11 alloy having the lowest concentration present. Percentage P present in the substrate 
surface rose with the addition of Y in the alloys. 
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Figure 4.5. Average weight % of Ca and P on the surface of extruded Mg alloy samples after 3 
days culture with MC3T3 cells, as determined by EDX. Groups marked with * were significantly 
different from one another. n = 4 for each group. 
4.3.2 Viability and proliferation of cells indirectly exposed to degradation products of 
Mg-Y-Ca-Zr based alloys 
Figure 4.6 shows the indirect cytotoxicity results of WX11 samples performed using MC3T3-E1 
cells and the MTT assay. For both culture periods, cell viability was expectedly most reduced 
with 100% extract concentration, and increased as the extract percentage decreased.  After 1 day 
of culture with extracts (Figure 4.6a), no cytotoxicity was observed for 25% and 10% extract 
concentrations as no reduction in cell viability was observed. After 3 days of culture (Figure 
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4.6b), the cell viability was reduced to above 70% at 25% and 10% extract concentrations. This 
is consistent with findings that show high extract concentrations are cytotoxic and lead to 
osmotic shock, suggesting that a 10-fold extract dilution be used as an indicator for acceptable 
cytocompatibility response for as-cast magnesium materials [182]. WX11 as-cast also displayed 
significantly higher cell viability at 50% extract concentration compared to WX11 T4, WX41 as-
cast, WX41 T4, and pure Mg after 1 day and 3 days in extract media. After 1 day of culture with 
extract, however, WX11 and WX41 as-cast and T4 treated alloys showed significantly higher 
cell viability compared to pure Mg at 25% extract concentration, though no difference between 
them could be observed after 3 days of culture. 
 
 
Figure 4.6. Viability of MC3T3 cells cultured for a) 1 day and b) 3 days in extract media from 
as-cast and T4 heat treated WX11 and WX41 alloys and as-cast pure Mg. Significant difference 
(p < 0.05) between * and other groups or as connected. n = 5 per extract concentration per group 
per time point. 
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The MTT assay conducted with MC3T3 cells with extract from extruded alloys (Figure 
4.7) displayed low toxicity of the alloy extract, with at least 70% cell viability observed for all 
extract dilutions. Reduction of cell viability by more than 30% is considered a cytotoxic effect 
according to EN ISO 10993:5, thus the alloys may be considered non-cytotoxic. Comparing the 
alloys, WK11 and WK41 were observed to cause slightly reduced viability after 3 days culture at 
100% extract concentration, though viability was restored after 3 days of culture. 
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Figure 4.7. Viability of MC3T3 cells cultured for a) 1 day and b) 3 days in extract media 
containing degradation products from extruded alloys and commercial AZ31 and pure Mg. 
Groups labeled * significantly different (p < 0.05) from one another. Groups labeled with † 
significantly different (p < 0.05) with groups labeled with ‡. n = 4 per extract concentration per 
group per time point. 
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4.3.3 Proliferation of pre-osteoblasts and human mesenchymal stem cells indirectly 
exposed to degradation products of Mg-Y-Ca-Zr based alloys 
Proliferation of MC3T3 cells was assessed using the CyQUANT assay which utilizes the 
PicoGreen fluorochrome to bind to dsDNA to indicate relative levels of proliferation. After 3 
days culture of MC3T3 cells with extruded alloy extracts (Figure 4.8), proliferation was again 
most reduced with 100% extract concentration, and increased as the extract percentage 
decreased.  With 100% extract concentration, WZ42 yielded significantly higher proliferation 
compared to the other groups. All the alloys displayed similar proliferation at all other 
concentrations. However, the extract collected from extruded AZ31 obtained commercially 
resulted in reduced proliferation compared to other groups when diluted to 1% and 0.1 % while 
the AZ31 made in-house and extruded to the 10:1 ratio indicated much higher proliferation than 
commercial AZ31 and similar to the other Mg alloys. Fluorescent images showing cells 
incorporating the DNA-binding dye are shown in Figure 4.9, confirming the stable proliferation 





Figure 4.8. Proliferation of MC3T3 cells cultured for 3 days with extruded alloy extracts of 
AZ31, KX11, WK11, WK41, and WZ42 diluted to 25%, 10%, 1%, and 0.1%, compared to 
commercial pure Mg and AZ31 as a percentage of control cells cultured with regular extract 
media. Groups labeled * significantly different (p < 0.05) from other groups at same extract 
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Figure 4.9. Florescence images of MC3T3 cells exposed to extruded alloy extracts diluted to 
25%, 10%, 1%, and 0.1%, after 3 days culture with DNA bound to the CyQUANT dye. Scale bar 
(lower right, same for all images) = 200 µm. 
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Cell proliferation was also tested using hMSCs for 1, 3, and 5 days culture (Figure 4.10). 
For the alloys tested, near or above 100% proliferation compared to the growth media control 
without extract was observed for all the three time points. Cell number was also significantly 
higher compared to that of AZ31 after 1 day culture and at 100% extract concentration after 3 
and 5 days culture. Fluorescent images showing cells incorporating the DNA-binding dye after 5 
days culture are shown in Figure 4.11, confirming the attachment of proliferating of cells 




Figure 4.10. Proliferation of hMSCs cultured for a) 1 days, b) 3 days, and c) 5 days with 
extruded alloy extracts diluted to 50%, 25%, and 10% of AZ31, KX11, WK11, WK41, AND 
WZ42, compared to commercial pure Mg and AZ31 as a percentage of control cells cultured 
with regular extract media. Groups labeled * significantly different (p < 0.05) from one another. 
Groups labeled with † significantly different (p < 0.05) from all other groups at that time point. 
Groups labeled with ‡ significantly different from all other groups at that time point except 







Figure 4.11. Florescence images of hMSCs exposed to extruded alloy extracts diluted to 
50%, 25%, and 10% after 5 days culture with DNA bound to the CyQUANT dye. Scale bar 
(lower right, same for all images) = 200 µm. 
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4.3.4 Differentiation of human mesenchymal stem cells indirectly exposed to degradation 
products of Mg-Y-Ca-Zr based alloys 
Human mesenchymal stem cells (hMSCs) were exposed to degradation products of the Mg 
alloys as collected in growth media and their ALP activity was accordingly compared to cells 
cultured in fresh growth media and differentiation media (Figure 4.12) after 3 days, 7 days and 
14 days of culture with extracts. Higher ALP activity with lower concentration of extract was 
observed overall, with the highest ALP activity of the hMSCs occurring when exposed to 10% 
extract media. The ALP activity in cells exposed to Mg alloy extracts at lower concentrations of 
10% and 25% remained similar to that of cells cultured with regular growth media after 3 days, 
while all groups demonstrated lower ALP activity than cells cultured in differentiation media, as 
expected. After 3 days, no difference in the ALP activity between the alloy extracts was 
observed. Higher ALP activity with the Mg alloy WZ42 was observed at 50%, 25%, and 10% 
extract concentration compared to commercial AZ31 and pure Mg at 7 days. After 14 days 
culture, no significant difference in ALP activity between the alloy extract groups and the growth 
media control were observed.  
 111 
 
Figure 4.12. ALP quantification (normalized with DNA) using hMSCs in indirect method for 
extruded Mg alloys after a) 3 days, b) 7 days, and c) 14 days of culture with extracts diluted to 
50%, 25%, and 10%. GM = growth media control; DM = differentiation media control. Groups 
labeled * significantly different (p < 0.05) from one another. Groups labeled with † significantly 
different (p < 0.05) from all other groups at that time point. n = 4 per extract concentration per 









































































































Osteogenic differentiation markers based roughly on their stages of upregulation in 
differentiating mesenchymal stem cells - early (RUNX2), middle (ALP), and late stage (OCN), 
were measured to determine the effect of the degradation product of the Mg alloys on 
differentiation of hMSCs following 7 days, 14 days and 21 days exposure to 10% dilution 
extracts collected in hMSC differentiation media (Figure 4.13). WZ42 was the only alloy 
observed that appeared to result in upregulation of osteogenic markers, with higher fold increase 
compared to cells cultured in differentiation media without extracts of ALP after 7 days and 21 
days culture, with higher osteocalcin expression observed after 14 days. Severe downregulation 
of osteocalcin, the late stage osteogenic differentiation marker at 14 and 21 days was observed in 
cells exposed to extract products of AZ31 and pure Mg. Relative to these controls materials – 
AZ31 and pure Mg, the novel alloys tested displayed upregulation of RUNX2 after 7 days, ALP 
after 14 days (except for WK11), and OCN after 21 days. However, this study was only 







Figure 4.13. qRT-PCR gene expression data showing the expression of RUNX2, ALP, and OCN 
hMSCs cultured for a) 7 days, b) 14 days), and c) 21 days with 10% extracts diluted in 
differentiation media normalized with respect to cells cultured in growth media and compared to 
differentiation media group where media did not contain extracts. n = 1 for all groups. 
4.3.5 Proliferation of human mesenchymal stem cells exposed to salts of Mg, Y, Ca, Zr, 
Zn, and Al 
hMSCs cultured with chloride salts in growth media of Mg (in concentrations of 50 mM, 20 mM, 
10 mM, and 1 mM) and Y, Ca, Zr, Zn, and Al (in concentrations of 1 mM, 0.1 mM, 0.01 mM, 
and 0.001 mM) were assessed for proliferation using the CyQUANT assay after culture for 1, 3, 
and 5 days and normalized with respect to regular growth media. After 1 day culture (Figure 
4.14a), proliferation in the presence of Ca, Y, Zr, and Al was generally unaffected by the 
presence of the metal salts at all concentrations. For Mg and Zn, the upper concentrations tested 



















































was restored with further dilution. At 3 days of culture (Figure 4.14b), again high concentration 
of Mg and Zn reduced cell number, but an increase in cell number was observed at higher 
concentrations of Y, Zr, and Al. These trends were also retained after 5 days of culture. The dyed 
cells were imaged and shown in Figure 4.15, confirming the differences in cell numbers 
quantified in Figure 4.14. 
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Figure 4.14. Proliferation of hMSCs cultured for a) 1 days, b) 3 days, and c) 5 days with 
chloride salts of Mg (in concentrations of 50 mM, 20 mM, 10 mM, and 1 mM) and Y, Ca, Zr, 
Zn, and Al (in concentrations of 1 mM, 0.1 mM, 0.01 mM, and 0.001 mM) dissolved in growth 
media, as a percentage of control cells cultured with growth media and differentiation media. 
Groups labeled * were significantly different (p < 0.05) from control cells cultured in fresh 









Figure 4.15. Florescence images of hMSCs exposed to alloying element chloride salts of Mg (in 
concentrations of 50 mM, 20 mM, 10 mM, and 1 mM) and Y, Ca, Zr, Zn, and Al (in 
concentrations of 1 mM, 0.1 mM, 0.01 mM, and 0.001 mM) dissolved in growth media after 5 
days culture with DNA bound to the CyQUANT dye. Scale bar (lower right, same for all images) 
= 200 µm. 
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4.3.6 Differentiation of human mesenchymal stem cells exposed to salts of Mg, Y, Ca, Zr, 
Zn, and Al 
ALP activity of hMSCs exposed to metal salts of elements present in the Mg alloys was 
compared to cells cultured in fresh growth media and differentiation media (Figure 4.16) after 14 
days culture. Compared to growth media, the diluent in which the salts were dissolved into, Mg 
at 20 mM and 10 mM, Ca at 0.01 mM, and Zn at 1 mM resulted in cells with higher ALP activity 
than growth media and similar to that of hMSCs cultured in differentiation media. High 





Figure 4.16. ALP quantification (normalized with DNA) using hMSCs in culture with chloride 
salts of Mg (in concentrations of 50 mM, 20 mM, 10 mM, and 1 mM) and Y, Ca, Zr, Zn, and Al 
(in concentrations of 1 mM, 0.1 mM, 0.01 mM, and 0.001 mM) dissolved in growth media for 14 
days. Significant difference between groups labeled * and growth media control ALP activity. 
GM = growth media control; DM = differentiation media control. n = 3 per extract concentration 
per group per time point. 
4.3.7 In vivo murine subcutaneous study 
H&E staining of the local site of implantation of Mg-Y-Ca-Zr as-cast alloys, pure Mg, and AZ31 
in the subcutis of nude mice is shown in Figure 4.17a-l. Minimal toxicity of the implanted alloys 
to the surrounding tissue was observed, while the region surrounding the implants appeared to be 
undergoing normal tissue repair. No significant accumulation of inflammatory cells was 
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* * * 
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fibroblasts was seen after 7 days. At this time point, a relatively high density of fibroblasts in 
tissues adjacent to as-cast WX11 and WX41 alloy pellets suggests their presence did not inhibit 
the normal healing response in the implantation site. After 40 and 70 days implantation, dense 
collagenous connective tissue was seen surrounding the location of the Mg implants, without the 
presence of a high density of chronic inflammatory cells. Normal adipocytes could be faintly 





Figure 4.17. a-l) Histology images (H&E staining) of the skin above the implants of a, e, i) 
WX11 and b, f, j) WX41 as-cast alloys, c, g, k) pure Mg, and d, h, l) AZ31 after 7 days (a-d), 40 
days (e-h), and 70 days (i-l) in the subcutis of nude mice. 
 
In vivo corrosion as determined through mass loss (Figure 4.18) of as-cast WX41 was 
much lower than as-cast WX11 and similar to pure Mg and slightly higher compared to AZ31 
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after 70 days. This result is consistent with the in vitro corrosion behavior of the Mg-Y-Ca-Zr 
alloys, in which the higher Y-containing alloy, WX41, corroded more slowly than WX11. 
 
Figure 4.18. Corrosion rate as calculated by mass loss of pellet samples before and after murine 
subcutaneous implantation at time points of 40 and 70 days. n = 1 for each group. 
 
The samples explanted after 70 day implantation were dried and imaged using SEM to 
assess the corrosion products formed (Figure 4.19) in comparison to those formed after static 
immersion (Figure 3.3). After in vivo corrosion, it can be seen from the elemental maps of the 
corrosion products, layers rich in C and O were observed to have formed on the alloy surface, 
similar to results from the immersion study. The cracked corrosion layer was seen to contain 
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higher Ca and P content compared to agglomerates of corrosion deposits. Removal of corrosion 
products revealed widespread corrosion resulting in irregular surface topography on all the 
explanted alloy materials as seen in Figure 4.20. 
 
Figure 4.19. SEM images showing surface morphologies of a) WX11 as-cast; b) WX41 as-cast; 
c) pure Mg; d) AZ31 after 70 days implantation in murine subcutaneous tissue. EDX was 
performed at various spots as denoted by arrows. 
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Figure 4.20. SEM images showing surface morphologies of a) WX11 as-cast; b) WX41 as-cast; 
c) pure Mg; d) AZ31 after 70 days implantation in murine subcutaneous tissue and cleaning with 
CrO3/AgNO3 solution. 
4.4 DISCUSSION 
The alloying elements used in this study have all shown to be biocompatible based on the 
literature as well as indicated in Table 4.1 showing the daily allowance and toxicity. Y has been 
shown to be non-toxic in longevity studies [181], non-hepatotoxic [187], and incorporated in 
alloys which were clinically well-tolerated as an absorbable metal stent [188] and fixation screw 
for chevron osteotomies in hallux valgus surgeries [95]. Y also has a high affinity for areas of 
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osteoblastic activity in bone through events leading to organic matrix formation [189] and may 
promote osteoblast proliferation and differentiation at concentrations of 1 x 10-9 – 1 x 10-4 M and 
1 x 10-7 M, respectively [190], which may be related to altered vitronectin and collagen 
conformation and bioactivity [191]. Ca is well-known and an essential component in bone, while 
requiring Mg for incorporation into bone [192]. Zr ions have low cytotoxicity [176] and 
zirconium coatings have demonstrated improved osseointegration of metal implants in vivo 
[193]. Effects on in vitro cytocompatibility, proliferation, and differentiation from the Mg-Y-Ca-
Zr alloys discussed above were determined by 1) exposing murine pre-osteoblast and human 
mesenchymal stem cells to media containing degradation products of the materials, 2) seeding 
cells directly onto the alloys and observing live and dead cell densities through the LIVE/DEAD 
assay, and 3) adding media containing various concentrations of the alloying element salts to the 
cells.  
Figure 4.6 and Figure 4.7 present the results from the MTT assay, in which at high 
extract concentrations, (100% and 50%), cell viability was reduced in the as-cast and T4 treated 
alloys of Figure 4.6, as well as with the extruded WK11 alloy in day 1 and WK11 and WK41 
alloys at day 3 at 100% extract concentration. This was likely due to reports of high extract 
concentrations causing cellular osmotic shock, suggesting a 10-fold extract dilution be used as an 
acceptable dilution for as-cast magnesium materials [182]. Indeed, at lower concentrations of 
extract (25% and 10% for as-cast and T4 treated WX11 and WX41 alloys and 50%, 25%, and 
10% for all extruded alloys), high cell viability was observed for the alloys, indicating higher 
alloy degradation products resulted in lower cytotoxicity. Higher than 100% cell viability was 
observed from 25% and 10% extracts of WX11 and WX41 as-cast and T4 treated alloys after 1 
day of culture, which may be facilitated by enhanced osteoblast activity in the presence of 
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corrosion product magnesium hydroxide [194]. Similarly, high density of live cells was observed 
attached to the surface of the Mg-Y-Ca-Zr alloys in Figure 4.1 and Figure 4.2. By directly 
culturing cells onto Mg-alloy substrates, this assay qualitatively shows the effect of hydrogen gas 
production, increased pH levels, and local concentration of corrosion products on cell attachment 
and viability. The differences observed in the corrosion rate however, did not appear to have 
bearing on the in vitro cytocompatibility results, with all as-cast and T4 treated Mg alloys 
harboring similar number of attached active cells, while appearing to have lower cell density 
compared to tissue culture plastic. This is consistent with these alloys’ 3 day MTT results at 
100% and 50% extract concentrations in which cell viability was lower than the control. The 
elongated, spread morphology of the adherent cells on the Mg-Y-Ca-Zr alloys after both 1 and 3 
days of culture confirmed the cytocompatibility of the alloys, which did not corrode too rapidly 
to inhibit cell attachment. It appeared that higher densities were present on relatively slower 
corroding alloys (WK41 and WZ42 compared to KX11), which also were revealed to have 
higher percentages of Ca and P deposited on their surface where cells were attaching (Figure 
4.5). This may indicate a correlation between corrosion stability with higher amounts of CaP 
deposits forming on the Mg alloy surface allowing for improved osteoblast adhesion and 
proliferation, as has been observed with CaP coatings on the surface of titanium [195]. 
In this study, cytocompatibility was conducted using MC3T3-E1 cells with samples 
immersed in αMEM + 10% FBS, and the presented results may vary with the use of different cell 
lines and respective cell culture media. Cells cultured in other media such as DMEM may exhibit 
different cytocompatibility results compared to αMEM, due to the presence of higher L-
glutamine content in DMEM, which functions as a chelating agent for magnesium ions [196], 
potentially causing increased Mg ion release from alloys immersed in DMEM [197]. Thus, the 
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obtained cytocompatibility results presented here should be solely considered under cell culture 
conditions using αMEM as opposed to other media such as DMEM or HBSS, which would 
likely result in a higher corrosion rate of tested alloys, applying a different local environment to 
cultured cells. 
Proliferation of the extruded alloys was also measured using the CyQUANT assay of 
DNA quantification. Proliferation was reduced with higher concentration of Mg alloy extract in 
Figure 4.8 similar to reduced viability seen in the MTT assay of Figure 4.6. hMSC proliferation 
on the other hand, was higher than MC3T3 cells in the presence of extract media, suggesting 
greater tolerance of hMSCs compared to MC3T3 cells. With hMSCs after 5 days of culture, 
proliferation was higher than cells cultured in regular growth media. Li et al [198] observed 
increase in hMSC proliferation with Mg-1Y (wt.%) alloy having a superior effect on 
proliferation compared to Mg-2Ca alloy. The increased proliferation was influenced via SMAD-
dependent signaling pathway, with the largest increase in SMAD4 observed in the Y containing 
alloy. Y3+ ions also promoted the proliferation of mouse osteoblasts [190]. However, AZ31 
resulted in reduced proliferation of both MC3T3 cells and hMSCs, with this negative effect on 
cell viability also being observed by other groups studying both AZ31 and AZ91 [199]. Little 
induction of differentiation due to the presence of Mg alloy extract media was observed as 
measured by ALP activity (Figure 4.12) and RUNX2, ALP, and OCN expression (Figure 4.13), 
with WZ42 alloy demonstrating a higher propensity compared to the other Mg alloy and pure 
Mg groups studied for promoting osteogenic differentiation. This may be due to this alloy 
containing a combination of Y – which promotes differentiation into osteoblast at low 
concentrations [190], while also including Zn excluded in the other alloys – which stimulates 
ALP activity and collagen concentration when tested with concentrations between 1 and 25 µM 
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[200].  Mg-Y also was found to increase levels of ALP in hMSCs by Li et al [198] compared to 
other Mg alloys and pure Mg. These encouraging findings regarding WZ42 corroborated the data 
from Specific Aim 2 to use this alloy for the animal model in the next aim. 
In order to elucidate the effects of alloy addition to cells, it was also considered that each 
alloying element in the form of chloride salt be dissolved individually in media to use for cell 
culture and evaluation. It was found that in the range of concentrations tested (0.001 mM – 1 
mM) of Ca, Y, Zr, and Al, cell proliferation was not affected, while at high concentrations of Mg 
(50 mM) and Zn (1 mM), proliferation was reduced, though upon further dilution the reduction 
in proliferation was restored. The 50 mM Mg concentration was above that of 10 mM Mg ions 
that Hallab et al [201] observed to result in in approximately 50% reduction in viability of MG-
63 osteoblasts. The 1 mM Zn concentration also was above the IC50 of 0.09 mM for MC3T3 and 
L929 cells reported by Yamamoto et al [176]. Yamamoto also reported that the MC3T3 cell 
IC50 for Zr as 2.83 mM and for Al as 2.92 mM, above the maximum 1 mM used, resulting in no 
loss in proliferation. The IC50 for MC3T3 cells exposed to Y however, was 0.142 mM. In the 
present study, as seen in Figure 4.10, the 1 mM concentration Y salt did not cause a decrease in 
hMSC proliferation. 
Promotion of osteoblastic differentiation of hMSCs due to alloying element salts was also 
investigated, which concluded that Mg at concentrations of 10 – 20 mM resulted in increased 
ALP activity from cells in the differentiation media. Yoshizawa et al [202] observed that 5 and 
10 mM MgSO4 concentration enhanced mineralization of ECM from human bone marrow 
stromal cells (hBMSCs) with maximum promotion of osteogenic factors at 10 mM Mg via HIF-
2α and PGC-1α. The increase in activity for Zn at 1 mM concentration may not be indicative of a 
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positive effect on differentiation due to the reduction in cell number that resulted from Zn 
addition as seen in Figure 4.14, since ALP activity is normalized to DNA quantity. 
Variations in the various in vitro cell tests conducted in this specific aim may be due to a 
number of factors. First, cell number may have varied from well to well, while variations in alloy 
sample dimensions and surface finishing may have deviated resulting in differences in the local 
environment of degradation products that cells were exposed to. Variations in pipetting volume 
of reagents and media may also have caused slight experimental error, as well as the method of 
measurements such as the microplate reader. 
Past studies have shown acceptable host response and biocompatibility of RE-containing 
Mg alloys upon in vivo implantation [203]. Subcutaneous implantation of Mg–1.5%Nd–0.5%Y–
0.5%Zr alloys with and without 0.4%Ca demonstrated adequate Mg metabolism, renal function, 
and host-tissue response as the Ti-6Al-4V control implant [204]. The murine subcutaneous study 
was conducted here in order to compare the in vivo corrosion and local tissue response of the 
selected materials: WX11 as-cast, WX41 as-cast, pure Mg, and AZ31. Histological slides stained 
using H&E (Figure 4.17) showed the Mg-Y-Ca-Zr alloys did not introduce toxicity or excessive 
inflammatory response to the surrounding tissue, presenting an acceptable host response with 
natural wound healing occurring as seen in the presence of a high density of fibroblasts which 
deposit collagen fibers in order to form new extracellular matrix during the tissue repair process 
[205]. This dense connective tissue was observed adjacent to the Mg alloy implants at all time 
points, indicating biocompatibility at varying magnitudes of alloy degradation. The in vivo mass 
loss corrosion rates (Figure 4.18) of the tested Mg alloys were lower than those measured from 
in vitro immersion. Witte et al. [206] concluded that in vitro corrosion tests could not accurately 
predict in vivo corrosion rates after observing a four order of magnitude reduction of corrosion 
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rate in vivo compared to in vitro. Different environmental conditions, dynamic blood flow 
around the implant, and variations in pH as well as the local chemical environment of buffering 
ions could also be among reasons that could be provided to explain the discrepancy. The lower 
corrosion rates measured in vivo versus in vitro was in agreement with studies of Mg alloys 
implanted intramedullary in guinea pig femurs [206] and in a subcutaneous environment in 
Lewis rats [207]. Explanted samples displayed the formation of similar corrosion products and 
morphology to samples from immersion testing. After 70 days implantation, the extent of in vivo 
corrosion is clearly greater than after 3 weeks in vitro, as can be construed from the SEM images 
of the surfaces seen in Figure 4.19 and Figure 4.20. At the same time, corrosion products rich in 
C and O with the presence of Ca and P were still identified. The corrosion product morphology 
of a cracked corrosion layer with corrosion products deposited on top as seen both in vitro and in 
vivo is in agreement with results found in other studies [207, 208]. 
Nonetheless, in vivo corrosion rate following 40 and 70 days of implantation for as-cast 
WX41 was lower than as-cast WX11 and comparable to pure Mg and AZ31 after 70 days, which 
was consistent with the measured in vitro corrosion rates (Figure 3.1). This result is in agreement 
with established knowledge that while in vitro corrosion tests currently cannot accurately predict 
those seen in vivo, they may serve as a relatively inexpensive screening method to assess the 
relative corrosion resistance of Mg alloys. It can therefore serve to select alloys that could 
potentially yield a favorable response in vivo since a faster corroding alloy composition 
compared to a more stable system could likely also display faster corrosion under in vivo 
conditions. On an absolute scale, it may not be easy to derive the same conclusions due to the 
various factors of materials as well as the local chemical and biological environments that can 




5.0  SPECIFIC AIM 4: ASSESS THE IN VIVO CORROSION, BONE FORMATION, 
AND HOST RESPONSE OF MAGNESIUM-YTTRIUM-ZINC-CALCIUM-ZIRCONIUM 
ALLOY IN A RAT FEMUR OSTEOTOMY MODEL 
5.1 INTRODUCTION 
As discussed in earlier Chapters, magnesium based alloys have received the most attention in the 
medical products space for use in orthopedic applications ever since its reintroduction into 
biomedical research this millennium. Numerous studies in small animals (e.g. mice, rats, guinea 
pigs, and rabbits), large animals (e.g. sheep and goats), as well as humans have overall shown the 
good biocompatibility of magnesium alloys when implanted within in or surrounding bone. This 
combined with the high strength to weight ratio of Mg and its ability to degrade, thus reducing 
the need for secondary removal surgeries as conducted for permanent metallic hardware, have 
made Mg and Mg alloys an attractive option that is poised to be at the forefront to challenge the 
dominance of the current state of the art inert metallic and degradable polymeric orthopedic 
device landscape. Other important properties of magnesium that have been demonstrated include 
enhanced bone formation adjacent to or near the Mg alloy, high deposition of Ca-P minerals, and 
direct contact between the degradation product layer of Mg and new bone [154].  
Of the various studies involving implantation of Mg alloys into bone, the vast majority 
comprised implanting rods, pins, or screws of Mg alloys into the femoral diaphysis (~8), with a 
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few in the femoral condyle and marrow cavity [154]. None of the 23 papers reviewed by Zheng 
et al [154] wherein Mg alloy was implanted into the bone, none represented a load bearing 
model, in every case a hole was predrilled into the bone with the implant then either press fit or 
screwed into place. The only cases in which a Mg implant was used to bear load to provide 
fixation for fractured bone was the plate and screw studies conducted by Chaya et al [127, 179]. 
In these studies, a full fracture was created in the ulna of New Zealand white rabbits with holes 
predrilled into the two sides of the fractured ulna to allow for placement of the plate and screw to 
stabilize the fracture. Despite these studies being the only assessments of a loaded fracture 
environment evaluating Mg orthopedic implants, all the rabbit radii were left intact during 
healing, which provided additional support to the fracture, supplementing that of the plate and 
screw.  
In this study, it was decided to pursue a fully load bearing model where a full fracture of 
the rat femur was only fixed using implant pins of the Mg alloy Mg-Y-Zn-Zr-Ca (WZ42), whose 
materials and biological characteristics have been described in the preceding chapters, and 
compared to performance of the common medical titanium alloy, Ti6Al4V. This model selected 
has conceptual similarities mimicking orthopedic fixation devices such as Kirschner wires (K-
wires) and Steinmann pins, thin rods that are drilled through bone fracture fragments to maintain 
the anatomical congruity and biomechanical stability required for optimal bone healing. 
Unfortunately, currently used K-wires need to be removed after the bone has healed, 
necessitating a secondary procedure. To allow for easy removal, the ends of the wires are usually 
left outside the skin, forming a “pin-tract” that acts as a conduit for causing infection and other 
complications. These shortcomings of these common orthopedic devices could be avoided 
though through the use of degradable Mg alloy K-wires. 
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In addition to the intramedullary fracture fixation pins, in separate animals, WZ42 wires 
were wrapped around the mid-diaphyseal region of unfractured femurs forming a cuff to 
compare degradation and tissue response to the Mg alloy implanted in different regions – 
intramedullary versus over the cortical bone. Furthermore, another goal of the study was to 
assess systemic toxicity through a complete blood profile as well as organ and tissue analysis 
comprising kidney and liver. 
5.2 MATERIALS AND METHODS 
5.2.1 Preparation of Mg-Y-Zn-Ca-Zr implants 
The WZ42 alloy was melt and cast as described in section 2.2.1, with the nominal composition 
of  Mg-4.0%Y-2.0%Zn-1.0%Zr-0.6%Ca (wt. %). After casting, a solution treatment of 400 °C 
was applied for 20 hours and the ingot was quenched in room temperature water to increase the 
alloys’ ductility and homogenize the secondary phases. The ingot diameter was machined using a 
lathe down to 37.8 mm to allow it to be extruded with an extrusion ratio of 30 while being heated 
at 450 °C. The extruded WZ42 rod of diameter ~6.9 mm and control material of Ti6Al4V rod of 
diameter 5 mm (Goodfellow Corporation, Coraopolis, PA) were machined using a lathe into pins 
with dimensions of 15 mm length x 1.66 mm diameter and wires of 20 mm length and 0.68 mm 
diameter. Schematics and photographs of machined pins and wire cuffs are shown in Figure 5.1. 
The implants were sonicated in washes of pure acetone and isopropanol and dried before 
undergoing sterilization by gamma radiation (2x106 cGy, 23.5 Gy/min, cesium 137 source, Mark 
I 68, JL Shepherd and Associates, San Fernando, CA). 
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Figure 5.1. Schematic (a) and photograph (b) of pins (lower) inserted into the femoral 
intramedullary cavity and wire cuffs (upper) wrapped around the mid-diaphyseal region. In a) the 
wire was machined straight then bent around the femur during surgery. 
5.2.2 Animal model 
All animal experiments were approved by the University of Pittsburgh’s Institutional Animal 
Case and Use Committee (IACUC). Before surgery, female Sprague-Dawley rats weighing 250-
300 g were anesthetized by inhalation of isoflurane at a concentration of 2-5% for initiation of 
sedation, and 0.25-4% for maintenance. Each rat only received surgery in their right hind limb. 
Photographs of the surgical procedure are shown in Figure 5.2. First, the right hind limbs were 
shaved and disinfected, and an approximately 2 cm incision was made over the right femur, with 
location indicated in Figure 5.2a. The skin and mid-diaphyseal region of the right femurs were 
exposed through a lateral approach. A complete femoral osteotomy was created using a hand 
held drill (Figure 5.2b). The WZ42 or Ti6Al4V fixation pins were inserted first into the 
intramedullary space of the distal portion of the fractured femur (Figure 5.2c), then inserted into 
the intramedullary space of the proximal femur (Figure 5.2d), with the fracture approximated as 
seen in Figure 5.2e. In the case of the wire cuffs, the right femur was not cut, and the wires were 
wrapped around the midsection of the diaphysis and pressed against the bone to avoid translation 
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along the shaft of the femur or migration (Figure 5.2g). After the samples were implanted, the 
fascia and muscles were closed with VICRYL (J315) and the skin closed using non-absorbable 
monofilament polyamide sutures. 
Post-operative pain and distress was observed daily for expressions of stress and 
behavioral abnormalities, changes in movement, food, and water intake. Furthermore, the right 
hind limbs were observed visually for signs of infection or presence of gas pockets. 
 
Figure 5.2. Surgical procedure used to implant metallic samples: a) Photograph of pins 
inserted into the femoral intramedullary cavity (bottom) and wire cuffs wrapped around the mid-
diaphyseal region (top). Pin model - a) Lines indicating where incision was made to expose the 
femur; b) Fracture being created in rat femur using circular saw; c) Pin inserted into marrow 
space of one side of fractured femur; d) Pin inserted into other side of femur to bridge the 
fractured femur; e) Fracture closed with pin maintaining alignment and fixation; f) Surgical site 
fully closed and sutured. Cuff model - g) After incision to expose femur, the bone was left intact 
without osteotomy and a wire was wrapped around the midsection of the femur. 
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Groups of 5 animals for both WZ42 and Ti6Al4V pins were used for each time point of 2, 8, and 
14 weeks for blood, liver, kidney, histology, and micro-CT analysis, and groups of 6 animals 
were implanted with wire cuffs with a single time point of 14 weeks, as displayed in Table 5.1. 
Rats were sacrificed using a gradual overdose of carbon dioxide followed by cervical dislocation. 
Immediately following sacrifice, the liver, kidney, and experimental group femurs were collected 
and stored for further analysis as described in the following sections. Three rats receiving no 
surgery were also sacrificed to serve as an operated control group. 
 
Table 5.1. Summary of number of rats in each groups at time points used in study. 




 Intramedullary Pin Cuff 
Ti6Al4V 5 5 5 6 
WZ42 5 5 5 6 
 
5.2.3 X-ray imaging 
X-ray imaging was performed on rats one week post-operatively to examine the position of the 
implants and stability of the fracture.  
5.2.4 Blood-cell count and serum biochemical measurements  
Blood samples were collected from animals before operation under anesthesia by tail snip and 
terminally (2, 8, and 14 weeks after implantation) by cardiac puncture and aspiration. For 
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determination of blood cell count, blood was collected in K2-EDTA tubes and analysis was 
performed by Marshfield Labs (Cleveland, OH) using a Sysmex XT2000i Automated 
Hematology Analyzer (Sysmex Corporation, Kobe, Japan). Serum samples were obtained by 
centrifuging collected blood at 2,000 rpm for 10 minutes at 4 °C. Serum biochemical tests were 
conducted by Marshfield Labs using an Olympus AU chemistry analyzer (Olympus Corporation, 
Tokyo, Japan). 
5.2.5 Micro-computed tomography imaging 
Plastic embedded rat femurs as  were used for high resolution micro-computed tomography 
(µCT) scanning. Samples were scanned with continuous rotation µCT at 10.5 µm voxel size 
before implantation and immediately after retrieval post-operatively at 2, 8, and 14 weeks. The 
reconstructed data sets were used to generate a 3D volume from which we distinguished the 
remaining metal rod from surrounding degradation products and bone by using a histogram of 
grey values based on densities. A density threshold for the metal pins was used to isolate the 
volume of remaining magnesium alloy from surrounding material and compared to volume of 
the pins before implantation to estimate in vivo corrosion rate using the following equation:  
C = (K × V)/(A × T) 
Where C is the corrosion rate (mm year-1, mmpy), the constant K is 8.76 x 104, V is the volume 
loss (cm3), A is the initial sample area exposed (cm2), and T is the time of exposure (h). 
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5.2.6 Histological preparation and analysis 
Specimens of liver and kidney were fixed in 10% neutral buffered formalin, dehydrated, and 
infiltrated and embedded in paraffin. They were then inspected with hematoxylin and eosin 
(H&E) staining to assess whether the degradation of the WZ42 alloy resulted in any pathological 
changes in these critical visceral organs. 
Femurs were fixed in 70% ethanol, dehydrated, and infiltrated and embedded in Osteo-
Bed Plus methyl methacrylate-based embedding kit (Polysciences, Inc., Warrington, PA). The 
plastic blocks were sectioned with a rotary microtome (Leica RM 2255, Leica Biosystems, 
Buffalo Grove, IL) and stained using Goldner’s Trichrome and alkaline phosphatase stains. 
5.2.7 Tissue digestion and elemental analysis 
Liver and kidney tissues were digested to allow for measurement of elemental concentration 
using ICP-OES. First, tissues were dried at 70 °C for 24 hours, then homogenized and weighed. 
Samples were then digested by immersion in 20 ml nitric acid/g tissue for 6 hours at 70 °C, 
followed by adding 4 ml hydrogen peroxide/g tissue for 1 hour, and 4 ml sulfuric acid/g tissue 
for 1 hour. Samples were then diluted 50x in water purified by a Milli-Q system (18 MΩ cm 
deionized water, Milli-Q Academic, Millipore, Billerica, MA), filtered in 0.45 µm syringe filters, 
and analyzed for Mg concentration by ICP-OES (Thermo Fisher). 
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5.3 RESULTS 
5.3.1 Fixation of femoral defect using Mg-Y-Zn-Ca-Zr alloy pin 
In order to provide fixation of a full osteotomy to the midsection of a femur, pins with sharpened 
ends were fabricated from the WZ42 alloy and Ti6Al4V alloy and inserted into the 
intramedullary cavity of the two halves of the fragmented femur. In addition, WZ42 and 
Ti6Al4V wires were wrapped around the midsection of native femurs to compare tissue response 
of the biomaterials inserted in the bone versus at the outer surface of the bone. The pins were 
successfully inserted into all femurs during surgery with the fractures being approximated as 
seen in the 7 day X-ray images of Figure 5.3a and b despite slight mismatches between the pin 
diameter and the diameter of the intramedullary cavity observed in some cases (Figure 5.3c, red 
arrow) resulting in a small gap. Some wire cuffs snapped during implantation but all maintained 




Figure 5.3. One week X-ray images of implanted WZ42 magnesium alloy (a) and 
Ti6Al4V (b) K-wires (designated by white arrow) in the right femur of rats; c) fracture 
misalignment (red arrow) and empty spaces near the WZ42 implants (yellow arrow, circled) 
were observed in some X-ray images. One week X-ray images of implanted WZ42 magnesium 
alloy (d) and Ti6Al4V (e) wire cuffs (designated by white arrow) in the right femur of rats. 
 
 Small pockets of empty space, as seen in Figure 5.3c, noted by the yellow arrow, were 
observed in the X-rays of 75% of rats with implanted WZ42 alloy pins or cuffs, likely caused by 
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hydrogen gas evolved from the degrading Mg implants. Despite their presence in the X-ray 
images, no bulges in the skin in the hind limb of rats were observed during frequent visual 
inspection of the rats. The rats regained mobility by 7 days post-operation. 
5.3.2 Systemic toxicity to Mg-Y-Zn-Ca-Zr implants 
Total blood cell count is listed in Table 5.2 below, which generally did not indicate any 
disturbances in the blood count, with parameters remaining within references ranges or near pre-
operation levels. Small differences from the reference ranges or unoperated levels were observed 
from low platelet counts for WZ42 cuffs, and WZ42 and Ti6Al4V pins at 14 weeks, while 
elevated postoperative white blood cell count were seen at 2 weeks for both WZ42 and Ti6Al4V 
pins. 
 
Table 5.2. Average blood cell count of unoperated animals and animals implanted with WZ42 
and Ti6Al4V alloy pins at 2, 8, and 14 weeks after implantation. 
Name Implantation time 
Red Blood 
Cell Count Hemoglobin Platelet Count 
White Blood 
Cell Count 







Ref. ranges   (7.00-9.00) (13.7-16.8) (680-1280) (1.1-7.5) 
Unoperated   7.4 ± 0.3 14.1 ± 0.9 618.3 ± 200.6 6.8 ± 2.3 
WZ42 pin 2 weeks 8.0 14.3 839.0 8.6 
Ti6Al4V pin 2 weeks 7.8 14.9 656.0 9.0 
WZ42 pin 8 weeks 7.4 ± 0.5 13.8 ± 1.2 N/A 6.8 
Ti6Al4V pin  8 weeks 7.4 ± 0.3 14.2 ± 0.4 637.8 ± 168.6 5.9 ± 1.6 
WZ42 pin 14 weeks 7.7 ± 0.4 14.2 ± 0.5 595.8 ± 179.8 5.9 ± 2.1 
Ti6Al4V pin 14 weeks 7.5 ± 0.4 14.0 ± 0.7 563.0 ± 164.5 5.9 ± 2.7 
WZ42 cuff  14 weeks 7.1 ± 0.2 13.9 ± 0.4 461.0 ± 56.6 2.2 ± 1.0 
Ti6Al4V cuff 14 weeks 7.6 ± 0.4 13.8 ± 0.7 637.0 ± 96.5 5.8 ± 1.4 
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Similarly, serum biochemical parameters are shown in Table 5.3, with kidney function 
measured by creatinine and urea levels, and liver function measured by albumin, alkaline 
phosphatase, bilirubin, and glucose. All parameters remained within the reference ranges or near 
pre-operation levels, demonstrating little effect of the implanted alloy materials on the kidney 






























































































































































































































































































































































































































































































































































































































































































































































































Table 5.3. Average values of serum metabolic parameters unoperated animals and animals 
implanted with WX42 and Ti6Al4V alloy pins at 2, 8, and 14 weeks after implantation. 
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Electrolyte parameters calcium, sodium, chloride, phosphorous, and magnesium were measured 
from serum samples which are shown in Table 5.4. Importantly, magnesium levels remained in 
the low end of the reference ranges indicating no accumulation of degrading Mg from the 
implants in the collected blood. All other electrolytes similarly remained consistent with 
unoperated rats and the prescribed allowable reference ranges. 
 
Table 5.4. Average values of electrolyte parameters of unoperated animals and animals 
implanted with WX42 and Ti6Al4V alloy pins at 2, 8, and 14 weeks after implantation. 
Name Implantation time Calcium Sodium Chloride Phosphorous Magnesium 
Units   mg/dL mmol/L mmol/L mg/dL mg/dL 
Ref. ranges   (9.5-13.9) (146-151) (98-104) (5.6-16.8) (3.8-5.5) 
Unoperated   9.8 ± 0.2 138.2 ± 1.9 100.5 ± 1.0 5.5 ± 0.2 2.0 ± 0.2 
WZ42 pin 2 weeks 11.2 ± 0.1 144.8 ± 1.7 101.0 ± 1.4 8.5 ± 0.9 2.9 ± 0.3 
Ti6Al4V pin 2 weeks 11.5 ± 0.5 143.8 ± 1.6 100.2 ± 2.2 9.7 ± 1.9 3.4 ± 0.4 
WZ42 pin 8 weeks 11.6 ± 0.5 144.4 ± 1.9 100.6 ± 2.8 9.7 ± 1.4 3.5 ± 0.5 
Ti6Al4V pin  8 weeks 11.8 ± 0.6 146.5 ± 1.0 100.0 ± 1.4 11.3 ± 0.8 3.9 ± 0.4 
WZ42 pin 14 weeks 11.4 ± 0.3 147.8 ± 1.9 100.2 ± 2.0 9.8 ± 0.7 3.6 ± 0.2 
Ti6Al4V pin 14 weeks 12.2 ± 1.1 145.2 ± 2.6 99.0 ± 2.0 9.6 ± 1.2 3.6 ± 0.6 
WZ42 cuff  14 weeks 11.3 ± 0.2 147.0 ± 0.7 101.4 ± 0.9 9.1 ± 1.4 3.2 ± 0.2 
Ti6Al4V cuff 14 weeks 11.6 ± 0.3 147.6 ± 1.1 99.6 ± 1.7 9.2 ± 0.7 3.3 ± 0.2 
 
ICP-OES results of the acid-digested liver and kidney (Figure 5.4) demonstrated no 
accumulation of Mg exceeding the normal levels seen in unoperated control rats was observed in 
the collected liver and kidney tissue in the WZ42 or Ti6Al4V groups. Ca and Zn concentration in 
the liver and kidney also did not deviate from the normal levels. The concentration of other 
alloying elements (Y and Zr) measured from the digested liver and kidney were also perceived to 
be too low to be differentiated from normal levels, with Y being present in <0.7 µg/g dry mass in 




Figure 5.4. Average Mg (a), Ca (b), and Zn (c) concentration in digested liver and kidney 
samples of rats implanted with femoral pins and cuffs of WZ42 and Ti6Al4V for 8 and 14 weeks 
compared to unoperated control rats. Significant difference * (p <0.05) between Mg 
concentration in kidneys of rats implanted with WZ42 pins for 8 weeks and unoperated control 
rats and between † (p<0.05) between Zn concentrations in kidneys of rats implanted with WZ42 





5.3.3 Histological examination of liver and kidneys 
Liver and kidneys explanted from the Sprague-Dawley rats sacrificed at 8 and 14 weeks were 
processed into pathological sections and stained with hematoxylin and eosin (H&E). Optical 
microscopy images (Figure 5.5 for kidney and Figure 5.6 for liver) revealed that the cellular 
structure of the liver and kidney did not undergo morphological changes or infiltration by 





Figure 5.5. Photomicrographs of H&E stained kidneys of rats with femurs fixed by pins of 
WZ42 (a, c) and Ti6Al4V (b, d) after 8 weeks (a, b) and 16 weeks (c, d). Stained images of 
kidneys from rats with implanted wire cuffs of WZ42 (e) and Ti6Al4V (f) wrapped around bone 
for 14 weeks. Photomicrograph g) from rat that was left unoperated. Scale bar = 50 µm. 
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Figure 5.6. Photomicrographs of H&E stained livers of rats with femurs fixed by pins of WZ42 
(a, c) and Ti6Al4V (b, d) after 8 weeks (a, b) and 16 weeks (c, d). Stained images of livers from 
rats implanted with wire cuffs of WZ42 (e) and Ti6Al4V (f) wrapped around bone for 14 weeks. 
Photomicrograph g) from rat that was left unoperated. Scale bar = 50 µm. 
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5.3.4 In vivo corrosion of Mg-Y-Zn-Ca-Zr alloy pins and morphology of surrounding 
bone 
Example micro-CT slices obtained from the femur-implant complex are shown in Figure 5.7. 
 
 
Figure 5.7. To determine volume of the degrading WZ42 alloy, pins were distinguished from 
surrounding bone in micro-CT scans based on density thresholding with representative examples 
highlighted in green after implantation times of a) 2 weeks, b) 8 weeks, c) 14 weeks. Cuffs were 




After two weeks, the pins had broken as seen in Figure 5.7a. These pin failures occurred 
at the site of the femoral fracture, resulting in malunion. In addition, sites of corrosion appeared 
at junctions where the pins were clamped in collets during machining. Both these two regions 
where the corrosion/failure occurred corresponded with regions of higher stress. Progressive 
degradation throughout the pins was observed at 8 and 14 weeks (Figure 5.7b and c). Regions of 
the pin surrounded by the cortical bone appeared to degrade more slowly. Micro-CT scans of 
intact femurs with WZ42 wire cuffs wrapped around the midsection of the diaphysis (Figure 
5.7d) revealed what appeared to be new bone formation in the region surrounding the degrading 
cuffs, despite the cuffs having completely degraded after 14 weeks indicating the favorable 
response of the implanted Mg alloys. 
Following segmentation of the remaining WZ42 pins from the surrounding degraded 
product and bone, a 3D reconstruction of the pins was created from which the volume was 
calculated. This remaining volume was used to calculate the corrosion rate at the end of 2, 8, and 
14 weeks as shown in Figure 5.8.  
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Figure 5.8. Corrosion rate and % volume remaining of WZ42 pins implanted in rat femurs for 2, 
8, and 14 weeks. n ≥ 2 for each group at each time point. * and † represent significant difference 
(p < 0.05) compared to measurements made at other time points. 
 
Degradation was found to occur more rapid initially at 2 weeks, after which the corrosion 
appeared to have reduced and stabilized as seen by the lower corrosion rates perceived at 8 and 
14 weeks. This may be related to passivation of the WZ42 alloy and callus formation limiting 
fluid exposure to the degrading alloy after early stages of bone healing. 
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5.3.5 Local tissue response to Mg-Y-Zn-Ca-Zr alloy pin  
Femur explants were collected after 2, 8, and 14 weeks to assess the local tissue response to the 
WZ42 pins and cuffs and observe any fracture healing. Sections of the bone from femurs 
containing the pins were stained using Goldner’s Trichrome and are shown in Figure 5.9. 
 After 2 weeks in rats implanted with the WZ42 alloy, empty pockets were observed over 
the fracture site in the fibrous tissue over the bone. This was likely due to accumulation of 
hydrogen gas forming gas pockets (GP) from the degrading magnesium alloy, as this is not 
observed in the Ti6Al4V pins. The presence of osteoids (Od) was observed surrounding the bone 
with fibrous tissue (Ft) surrounding the fracture site indicated by the dashed line demarcating the 
implant-bone interface. After 8 weeks, the gas pocket over the fracture site was not perceived to 
be as prominent, potentially due to a slowing of the corrosion rate, dissipation of gas, and 
ingrowth of fibrous tissue. A greater presence of osteoids as well as new bone formation (Nb) in 
the periosteal region was observed progressively after 8 and 14 weeks. After 14 weeks, the 






Figure 5.9. Photomicrographs of Goldner’s Trichrome stained sections (40x) of soft and hard 
tissue at the defect site fixed by pins of WZ42 magnesium alloy (a, c, e) and Ti6Al4V (b, d, f) 
after 2 weeks (a, b), 8 weeks (c, d), and 14 weeks (e, f) of implantation; g) representation of 
region of interest imaged along longitudinal plane at defect site. Cytoplasm, fibrin, muscle, and 
osteoids are represented in red; collagen and bone are represented in green. The dashed line 
approximates the implant pin-bone interface. 




 Alkaline phosphatase staining was conducted to indicate osteoblast activity and the 
process of new bone formation in the region surrounding the defect. Osteoblast activity was 
more prolific surrounding the fracture in the femurs containing WZ42 (Figure 5.10a, c, e) 
compared to the femurs containing Ti6Al4V (Figure 5.10b, d, f). Presence of osteoblasts 
appeared to peak at 8 weeks for the WZ42 group.  
 
 
Figure 5.10. Photomicrographs of the localization of ALP at 40x and 100x (inset) of tissue at the 
defect site fixed by pins of WZ42 magnesium alloy (a, c, e) and Ti6Al4V (b, d, f) after 2 weeks 
(a, b), 8 weeks (c, d), and 14 weeks (e, f) of implantation. Scale bar = 200 µm in 40x images, 
100 µm in 100x. Pin located on left side of image in all. 
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In Goldner’s Trichrome stained sections of tissue near the site of wire cuff implantation 
(Figure 5.11), new bone as seen in light blue-green as well as fibrous tissue was found in the 
region surrounding the Mg alloy cuff implant (Figure 5.11a). On the other hand, new bone 
formation was not seen around the inert Ti6Al4V cuff (Figure 5.11b). 
 
 
Figure 5.11. Photomicrographs of Goldner’s Trichrome stained sections (40x) of soft and 
hard tissue at the implant-bone interface where wire cuffs of WZ42 magnesium alloy (a) and 
Ti6Al4V (b) were wrapped around bone for 14 weeks of implantation. c) Representation of 
region of interest imaged along longitudinal plane at defect site. Cytoplasm, fibrin, muscle, and 
osteoids are represented in red; collagen and bone are represented in green. The dashed line 
approximates the location of the WZ42 wire. 




In this specific aim, the effects of the WZ42 magnesium alloy in terms of biocompatibility and 
systemic toxicity, degradation behavior, and local tissue response and healing was investigated. 
This animal model, a closed femoral fracture stabilized by an intramedullary pin, has been 
characterized by various groups studying the expression of genes for bone and cartilage matrix 
constituents [209] and growth factors [210], the production of cytokines [211], cell proliferation 
and apoptosis [212, 213], and to compare metals for bone healing and mineralization by 
permanent metals [214]. Despite these instances of stainless steel and Ni-Ti alloys being used to 
fix full osteotomies in rats, such an aggressive model representing a manifestation of large 
dynamic stress that favors corrosion had not been tested with magnesium alloys. In fact, no 
models of full load-bearing had been applied to a fracture fixation device manufactured from 
magnesium to date. It was also the intent to confirm the safety of Mg in this aggressive model 
and analyze the degradation behavior as a result of the high stress being placed on the Mg pins. 
 To assess the safety of the WZ42 implants, biochemical analysis of the blood and serum 
was also conducted. The lower than expected platelet levels for the WZ42 and Ti6Al4V pin 
groups at 14 weeks and WZ42 wire cuff group also at 14 weeks was likely due to platelet 
clumping in samples, which was reported in many samples analyzed.  The elevated levels of 
white blood cells 2 weeks after surgeries for both WZ42 as well as Ti alloys represents a 
common indication of normal inflammation seen after surgical procedures are performed [215]. 
Blood cell counts measured at later time points saw the white blood cell count return to normal 
levels, suggesting that signs of any immediate infection or a long-term inflammatory response 
was not present. The consistent electrolyte levels as measured in blood and the stable Mg 
concentration measured in the digested kidney and liver signifies that the degradation of WZ42 
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did not cause disturbances in the balance of electrolytes necessary for the body’s normal 
function. Other studies have similarly found that blood biochemistry and liver and kidney 
function were not affected by magnesium alloy degradation when implanted in bone, indicating 
the general safety of degradation Mg alloys [216-218]. Variability observed in the blood testing 
was expected from animal to animal, with additional error stemming from differences in blood 
sample quality such as hemolysis, clotting, and lipemia.  
 Along with the unaltered serum biochemical parameters suggesting that liver and kidney 
functions were not affected by the WZ42 alloy degradation, concentrations of Mg, Ca, and Zn 
(elements contained in the WZ42 alloy) in the liver and kidney did not rise above levels 
measured in unoperated rats (Figure 5.4) with Y and Zr too low to be differentiated from 
baseline levels. Concentrations were also consistent with rats implanted with Ti6Al4V samples 
compared at the same time points. Expected differences between animals, potentially incomplete 
dissolution of tissue in acid, and deviations in ICP-OES measurements may have resulted in 
variations in ion concentrations within groups. 
To further demonstrate systemic biocompatibility, H&E staining of the liver and kidney 
did not reveal any signs of organ damage. No dark deposits of focal mineralizations, acute 
inflammatory cells, or necrosis were observed in the kidney tissue. In the liver, no aggregates of 
inflammatory cells or features of hepatocellular necrosis such as irregular patchy areas of 
coagulation necrosis were observed. These results clearly suggest that the degradation products 
of the WZ42 alloy have good systemic biocompatibility. Hartwig stated that intake of high 
concentration of Mg ions would not cause adverse reactions due to the high aptitude for the 
excretory system of the kidney and storage buffering capacity from bones to allow the body to 
maintain a balance of serum magnesium [219]. 
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 Progressive degradation was observed in the intramedullary WZ42 pins as seen in the 
reducing cross sectional area of the implants seen in Figure 5.7(a-c), and calculated corrosion 
rate and volume loss shown in Figure 5.8. Degradation appeared to occur preferentially at the 
fracture site, perpendicular to the fracture, where the stresses acting on the implanted pin would 
be perceived to be the highest. This synergy of mechanical loading combined with the corrosive 
environment of surrounding fluids in the body has been shown to cause sudden fracture of 
implants via the well-known stress corrosion cracking (SCC) mechanism [220]. This 
embrittlement phenomenon can occur even when applied stress does not exceed the yield 
strength of the material, reducing the time to fracture and causing premature brittle failure. 
Magnesium, suffering from pitting corrosion, a source from which SCC can develop, has shown 
susceptibility to SCC in chloride solutions and simulated body fluids [220, 221]. Other localized 
regions of corrosion, such as near the end of the pin in Figure 5.7a, occurred due to pre-existing 
flaws imparted during machining, which increased the susceptibility to SCC [222]. Degradation 
at the site of fracture was also promoted by the higher exposure to the surrounding fluid 
electrolyte, acting to produce fluid shear stress and remove local OH- ions to reduce the 
protection from the passivation layer [223, 224]. The reduction in corrosion rate after the initial 2 
week time point occurred as the surface of the Mg implant as expected became passivated and 
enclosed in fibrous tissue and newly formed bone, as observed in other studies of Mg implanted 
into bone [206]. The percentage volume remaining did not significantly change between 2 and 8 
weeks because measurements were taken from different samples at each time point. For the 
implants used to calculate the 8 week measurements, the corrosion rate was lower so that over 
time, the volume remaining ended up the being not significantly different from the samples 
measured after 2 weeks which degraded at a much faster rate. In another sense, the corrosion rate 
 159 
for 8 week samples was approximately one quarter of the 2 week corrosion rate, however, since 
the volume remaining was compounded over four times the length of time, the volume remaining 
ended up being similar. The variation between samples that caused the difference in degradation 
for 2 versus 8 week samples may be due to variability in when the pins failed, or pins not being 
fully surrounded by cortical bone thus being exposed to more surrounding fluid leading to more 
rapid corrosion. 
 The effect of the degrading Mg alloy on the surrounding tissue was investigated via 
Goldner’s Trichrome and ALP staining after 2, 8, and 14 weeks implantation of the WZ42 and 
Ti6Al4V intramedullary pins and extra-cortical cuffs. After 2 weeks in rats implanted with the 
WZ42 alloy (Figure 5.3a, Figure 5.9a), gas pockets (GP) were observed over the fracture site 
forming empty cavities in the surrounding in fibrous tissue. This was likely due to accumulation 
of hydrogen gas from the degrading magnesium alloy, as this is not observed in the Ti6Al4V 
pins. The presence of osteoids (Od) was observed near bone with fibrous tissue (Ft), or callus 
surrounding the fracture site, part of the normal bone healing process. After 8 weeks (Fig. 5.7c), 
the gas pocket over the fracture site was not as prominent, potentially due to slowing of 
corrosion rate, dissipation of gas, and ingrowth of fibrous tissue. A greater presence of osteoids 
as well as new bone formation (Nb) in the periosteal region was observed progressively after 8 
and 14 weeks. After 14 weeks (Figure 5.9e), the fracture was not yet completely healed when 
fixed with either WZ42 or Ti6Al4V pins. The elevated new bone formation seen in the WZ42 
group at 8 and 14 weeks that was further confirmed by ALP staining. Osteoblast activity as 
indicated by ALP staining demonstrated promotion of new bone formation in the region 
surrounding the defect, at the leading edge to heal the fracture. Presence of osteoblasts peaked at 
8 weeks for the WZ42 group with higher activity compared to the Ti6Al4V group. In the case of 
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the wire cuff placed over the cortical bone (Figure 5.11a), new bone formation as seen in blue 
was found in the region surrounding the Mg alloy cuff implant compared to the inert Ti6Al4V. 
Despite the fracture not having healed fully due to the instability of the intramedullary fixation, 
the healing process did not appear to be encumbered. In fact, the prevalence of new bone 
formation as seen in the mineralized new bone and osteoblast activity in regions adjacent to both 
types of Mg alloy implants confirms results of numerous studies reporting enhanced new bone 
formation around Mg-based implants [125, 127, 179] related to the cellular activity of Mg as 
discussed in Specific Aim 3 in Chapter 4 and due to osteoconductivity of the phosphate layer 
forming on the surface of magnesium-based implants [218]. Additionally, the consistent 
observations of a normal healing response of a fibrous capsule enclosing the operation site with 
no abnormal presence of inflammatory cells at the implant site as seen in other reports of Mg 
scaffolds showing good biocompatibility [225] indicated the local biosafety of the Mg alloy.  
 Overall, the positive biocompatibility and signs of healing with new bone formation 
indicate that the WZ42 alloy is a suitable candidate for orthopedic applications. Care must be 
taken however with limiting the mechanical stresses placed on the implant and that a consistent 
finish on the alloy is machined so as to reduce the onset of rapid corrosion and potential failure 
brought on by stress corrosion cracking. The model tested here represented an unusually high 
dynamic stress initiator on the implant site thus loading the femur completely transferring the 
load onto the Mg intramedullary pin leading to a highly aggressive load and corrosion condition 
causing the pins to ultimately fail. This aggressive load model nevertheless showed that despite 
having such an aggressive condition that could be perceived as an extreme event, the local and 
systemic safety of the alloy was still maintained under such high stresses leading to the alloy 
undergoing accelerated corrosion. Despite this release of degradation products, hydrogen gas 
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formation was not externally noticeable and the surrounding tissue response, kidney and liver, 
and blood parameters all remained normal. Thus, with temporary unloading as is required in the 
treatment of orthopedic injuries, the risk of failure of the WZ42 alloy would likely be 
diminished, still rendering the alloy as a promising orthopedic implant material, with possibilities 
in other medical device applications to be explored. In summary, considering the aggressive 
nature of the model providing high stress and accelerated corrosion conditions initially as is 
demonstrated by the results discussed, the fact that bone healing was observed as well as more 
importantly, all the serum and blood pathology profiles being normal combined with the 
histological analyses of the vital organs (liver and kidney) indicates the promise of the particular 
alloy, WZ42 for orthopedic fixation applications. The high strength and the favorable in vitro 
results discussed in aims 2 and 3 further complements the in vivo results discussed herein 
showing the promise of the system for possible exploration of its efficacy in other medical 
device applications. It is of the opinion of the author that semi or non-load bearing environments 
be placed on orthopedic Mg implants to fully demonstrate their safety and efficacy in these 
settings before targeting more demanding applications. Normally, orthopedic injuries are 
immobilized during early treatment, which should help reduce risk of Mg device failure as seen 
in the model here. Already, this pathway of lesser resistance has been observed in the Syntellix 
and K-Met screws used for minimally demanding bone fixation. To take our alloys further, first 




6.0  OVERALL CONCLUSIONS AND FUTURE WORK 
This dissertation has presented a stream of research beginning with the alloy materials design 
and synthesis of Mg-Y-Ca-Zr-based alloys and testing of these alloys to validate the materials 
properties, evaluate their mechanical and corrosion behavior, investigation of their 
cytocompatibility and effects of the degrading Mg alloys on cells in vitro, and finally assess the 
in vivo biocompatibility, degradation, and bone healing response to implants manufactured from 
the Mg-Y-Zn-Zr-Ca alloy showing optimal properties in the previous results. A variety of alloy 
design parameters were modified to achieve the enhanced properties, including the addition of 
varying amounts of yttrium from 0 to 4.0 wt.%, adding Zn, applying the solution heat treatment, 
and hot working of the alloys using hot extrusion at various extrusion ratios. The work presented 
here represents novel alloy materials development for medical devices encompassing the 
selection of the alloy material components and analyzing the desired properties for various 
testing based on FDA, ISO, and ASTM standards adopted for degradable metals, for the ultimate 
goal of vetting the materials for orthopedic implant application, which was tested in the animal 
study. This thorough process described and discussed here can be applied to other degradable 
materials, serving as a basis for materials testing for resorbable orthopedic devices. 
In the first aim, a variety of Mg-based alloys were processed, with the intention to control 
the corrosion rate, improve the mechanical properties, and maintain low toxicity in in vitro and 
in vivo studies. The initial study investigated as-cast and solution heat treated Mg-Y-Ca-Zr alloys 
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containing 1 wt.% and 4 wt.% Y [226] found that higher Y content present in WX41 contributed 
to an increase in grain size, while T4 solution treatment also resulted in grain coarsening. Upon 
applying extrusion to the cast alloys and heat treated alloys, grain size was dramatically reduced 
through the hot working and dynamic recrystallization processes. Despite X-ray diffraction 
showing the presence of single phase magnesium in all the alloys except the LPSO phases 
observed in the as-cast WZ42, secondary phase precipitates containing the alloying elements of 
Y, Ca, Zr, and Zn were present in all alloys at both the grain boundaries and within the grains. 
These precipitates became more dispersed after heat treatment and broken down during 
extrusion. The WZ42 alloy containing Y and Zn also contained the secondary phase Mg12YZn 
intermetallic which yielded enhanced properties as determined in later aims.  
In specific aim 2, the corrosion and mechanical properties of the Mg-based alloys was 
investigated following synthesis in aim 1. Changes in the grain size through extrusion or heat 
treatment appeared to result in more uniform corrosion with the secondary phases being 
dissolved or disrupted to disperse the sites for microgalvanic corrosion as seen in section 3.3.1. 
By increasing the Y content in the Mg-based alloys, a more passive layer was formed as reported 
in first-principle studies on the stability of Y in Mg alloys conducted in the group earlier [139]. 
Strength of the alloys likewise improved with greater Y content in as-cast form, however in 
extruded alloys, addition of Y did not result in significant increase in strength due to the higher 
temperature required for extrusion leading to dynamic recrystallization and grain growth, 
partially negating the grain refining effect of extrusion and precipitation strengthening of the 
secondary phase. With extrusion and the significant grain refinement imparted, drastic 
improvements in strength and elongation however occurred as explained through the Hall-Petch 
relationship [105]. Above all other alloys and the commercial pure Mg and AZ31 materials 
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tested, the WZ42 (Mg-Y-Zn-Zr-Ca) alloy demonstrated significantly higher strength, placing it 
at the upper end of Mg alloys reported in literature, while maintaining a relatively low corrosion 
rate among those tested. 
The results in specific aim 3 elucidated the effects on pre-osteoblasts and human 
mesenchymal stem cells cultured in vitro when directly in contact with the alloys and indirectly 
when in the presence of media containing the degradation products and alloying element chloride 
salts of the alloys discussed previously. High viability of the alloys, especially in extruded state 
was confirmed by MTT and Live/dead assays. The inspiration for the indirect studies drew from 
FDA recommendation of the use of ISO 10993:12 [227] where extract is collected from implant 
materials to expose to cells, as well as reports that diluting the collected extract at least 10x is 
required to [182] to obtain reliable in vitro cytotoxicity results of degradable materials. When 
testing both alloy extracts and the alloying element salts themselves, Mg-Y alloy degradation 
products and Y salts resulted in improved proliferation and higher ALP activity suggesting 
promotion of osteogenic differentiation. The WZ42 alloy in particular allowed for maximum 
proliferation and osteogenic differentiation, which along with the results from specific aim 2 
warranted its selection to be implanted in the animal study of specific aim 4. 
To culminate the transition from materials development to in vivo safety evaluation, the 
WZ42 pins were implanted into the intramedullary cavity of fractured rat femurs and as wires 
wrapped around the midsection of un-altered femurs, comparing the alloy to Ti6Al4V. Rats were 
sacrificed at 2, 8, and 14 weeks with material performance assessed based on 1) systemic toxicity 
analyzed by bloodwork, liver, and kidney histology, degradation product accumulation), 2) 
degradation measured by micro-CT reconstructions of the remaining WZ42 implants, and 3) 
local tissue response evaluated by histopathology of the local bone and surrounding soft tissue. 
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After successful implantation and maintained fracture stability after 1 week as confirmed by X-
ray, it was found that degradation occurred leading to intramedullary pin failure due to perceived 
high stress related corrosion. Micro-CT analysis from 2 weeks onward revealed alloy pin 
degradation and fracture validating the stress corrosion cracking hypothesis initiated at the 
osteotomy site of high mechanical loading. However, the WZ42 alloy was still found to be with 
no recognizable accumulation of Mg or alloying elements in the blood, liver, or kidney, with no 
adverse effects in the blood count, metabolism, or kidney and liver function. Finally, histology of 
the local area at the implant site showed normal fracture healing and new bone formation. No 
abnormal inflammatory response was observed surrounding the implants. 
Overall, the encouraging mechanical, bio-corrosion, and biological properties of the Mg-
Y-Ca-Zn-Zr alloys, especially the WZ42 alloy, are indicative of their potential as viable 
orthopedic and craniofacial implant biomaterials. Future studies can be directed to further 
improve the quality and efficacy of the alloy processing to optimize the phase, composition and 
the microstructure keeping in mind the in vitro assessment showcasing the effects of the various 
alloying elements. This will in turn lead to optimized alloys with likely better mechanical and 
corrosion properties. The new and improved alloys can then be further investigated to explore 
the efficacy of the various alloys in the Mg-Y-Ca-Zn-Zr system in more relevant animal models 
that more accurately reflect the use of these novel class of alloys in various germane and critical 
orthopedic medical devices under low, semi-load as well as load bearing conditions optimally 
targeted to balance the corrosion and mechanical response with the desired biological outcome. 
Research in these directions will certainly help further the current research described herein and 
will promote the ultimate aim of this research study primarily, to optimize Mg alloys for 





NOVEL PROCESSING OF IRON-MANGANESE ALLOY BASED BIOMATERIALS BY 
INKJET 3D PRINTING INKJET 3D PRINTING 
The present work provides an assessment of 3D printed iron-manganese biodegradable scaffolds 
as a bone replacement materials. Iron-based alloys have been investigated due to their high 
strength and ability to slowly corrode. Current fabrications of Fe-based materials generate forms 
which must be machined into their desired form. By using 3D printing, mechanically milled Fe-
30Mn (wt%) powder was directly processed into scaffolds, a technique which generates 
complex, customizable parts from powders. The 3D printed parts maintained an open porosity of 
36.3% and formed a mixed phase alloy of martensitic ε and austenitic γ phases. Electrochemical 
corrosion tests showed that the 3D printed Fe-Mn to corrode significantly more rapidly than pure 
iron. The scaffolds exhibited similar tensile mechanical properties to natural bone which may 
reduce the risk of stress shielding, a harmful outcome of currently used permanent metallic 
biomaterials. Cell viability testing of MC3T3-E1 pre-osteoblast cells seeded directly onto the Fe-
Mn scaffolds using the live/dead assay and with cells cultured in the presence of the degradation 
products of the scaffolds indeed demonstrated good in vitro cytocompatibility compared to tissue 
culture plastic. Cell infiltration into the open pores of the 3D printed scaffolds was also observed. 
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Based on this preliminary study, it was concluded that 3D printed Fe-Mn is a promising material 
for craniofacial biomaterial applications, and represents an opportunity for other biodegradable 
metals to be fabricated using this unique method. 
A.1  INTRODUCTION 
Critical size defects (CSDs) in bone arise when bone loss occurring through trauma, infection, or 
tumor resection exceeds a critical size whereby the injured bone cannot heal itself though 
mechanical fixation [228]. These bone defects result in nonunion fractures, and occur in 5-10% 
cases of traumatic fractures in the U.S. [229]. Treatment of critical size defects has typically been 
accomplished using bone grafting, either autologous or allogenic. Autologous bone grafting 
remains the preferred treatment because it fulfills goals of being osteogenic, osteoinductive, and 
osteoconductive. Due to complications arising from harvesting autologous bone such as donor 
site morbidity and pain, cadaveric bone or allograft bone may be used, though these treatments 
bare the risk for disease transmission that can prove to be fatal. Increasing interest has therefore 
been placed on developing synthetic bone grafts or bone graft substitutes which are relatively 
more abundant than bone grafts and carry reduced risk of disease transmission.  
In order to fabricate synthetic bone scaffolds, three dimensional (3D) porous structures 
have been pursued to allow for bony ingrowth, infiltration of cells and fluids, and to mimic the 
natural cellular structure of bone [230]. Pore distribution, size, and orientation largely influences 
cell bone regeneration and scaffold degradation kinetics [231]. Furthermore, to treat these 
complexly shaped critical size defects in bone, alternative fabrication methods must be used and 
explored that go beyond the realms of conventional manufacturing classes of casting, 
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deformation, machining, and joining. Direct manufacture of porous scaffolds into desired 
geometries address needs of patients whose bone defect is outside the size range of pre-
manufactured implants and allow for improved surgical outcome by providing a custom-fit to the 
anatomical site [5]. Thus, solid free-form fabrication (SFF) approaches have been gaining much 
attention of late, for developing bone scaffolds using powder arranged and consolidated layer-
by-layer to generate 3D structures based on CAD models, which may be obtained from a variety 
of patient imaging modalities such as computed tomography (CT) or magnetic resonance 
imaging (MRI) [232]. SFF techniques such as electron beam melting (EBM) and selective laser 
melting (SLM) have been used to directly fabricate biomedical implants with specific 
microstructures and mechanical properties superior to wrought or cast parts of the same material 
[233]. The benefits of SFF approaches to recycle powder and control properties and design 
contribute to significant cost savings over conventional CNC machining [233]. Among SFF 
methods, the inkjet 3D printing (3DP) provides advantages such as its potential to selectively 
form parts from powder of any material given agglomeration through an appropriate binder 
formulation, as well as its high scalability, and cost efficiency. Developed in the early 1990s at 
MIT [234], this additive manufacturing technique begins with a thin layer of powder being 
spread across build platform using a roller. A printhead moves across the build platform, printing 
a layer of liquid binder selectively onto the layer of powder as defined by the CAD model. The 
roller spreads a new layer of powder on top of printed layer, and the process is repeated until 
each slice of the part has been completed. 3DP has been used to fabricate bone scaffolds from a 
wide range of materials among polymers, ceramics, and composites [235]. Metals, such as 
stainless steel [236], and titanium [237] and have also been fabricated and hold promise 
especially for load bearing applications. The use of a biodegradable metallic powder in 3DP 
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would allow for custom geometry parts to be fabricated with higher strength than attainable by 
polymers, higher ductility than attainable by ceramics, while degrading over time to allow for the 
scaffold to be replaced by new bone. Furthermore, 3DP could allow for control of the porous 
architecture of the printed scaffolds. 
Interest in biodegradable metals has been increasing rapidly in recent years for clinical 
applications in orthopedic implants and cardiovascular stents. In order to provide treatment for 
bone defects, the biodegradable material must provide full mechanical stability upon 
implantation. While new bone formation occurs, the implant material degrades gradually, 
transferring the load to the regenerated bone. Among biodegradable metals, Fe-based alloys 
degrade more slowly and possess better mechanical properties than Mg-based alloys [63], 
holding potential for bone scaffold applications. Iron has been investigated as a biodegradable 
stent, without producing a pronounced inflammatory response or systemic toxicity during an 18 
month period [74]. Fe stents also showed no significant obstruction of the stented vessel, 
however was believed to be infeasible as a biodegradable metal due to its slow corrosion rate 
[60]. 
Several studies have been performed to increase the degradation rate of Fe-based 
materials without compromising their mechanical properties. Alloying Fe [13, 58, 62-64, 66-68] 
and microstructural modification of pure iron have been pursued to accelerate corrosion [70, 71]. 
Among these approaches, powder metallurgy was used to process Fe-Mn alloys [13, 62, 63, 67] 
to generate bulk forms. Although reports have been made on biodegradable metals fabricated 
with a controlled structural topology by casting into a 3D printed template [238], no studies have 
shown biodegradable metals being inkjet 3D printed. In the present study, Fe-30Mn (wt%) 
powder was directly processed into scaffolds using 3DP. Fe-30Mn was one of the recommended 
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alloys by Hermawan et. al. [13] due to its magnetic, mechanical, and corrosion properties  with 
the objective of use as scaffolds for reconstruction of bone defects. For this application, the 
scaffold must fulfill the criteria of filling the complicated 3D defects, providing temporary load 
bearing while the tissue heals, fully degrading after the bone has fully regenerated, and more 
importantly, allowing for perfusion of biofactors [239]. Scaffolds must also find a suitable 
porosity to be dense enough to withstand the necessary loads during tissue regeneration by 
possessing mechanical properties at least equivalent to the native tissue, while be porous enough 
to allow for delivery of biofactors. In addition, the scaffold must allow for uninhibited osteoblast 
cell adhesion throughout the scaffold surface and pores for bone remodeling to occur. The 3D 
printed Fe-Mn biomaterials described in this work were evaluated in terms of these bone scaffold 
criteria by testing in vitro cytocompatibility using direct and indirect pre-osteoblast cell viability 
tests, determining electrochemical corrosion behavior, and measuring tensile mechanical 
properties. 
A.2 MATERIALS AND METHODS 
A.2.1 Materials preparation and characterization 
Elemental powders Fe (Alfa Aesar, Ward Hill, MA, 98%, -325 mesh) and Mn (Alfa Aesar, 
99.3%, -325 mesh) corresponding to Fe-30Mn (wt%) were milled in a P5 planetary mill 
(Fritsche, Idar-Oberstein, Germany) for 30 min. Morphology of the precursor Fe and Mn powder 
and the mixed Fe-30Mn powder was imaged using scanning electron microscopy (SEM, JSM-
6610, JEOL, Tokyo, Japan). The powder nominal compositions, determined by inductively 
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coupled plasma optical emission spectroscopy (ICP-OES, iCAP duo 6500 Thermo Fisher, 
Waltham, MA), are listed in Table A.1 and confirm to the originally measured nominal 
composition. The milled Fe-30Mn powder was 3D printed into parts for testing using an Ex-Lab 
(The ExOne Company LLC, North Huntingdon, PA) machine with a water-based organic binder. 
Parts were printed with a layer thickness of 100 µm. The parts were cured at 230°C for 3 h to 
remove binder and increase green strength to allow unbound powder to be removed using 
compressed air, after which the parts were sintered at 1200°C for 3 h in ultra-high purity N2. 
Parts of dimensions 5 mm x 8 mm x 3 mm (n = 11) were measured before and after sintering to 
determine part shrinkage, with averages and standard deviations reported. Phase analysis of the 
mixed and sintered Fe-30Mn was conducted using X-ray diffraction (XRD) employing an X'pert 
Pro system (Philips, Amsterdam, the Netherlands) equipped with CuKα radiation (λ = 1.5418 Å) 
with a Si-detector (X’celerator) operated at 45 kV and 40 mA. Absolute density of the mixed 
powder and sintered 3DP parts were measured using an AccuPyc II 1340 helium pycnometer 
(Micromeritics, Norcross, GA). Envelope density of sintered 3DP parts was measured using a 
GeoPyc 1360 (Micromeritics). Using these density values, percent open porosity was calculated 
using the following equation: 
Open porosity (%) = (absolute density – envelope density)/absolute density  Eq. 1 
To determine the extent of oxide formation and debinding during the curing and sintering 
process, the oxygen and carbon content of polished sintered samples were measured using LECO 
TC600 and LECO CS600 systems (LECO, St. Joseph, MI) which operate by the inert gas fusion 
thermal conductivity method. 
 173 
A.2.2 Microstructure characterization 
3DP Fe-30Mn samples were mounted in epoxy (EpoxiCure, Buehler), mechanically polished 
(Tegramin-20, Struers, Ballerup, Denmark), and chemically etched in a nital solution (2% HNO3 
in ethanol). The microstructure was observed under an optical microscope (Axiovert 40 MAT, 
Carl Zeiss, Jena, Germany) and SEM (JEOL JSM-6610 and Philips XL-30FEG, Amsterdam, the 
Netherlands) with energy dispersive X-ray (EDX) analyzer attached to the SEM to conduct 
elemental analysis. 
 
Table A.1 Chemical composition with standard deviation of the mixed Fe-30Mn (wt.%) powder 
used for 3D printing. 
Material Chemical composition (wt.%) 
 Fe Mn Ni Si C 
Fe-30Mn 71.221 ± 0.609 28.718 ± 0.611 0.015 ± 0.001 0.046 ± 0.001 >.001 
 
A.2.3 Mechanical properties  
Bar samples were printed, cured, and sintered, followed by machining into standard dogbone 
specimens (gage length 13.5 mm, width 3 mm, thickness 3 mm) along the direction of the inkjet 
printed lines in accordance with ASTM-E8-04 [240]. The uniaxial tensile tests were conducted at 
room temperature at a cross-head speed of 1.3 mm/min using an MTS11 – 50kN electro-
mechanical load frame (MTS, Eden Prairie, MN) equipped with laser extensometer. A tensile 
stress-strain curve was generated from each sample, from which yield strength (YS), ultimate 
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tensile strength (UTS), Young’s modulus (E), and percent elongation (%) were determined. The 
tensile yield strength was determined from the linear portion of the stress-strain curve. An 
average and standard deviation of measurements from 3 samples was reported. 
A.2.4 Electrochemical corrosion test 
Potentiodynamic polarization was used to test corrosion of the 3DP Fe-30Mn alloy (n = 4) 
compared to bulk pieces of pure Iron (Alfa Aesar, 99.97+%). Samples with an exposed surface 
of ~0.5 cm2 were connected to a copper wire lead and mounted in epoxy resin. The mounted 
samples were mechanically polished down to 1 µm, leaving one surface exposed to the 
electrolyte, and were tested immediately and cleaned with isopropyl alcohol before use. Tests 
were carried out on an electrochemical workstation (CH-604A, CH Instruments, Inc., Austin, TX) 
and consisted of stabilization for one hour to reach open circuit potential followed by 
potentiodynamic polarization at a scanning rate of 1 mV/s and potential window of 500 mV 
above and 200 mV below the open circuit potential (OCP). A three electrode cell was employed 
with platinum as the counter electrode, Ag/AgCl as the reference electrode, and the sample as the 
working electrode. To simulate physiological conditions, tests were conducted in pH 7.4 
Hanks‘ Balanced Salts solution (HBSS H1387, Sigma Aldrich, Canada) supplemented with 0.35 
g/l sodium bicarbonate and held at 37.4 °C. The cathodic and anodic portions of the generated 
Tafel plots were fit linearly to allow determination of the total corrosion current, Icorr, at the 
intersection point with the corrosion potential, Ecorr. In curves where the intersection did not 
occur at the corrosion potential, Ecorr, the current where the anodic extrapolation intersected the 
corrosion potential was used to determine Icorr since this would be more indicative of the alloy 
corrosion.  
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Corrosion current density, icorr, was calculated by dividing Icorr by the exposed surface 
area of the specimen. Two values of exposed surface area were used to estimate icorr values. 
Nominal surface area was measured assuming the surface of the polished sample was flat 
without porosity, while true surface area was estimated with inclusion of surface area from open 
porosity. True surface area was approximated first by determining distribution of pore sizes 
using ImageJ (Version 1.46r, National Institutes of Health, Bethesda, MD). 200x magnification 
micrographs of random locations (n = 5) on samples polished to 1 µm were converted to binary 
to distinguish between the pores and matrix. The area of each pore was measured using the 
particle analysis function. Average pore depth was estimated by using the measuring tool of 
ImageJ drawn from the bulk surface to root of the pore in SEM images of random locations 
taken where the sample edge meets the surface (n = 8). Pores were approximated as cylinders 
and surface area of pores was extrapolated from the 500 µm × 375 µm window of the 200x 
micrograph to the entire nominal surface area. 
From the icorr value, corrosion rate (CR) utilizing nominal and true surface area was 
estimated according to calculations from ASTM G102-89 [241]: 
𝐶𝐶𝐶𝐶 = 𝐾𝐾 𝑖𝑖𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
𝜌𝜌
𝐸𝐸𝐸𝐸     Eq. 2 
where CR has units of mm per year (mmpy), K = constant, (3.27 × 10-3 mm g/µA cm yr), 
icorr = corrosion current density, ρ = density (g/cm3), and EW = equivalent weight (g/eq). 
Equivalent weight was calculated based on the oxidation reaction of Fe and Mn to form Fe2+ and 
Mn2+. For pure Fe, EW = 27.92 g/eq, for Fe-30Mn, EW = 27.78 g/eq. As measured absolute 
density values were used. Samples were rinsed with ethanol and air dried, and subsequently 
characterized using optical microscopy, SEM, and EDX to assess the formation and composition 
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of the corrosion products. Corrosion products were removed by brief immersion in a solution of 
1000 ml HCl, 20 g Sb2O3, 50 g SnCl2, and surface morphology was again captured using SEM. 
A.2.5 Indirect cytotoxicity test  
3DP Fe-30Mn samples (n=5) were barrel finished in a mass finishing unit (Denta2000, Howard 
Lake, MN), ultrasonically cleaned in isopropyl alcohol, air dried, and sterilized by ultraviolet 
radiation for 1 h. The specimens were incubated in modified Eagle’s medium alpha (αMEM) 
supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 μg/ml 
streptomycin at a sample weight to extraction medium ratio was 0.2 g/ml in accordance with the 
EN ISO standard 10933:12, and incubated at 37 °C in a humidified atmosphere with 5% CO2 for 
72 h. The extract was collected, with less concentrated extracts prepared by diluting the 100% 
extract into 50%, 25%, and 10% extract solutions. Extracts were sterile filtered using 0.2 μm 
syringe filter before being added to cells. Fe and Mn concentration contained in the extract 
solutions was measured using ICP-OES. The samples immersed in αMEM were rinsed with 
ethanol, dried, and subsequently characterized using SEM and EDX to assess the formation of 
corrosion products. 
The murine osteoblastic cell line (MC3T3-E1, American Type Culture Collection, 
Rockville, MD) used in in vitro cell cytotoxicity experiments was cultured in modified Eagle’s 
medium alpha (αMEM), 10% fetal bovine serum, 100 U/ml penicillin and 100 μg/ml 
streptomycin at 37°C in a humidified atmosphere with 5% CO2. The cells were seeded in 96-well 
cell culture plates at 6 x 103 cells/200 μl culture medium and incubated for 24 h to attach before 
adding the extraction medium. Fresh culture medium without extract served as the negative 
control while 10% DMSO in culture medium served as the positive control. The medium was 
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then replaced with 200 μl of extraction medium at 100%, 50%, 25%, and 10% extract 
concentrations and incubated under cell culture conditions for 1 and 3 days, after which the 
extracts were removed and replaced with fresh media. The MTT assay was performed to assess 
the cytotoxicity of the corrosion extracts according to the Vybrant MTT Cell Proliferation Kit 
(Invitrogen Corporation, Karlsruhe, Germany) by first adding 10 μl of 12mM 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dissolved in phosphate buffer 
solution (PBS, pH = 7.4) to each well. After 4 h of incubation at 37°C, 100 μl formazan 
solubilization solution (SDS-HCl solution) was added to each well and incubated for 12 h. The 
absorbance of the samples was measured using the Synergy 2 Multi-Mode Microplate Reader 
(BioTek Instruments, Winooski, VT) at 570 nm wavelength. The difference of sample 
absorbance and mean positive control absorbance was divided by the absorbance of the mean 
positive control subtracted from the mean negative control to determine percent viability of cells, 
with the negative control standardized as 100% viability. 
A.2.6 Direct cell viability and adhesion test  
To evaluate direct cell viability, MC3T3-E1 cells were cultured directly on 3DP Fe-30Mn 
samples. Cell culture conditions and media composition were the same as in the indirect 
cytotoxicity test. Samples were printed in dimensions of 10 mm x 10 mm x 1 mm, barrel 
finished, ultrasonically cleaned in isopropyl alcohol, air dried, and sterilized by ultraviolet 
radiation for 1 h. 3DP samples were incubated in culture media for 10 min after which cells were 
seeded on the samples at a density of 4 × 104 cells/ml. Viability of the seeded cells was evaluated 
after 1 and 3 days using the LIVE/DEAD Viability/Cytotoxicity Kit (Invitrogen Corporation, 
Karlsruhe, Germany) following the manufacturer‘s protocol. The assay determines the 
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viability/cytotoxicity of cells by differentiating between live and dead cells using fluorescence 
microscopy of two different dyes. Briefly, the 3DP samples with attached MC3T3-E1 cells were 
washed with PBS and stained for 30 min at room temperature in the dark with 2 μmol/L 
ethidium homodimer-1 and 4 μmol/L calcein AM dissolved in PBS. Live and dead cells images 
were then captured using fluorescence microscopy. To fix cells attached to the 3DP samples, 
they were rinsed in PBS, fixed in 2.5% glutaraldehyde solution for 15 minutes at room 
temperature, rinsed 3 times with the PBS, followed by dehydration in a gradient ethanol/PBS 
mixture (30%, 50%, 70%, 90%, 95%, 100%) for about 10 minutes each and dried. Sample 
surfaces with attached cells were then observed by SEM. 
A.2.7 Statistical analysis  
SPSS Statistics 17.0 (SPSS Inc., Chicago, IL) was used to conduct statistical analysis. A t-test 
was used to analyze the difference between the means of Fe-30Mn and Fe corrosion rates, 
whereas the Mann-Whitney U test was used to access difference in corrosion potential due to 
inequality of variance. Statistical significance was defined as P < 0.05. 
A.3 RESULTS 
A.3.1 Phase and microstructure characterization of Fe-Mn powder and 3D printed parts 
Powder morphology of the Fe and Mn precursor powders used in this study as well as the Fe-
30Mn powder after milling for 30 min are shown in Figure A.1. Both Fe and Mn powders were -
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325 mesh, with particle size confirmed as smaller than 44 µm. However, a large variation in 
powder size was observed, with the presence of much finer particles (<10 µm). Particle shape 
also varied significantly with both angular and more spherical particles among the precursor 
powders, while the final mixed Fe-30Mn powder (Figure A.1c) was generally angular in 
morphology. XRD (Figure A.2) show the as-milled powder to consist of α-Fe and α-Mn phases. 
After curing and sintering, the 3D printed parts derived from this milled Fe-30Mn powder 
showed formation of martensitic ε and austenitic γ phases. Sintered parts contained 0.18 wt.% 
carbon and 1.79 wt.% oxygen as measured using inert gas fusion infrared and thermal 





Figure A.1. SEM of powder precursors used to fabricate Fe-30Mn 3DP parts: a) Fe -325 mesh 
powder; b) Mn -325 mesh powder; c) 70 wt.% Fe – 30 wt.% Mn mixed powder. 
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Figure A.2. XRD patterns of Fe-30Mn mixed powder and Fe-30Mn after 3DP, curing, and 
sintering. 
 
Figure A.3 shows examples of the parts printed using the 3D printer using Fe-30Mn 
milled powder. Pores of diameter 1 mm (Figure A.3a) and 500 µm (Figure A.3b) were 
fabricated, demonstrating the potential of the technology to fabricate parts with user-controlled 
pore geometry. However, after curing the parts to remove the binder and improve the green 
strength, it was difficult to remove unbound powder from deep inside the pores without 
damaging the green construct. Figure A.3c and Figure A.3d display the ability of 3D printing to 
produce complex custom shaped designs as exemplified in the printing of the 3 cm long 
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miniaturized human femur. After sintering (Figure A.3c), however, the 3DP part surface is non-
uniform and rough. In order to create a polished, uniform finish and to remove the oxide layers 
formed on the surface, the printed parts were barrel finished after sintering, with the result seen 
in Fig. A.3d. After sintering, the parts encountered shrinkage as expected, due to reduction in 
porosity by repacking, characteristic necking, and inter-atomic diffusion and other sintering 
related phenomena causing reduction in grain boundary area. Rectangular parts encountered 
fairly uniform shrinkage in all three axes: 19.5% ± 0.8% (axis along direction of printed lines), 
18.0% ± 3.7% (axis perpendicular to direction of printed lines), and 21.2% ± 2.5% (axis normal 
to build platform). Density of the 3DP parts after sintering was also measured, with an absolute 
density of the Fe-30Mn 3DP parts as 7.62 g/cm3, while the envelope density was 4.85 g/cm3. 
Since absolute density measures the density of a specimen excluding open porosity while 
envelope density includes open porosity in its measurement, dividing the difference of absolute 
and envelope density by the absolute density gives an estimate of the percentage open porosity. 
Using Eq. 1, the percentage open porosity of the 3DP Fe-30Mn parts was found to be 36.3%, a 
value that can be considered conducive for facilitating cellular infiltration as well as inducing 
corrosion, a facet that is much needed in the Fe-based system as discussed earlier. 
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Figure A.3. Photographs of example parts 3D printed from Fe-30Mn powder after sintering: part 
with square pore sizes of lengths a) 1 mm and b) 500 µm; miniature human femur c) before 
tumble finishing and d) after tumble finishing. 
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Microstructure images are displayed in Figure A. 4, confirming the 3DP parts were not 
fully dense after sintering at 1200 °C for 3 h. The formation of classical necked regions between 
particles separated by grain boundaries was observed, with grain sizes ranging from 5 – 15 µm.. 
SEM and EDX analysis (Figure A. 4c) revealed grain boundaries containing higher Mn content 
compared to the bulk grain, indicating segregation of Mn-rich phases at the grain boundaries. 
The presence of Si in the EDX analysis may be attributed to polishing using SiC papers leaving 
residual SiC particles on the alloy surface. 
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Figure A. 4. Microstructure of Fe-30Mn 3DP parts after sintering imaged using a) optical 
microscopy after polishing; b) SEM without polishing; c) SEM after polishing with EDX 
performed at regions indicated by arrows. 
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A.3.2 Tensile mechanical properties of 3DP Fe-30Mn  
Tensile properties of the 3D printed Fe-30Mn alloy are presented in Table A.2 in comparison 
with sintered and rolled Fe-30Mn, pure iron, and natural bone. Due to the presence of pores, the 
tensile properties of the printed Fe-30Mn alloy were greatly reduced compared to the as-rolled 
Fe-30Mn and iron in terms of the reported values for yield strength, ultimate strength, and 
maximum elongation. However, the measured tensile properties for 3DP Fe-30Mn were very 
similar to those of natural bone:  within the reported ranges of bone for yield and ultimate tensile 
strength, slightly less in terms of elongation, but double the value of Young’s modulus, still very 
much lower than that of iron thus keeping the option for the 3-D printed material to exhibit 
reduced stress shielding when implanted as a metallic implant for orthopedic device applications. 
 
Table A.2. Mechanical properties of 3D printed Fe-30Mn compared to Fe-30Mn produced by 
sintering and rolling, pure Fe, and natural bone. 
Material Tensile properties 






Young’s modulus  
(GPa) 
Fe-30Mn 3DP 106.07 ± 8.13 115.53 ± 1.05 0.73 ± 0.15 32.47 ± 5.05 
Fe-30Mn sintered 
and rolled [13] 
239 ± 13 518 ± 14 19.0 ± 1.4  
Iron [13] 150 210 40 211 
Natural bone [11] 104-121 86.5-151 1-3 14.1-17.3 
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A.3.3 Corrosion behavior of 3DP Fe-30Mn 
Potentiodynamic polarization curves (Tafel plot) of polished 3DP Fe-30Mn and pure iron 
recorded at a scan rate of 1 mV/s in HBSS are shown in Figure A.5 as a representative plot of the 
multiple samples tested. As shown in the plot, corrosion current density, icorr, corrosion potential, 
and corrosion rate were estimated using the Tafel plots and are listed as averages in Table A.3, 
with corrosion current density and corrosion rate reported after calculating using both nominal 
surface area and estimated true surface area, the averages of which are also listed in the table. 
With the estimated true surface area being higher than the nominal surface area as indicated in 
Table A.3, both, the corrosion current and corrosion rates were decreased, accounting for the 
higher surface area exposed to the electrolyte with greater access to microsites of different 
potentials [62]. Even after factoring in open porosity, the corrosion current density and corrosion 
rates were significantly higher for the 3DP Fe-30Mn than pure Fe, while corrosion potentials 
were lower, indicating lower stability in HBSS.  
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Figure A.5. Representative potentiodynamic polarization curves of 3D printed Fe-30Mn 
compared to pure Iron conducted in Hanks‘ Balanced Salts solution at 37 °C. 
 
 Figure A.6 clearly shows the difference between the corroded surface of the 3DP 
Fe-30Mn compared to the relatively uncorroded surface of iron. Optical microscopy showed 
3DP Fe-30Mn (Figure A.6a) displayed red-brownish corrosion products on the surface, whereas 
the iron surface (Figure A.6b) and SEM image of iron (Figure A.6f) remained smooth, with 
scratches from polishing still apparent. EDX performed on various points on the corroded 
surface (Figure A.6d, inset of Figure A.6c) showed distinctive surface morphologies. Granular 
corrosion deposits rich in O and C, and also containing Na, as well as Cl, needle-like corrosion 
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products also rich in O and C as well as P and Cl were observed on the surface. Finally, most of 
the surface appeared to be blanketed by a cracked layer again rich in C and O with Na, Si, P, Cl, 
and Ca, on top of which the other corrosion products were observed. After removing the 
corrosion products as seen in the SEM micrograph of Figure A.6e, some areas of the surface 
appeared to have undergone corrosion while other areas appeared relatively un-corroded, 




Figure A.6. Optical microscopy (a & b) and SEM images (c-f) showing surface morphologies of 
a, c, d) 3D printed Fe-30Mn with EDX analysis after potentiodynamic polarization tests and e) 







Table A.3. Electrochemical corrosion measurements conducted in Hanks‘ Balanced Salts 
solution at 37 °C of 3D printed Fe-30Mn and pure Fe: corrosion potential, corrosion current 
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5.61 ± 2.54 0.065 ± 
0.030 
5.61 ± 2.54 0.065 ± 
0.030 
 
A.3.4 In vitro cytotoxicity of 3DP Fe-30Mn 
Figure A.7 plots the indirect cytotoxicity results of 3DP Fe-30Mn corrosion extracts on MC3T3 
cells cultured for 1 and 3 days using the MTT assay. After 1 day exposure to the corrosion 
extract, cells exhibited increasing viability with lower concentration of corrosion extract, 
indicating some cytotoxicity of the degradation products on the MC3T3 cells. After 3 days 
exposure to the corrosion extract, the MC3T3 cells displayed increased cell viability (>80% 
compared to the control of cell culture media without corrosion extract). Similar to results of 1 
day culture, cells after 3 days culture showed higher viability with lower extract concentration. 
The collected extract solutions contained an average concentration of 13.43 ± 2.33 ppm Mn and 
1.47 ± 0.30 ppm Fe after the 3 day incubation sample incubation period. After this immersion 
time in media, the samples were imaged using SEM (Figure A.8) to display again the effects of 
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corrosion on the alloy surface. Once again, corrosion products had formed, containing high 
amounts of C and O, with varying amounts of N, Na, and Cl. Pit formation was also observed 
with additional cracked corrosion deposits on the surrounding surface. Nonetheless, the surface 
of the samples appeared to have undergone relatively little corrosion and negligible weight loss 
after 3 days of immersion compared to the 3D printed alloy subjected to electrochemical 
corrosion.  
 
Figure A.7. Cytotoxicity of MC3T3 cells cultured for 1 and 3 days in extract media from 3D 
printed Fe-30Mn immersed in αMEM cell culture media supplemented with 10% FBS and 100 




Figure A.8. SEM image and EDX analysis of 3D printed Fe-30Mn sample after 3 days 
immersion in αMEM cell culture media supplemented with 10% FBS and 100 U/ml penicillin, 
and 100 μg/ml streptomycin. 
 
Fluorescence microscopy from the live/dead assay (Figure A.9) shows similar live 
MC3T3 cell (green) attachment, with very few dead (red) cells, on the surface of sintered 3DP 
Fe-30Mn (Figure A.9a) after one day compared to the tissue culture plastic control (Figure 
A.9b). After 3 days culture, 3DP Fe-30Mn again displayed high live cell attachment comparable 
to tissue culture plastic, with a higher cell density than day 1. SEM images of MC3T3 cells 
attached on the surface of the 3DP Fe-30Mn scaffold (Figure A.10) confirmed the live/dead 
assay results with high attached cell density not only on the surface, but also infiltrating within 
pores of the 3D printed parts. Again, SEM images of cells attached after 3 days culture (Figure 
A.10c & Figure A.10d) showed higher cell density compared to images of day 1 culture (Figure 
A.10a & Figure A.10b). The MC3T3 cells appeared to have formed cell–cell junctions (white 
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arrow in Figure A.10b) and developed cytoplasmic extensions on the substrate as well as 
bridging pore walls (black arrows in Figure A.10b & Figure A.10d). The high live cell coverage 
suggests good in vitro cytocompatibility of the sintered 3DP Fe-30Mn. 
 
 
Figure A.9. Fluorescent images from the live/dead assay of live (green) and dead (red) MC3T3 





Figure A.10. SEM images of MC3T3 cells on the surface of 3DP Fe-30Mn after 1 and 3 days of 
culturing at a & c) 250x and b & d) 750x magnification. White arrow denotes cell-cell junction; 
black arrows denote cellular extensions to pore walls. 
A.4 DISCUSSION 
This preliminary study was aimed to investigate the feasibility of three dimensional inkjet 
printing biodegradable metallic Fe-30 wt.% Mn powders for the application of bone scaffolds. 
They were assessed in terms of biocorrosion, tensile mechanical properties, and in vitro 
cytocompatibility. Conclusions drawn from this study will provide the basis for future work to be 
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conducted in this growing field of additive manufacturing that will be focused primarily on 
further improving upon the first generation biodegradable scaffold. 
3D printed parts were generated from mixed Fe and Mn powder and subsequently cured 
and sintered to facilitate particle bonding and part densification. The martensitic ε and austenitic 
γ phases present in the sintered parts are advantageous for medical applications because they 
have antiferromagnetic properties [72, 73] when present in Fe-Mn, thus allowing compatibility 
with magnetic resonance imaging (MRI). In Fe-Mn alloys with more than 23 wt.% Mn, the 
amount of ε decreases with increasing Mn, with more γ phase being present, as has been seen in 
as-cast and powder metallurgy of Fe-Mn alloys containing >28 wt.% Mn [13, 242, 243]. 
Whereas Fe-30Mn alloys produced by sintering and quenching formed a single γ phase [13], the 
3DP alloy formed a mixed phase of γ and ε due to the lack of quenching employed, favoring the 
γ  ε transformation to occur during cooling. The high porosity observed in the 3DP Fe-30Mn 
after sintering may also have acted as free surfaces for stress relaxation which could lower the 
driving force of the γ  ε transformation as suggested for Fe-Mn alloys [13, 244]. 
Despite sintering at 1200 °C for 3 h with the formation of classical necked regions seen 
in Figure A. 4 and encountering ~20% part shrinkage in all directions, the parts still exhibited 
open porosity of 36.3%. Poor packing of powder during the spreading step due to the 
inhomogeneous powder morphology and size may have led to the formation of pores in the 3DP 
parts. The use of spherical powder of more uniform size distribution may improve the flowability 
[245] and allow for improved packing of powder which reduces formation of defects in the final 
product, thus reducing shrinkage by allowing for a more dense green structure [246]. Difficulty 
was encountered in removing the unbound powder after printing, especially from within the 500 
µm pores of the part pictured in Figure A.3b, despite the maximum cavity diameter being over 
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five-fold larger than the average powder size, the limit to powder removal from pores [247]. 
Improvement of powder flowability also makes it easier to remove the loose powder, and thus 
may improve the maximum resolution of the printed parts [11]. 
Structurally, the bone scaffold should possess mechanical properties at least on par with 
natural bone to provide adequate initial strength and stiffness, while degrading to allow bone 
regeneration to restore the defect site’s ability to bear load [248-250]. While the mechanical 
properties of the 3DP Fe-30Mn were significantly lower than reported values for as-rolled Fe-
Mn and pure iron, they were very similar - within one order of magnitude, to natural bone. The 
reduced mechanical properties suggest the studied material may be more appropriate for non-
load bearing applications, such as for craniofacial scaffolds, as opposed to use in high load 
bearing areas such as the long bone. Nonetheless, the measured Young’s modulus of 32.47 GPa 
was only about twice that of natural bone, therefore 3DP Fe-30Mn should possess reduced risk 
for stress shielding compared to other metallic biomaterials of higher stiffness. The relatively 
low tensile properties may be attributed to several factors, the most prevalent being the open 
porosity. Furthermore, Mn segregation at the grain boundary has been argued to cause 
embrittlement in Fe-8wt.%Mn alloy in the absence of N and P [251], which may have occurred 
in this study due to higher Mn content observed in grain boundaries (Figure A. 4c) of the 3DP 
Fe-30Mn alloys. During the high temperature sintering process, oxidation may take place at 
grain boundaries of polycrystalline materials, acting as preferential sites for crack initiation and 
crack propagation [252]. With oxygen levels of 1.79 % remaining in the sintered parts as well as 
high oxygen content observed at the grain boundaries (Figure A. 4c), this oxidation-induced 
embrittlement may have led to low stress failure of the printed Fe-30Mn resulting in lower 
mechanical properties. Future work will attempt to improve mechanical properties by addressing 
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this issue using a reducing atmosphere to limit oxide content in sintered parts and by using 
powder with higher flowability to reduce void space between particles. 
Corrosion parameters (Table A.3) of 3DP Fe-30Mn show a significant increase in 
corrosion current density and corrosion rate compared to pure iron after computation using both 
nominal and estimated true surface area to exclude and include surface porosity in the 
calculation. It should be noted that these are only estimates and not a measure of the actual 
values but nevertheless, still indicate the beneficial accelerated corrosion obtained from the 3DP 
Fe-30Mn alloy compared to pure Fe. These rough estimates of surface pore area in this work 
may be improved upon to provide more accurate assessments of corrosion by a more rigorous 
analysis which will be part of future work. The 3DP Fe-30Mn alloy contained a bi-phasic 
composition of γ and ε phases, accelerating the corrosion through micro-galvanic sites compared 
to single phase iron or single phase Fe-Mn alloys [13]. Segregation of Mn at grain boundaries as 
seen in Figure A. 4c may have also contributed to micro-galvanic corrosion with Mn corroding 
preferentially, leading to higher Mn content (13.43 ppm Mn vs. 1.47 ppm Fe) leaching into 
solution after 3 days immersion in cell culture media. The corrosion potential of Fe-30Mn was 
lower than pure iron due to the formation in high-manganese alloys of unstable manganese oxide 
which has a low passivity coefficient, thus reducing its corrosion resistance [253]. 
The corroded surface of the 3DP Fe-30Mn alloy shown in Figure A.6 confirms its higher 
tendency for corrosion over pure iron. Formation of red-brownish and black corrosion layers 
observed in Figure A.6a was believed to be due to released metal ions Fe2+ and Mn2+ from the 
anodic reaction reacting with hydroxyl ions from oxygen depolarization to form insoluble 
hydroxides such as FeO, Fe3O4, and Fe2O3 [64], which coincides with high O measured by EDX 
on the corroded surface seen in Figure A.6d and Figure A.8. Hydrogen depolarization may also 
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occur, reducing hydrogen ions to gaseous hydrogen and causing formation of corrosion pits at 
locations of potential differences where hydrogen ions are absorbed [254]. Hydrogen desorption 
results in cracks in the hydroxide layers observed in Figure A.6d and Figure A.6, also to a slight 
extent in Figure A.10, preventing homogenous coverage of the surface, allowing Cl- ions in 
solution to attack and form metal chlorides with the Fe2+ and Mn2+ ions below the hydroxide 
layer, furthering pit formation [64, 254]. Although these metal chlorides are hydrolyzed by water 
expanding crater size in an autocatalytic reaction [64], corrosion products rich in Cl were still 
detected above the cracked hydroxide layers in Figure A.6d and Figure A.8. Deposition of Ca 
and P on corrosion products seen in Fig. A.6d was also observed in the work reported by 
Hermawan et al. [64], and may lead to formation of hydroxyapatite, the mineral component of 
natural bone. 
Past studies have demonstrated positive biocompatibility and cytocompatibility of Fe and 
Fe-Mn, with iron degradation products shown to be cleared by macrophages without inducing 
local toxic effects [60], and Fe-Mn alloys demonstrating low fibroblast metabolic inhibition [64]. 
The current study also demonstrates the cytocompatibility of Fe-Mn produced using 3D printing 
with in vitro cell viability tests on MC3T3 pre-osteoblast cells. When cells were exposed to the 
degradation products of 3DP Fe-30Mn, high cell viability was demonstrated after 3 days cell 
culture and with <25% extract concentration after 1 day culture (Figure A.7). Higher viability 
after longer cell culture time indicated cell metabolic activity was uninhibited by the corrosion 
products. The reduction in cell viability after 1 day culture at higher extract concentrations was 
likely due to the higher Mn concentration (2.44 × 10-4 M) found in the corrosion extract 
compared to Fe (2.63 × 10-5 M). The half-maximal inhibitory concentration (IC50) of Mn for 
MC3T3 cells was found to be 3.81 × 10-5 M while for Fe the IC50 was 3.28 × 10-4 M [176]. As 
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the corrosion extract concentration for Mn was found to be above its IC50, cell viability when 
exposed to undiluted, 50% extract, and 25% extract concentrations were reduced compared to 
the negative control. Because the measured corrosion extract concentration of Fe was an order of 
magnitude below the IC50 value, Fe was not responsible for the decrease in cell viability. 
Similarly, Mn has been shown to reduce viability of MG63 human osteoblast cells by 50% at a 
concentration of ~1 × 10-4 M [255], also below the measured extract concentration. However, it 
is possible that under in vivo conditions the local concentration would conceivably be lower than 
the IC50 levels or what was measured in vitro due to the dynamic and highly perfused solution 
environment. Direct culture of MC3T3 cells with 3DP Fe-30Mn substrates however did not 
demonstrate reduced cell viability, with high live cell attachment observed using fluorescence 
microscopy after 1 and 3 day culture compared to tissue culture plastic (Figure A.9). The higher 
cell density observed after 3 days culture on 3DP Fe-30Mn implied cell proliferation was not 
inhibited by the Fe-30Mn substrate, local change in pH, or its corrosion products, as observed 
from the indirect MTT experiment after 3 days culture. Porosity is beneficial for bone scaffolds 
to allow for cell proliferation and differentiation throughout the bulk of the material to facilitate 
widespread tissue formation [248], a process which appeared to have begun seen through cell 
proliferation across and into pores observed in the SEM images of glutaraldehyde fixed cells 
(Fig. A.10). The positive cytocompatibility of the printed Fe-Mn was further reinforced by 
observations of healthy elongated and spread morphologies of the adhered cells, suggesting the 
promising nature of these 3D printed custom designed Fe-Mn parts. Further studies are however 
necessary to elucidate in vivo corrosion and the corresponding inflammatory response and 
toxicology of Fe-Mn alloys, as despite past indications of limited local inflammation from pure 
iron implants, migration and accumulation of iron has been observed distant from the location of 
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the implant [256]. In vivo assessments also must determine the effect of porosity on corrosion to 
achieve clinically appropriate degradation and optimal cell infiltration and bone formation 
through the scaffold without compromising temporary mechanical function which occurs with 
increasing porosity [257]. These aspects are planned to be elucidated following animal 
implantation experiments that will be conducted in the near future. 
A.5 CONCLUSIONS 
3D printed Fe-30Mn was sintered to form and γ and ε phases with inter-particle necking 
indicating diffusion induced densification. Despite the presence of high open porosity, the 
printed scaffolds demonstrated mechanical property values very similar to those of natural bone 
and appropriate for low-load bearing applications such as craniofacial scaffolds. Considering the 
slow corrosion rate being the main detriment to pure iron as a candidate biodegradable metal for 
medical implants, the 3DP Fe-30Mn alloy presented an estimated corrosion rate higher than that 
of pure iron, while depositing corrosion products containing bone mineral components Ca and P 
indicating its promise for bone replacement applications. In vitro pre-osteoblast cell viability 
studies also suggested excellent cytocompatibility with pore infiltration of cells in Fe-30Mn 3DP 
parts. The overall results of this preliminary study suggest that 3D printed Fe-Mn may be useful 
for craniofacial biomaterial applications. Further optimization of the materials and methods will 
be attempted to increase the bulk densification and reduce oxidation of the printed scaffolds 
varying the sintering environments while comparing various pore orientations. In vivo corrosion 
rates for biodegradable metals are not easily predicted by in vitro corrosion tests [206], hence 
animal implantation of the printed scaffolds is necessary in order to assess corrosion, bone 
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formation, and local and systemic toxicity. Nevertheless, this being the first reported study on 
fabricating scaffolds of biodegradable metals using 3D inkjet printing based on an extensive 
review and compilation of the literature to date, it is anticipated that 3D inkjet printing will 
emerge as a promising method for fabricating other biodegradable alloy systems for various 




OPTIMIZATION OF T4 SOLUTION TREATMENT CONDITIONS 
Figure B.1 shows the WX41 alloy after T4 solution treatment at 400 °C for 10 h up to 70 h to 
investigate the effects of longer heat treatment at lower temperature. While T4 heat treatment 
had initially been conducted on the WX41 alloy at 525 °C for 6 h, due to grain growth, we 
investigated the effects of heat treatment at a lower temperature while extending the time to still 
promote diffusion of secondary phases. We found that precipitates (white areas) in Figure B.1 
became more dispersed with longer time. We also compared the degradation rate of each T4 heat 
treatment time to determine which was most effective at minimizing corrosion rate, which is 
shown in Figure B.2. Because after 20 h of T4 heat treatment at 400 °C the WX41 alloy resulted 
in the lowest relative corrosion rate while providing some dissolution of secondary phases and 
not increasing grain size, this condition was used for T4 heat treatment for KX11, WK11, 
WK41, and WZ42 alloys prior to extrusion. 
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Figure B.1. Backscattered electron microscopty of WK41 alloy with T4 solution treatment 
applied after casting at 400 °C for 10, 20, 40, and 70 h followed by water quenching. 
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Figure B.2. Corrosion rate of WX41 alloy as-cast and T4 heat treated at 400 °C for 
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